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SUMMARY 
Cellular liquid-liquid phase separation (LLPS) results in the formation of dynamic 
membrane-less granules that play an important role in many biological processes. On a molecular level, 
the clustering of proteins into a confined space results from an indefinite network of intra- and 
intermolecular interactions.  
Here, we introduce and exploit a novel high-throughput bottom-up approach to study 
how the interactions between RNA, the Dcp1:Dcp2 mRNA decapping complex and the scaffolding 
proteins Edc3 and Pdc1 result in LLPS and the formation of processing bodies (P-bodies). We find that 
the LLPS boundaries are close to physiological concentrations upon inclusion of multiple proteins and 
RNA. Within in vitro P-bodies the RNA is protected against endonucleolytic cleavage and the mRNA 
decapping activity is reduced, which argues for a role of P-bodies in temporary mRNA storage.  
Interestingly, the intrinsically disordered region (IDR) in the Edc3 protein emerges as a 
central hub for interactions with both mRNA and mRNA decapping factors. In addition, the Edc3 IDR 
plays a role in the formation of irreversible protein aggregates that are potentially detrimental for 
cellular homeostasis.  
Until now, a detailed structural characterization of the intrinsically heterogeneous LLPS 
process has been challenging. Here, we combine solid- and solution-state NMR spectroscopy to obtain 
atomic-level insights into the assembly and maturation of in vitro P-bodies. Our results reveal that Edc3 
domains exhibit diverse levels of structural organization and dynamics after LLPS. In addition, we find 
that interactions between the different Edc3 domains and between Edc3 and mRNA in solution are 
largely preserved in the condensed protein state, allowing P-bodies to rapidly form and dissociate upon 
small alterations in the cellular environment.  
Additionally, we aim at unraveling the role of the conserved helicase Dhh1 in the 
formation of (in vitro) P-bodies. We found that the LLPS process of Dhh1 contains contributions from 
the RNA, the IDRs at the N- and C-terminal regions and the folded helicase core domains. Based on 
mutants of the enzyme, we identified residues in the C-terminal part of the second helicase core 
domain to be crucial for LLPS of Dhh1. In addition, we found that ATP enhances Dhh1 phase separation, 
even in the absence of RNA. Our results will allow us to conclude to what degree the above interactions 
contribute in a constructive manner to LLPS and, by employing NMR spectroscopic methods, which 
residues are involved in the phase separation process.  
In summary, our work sheds light on both the molecular mechanisms that underlie 
liquid-liquid phase separation and provides clues about how this influences cellular processes.   
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SELECTED ABBREVIATIONS 
ADP/ATP Adenosine di/triphosphate 
CSA Chemical shift anisotropy 
CSP Chemical shift perturbation 
CV Column volume 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
Dcp(S) (Scavenger) Decapping protein 
DDX DEAD-box protein 
Dhh DEAD-box helicase homolog 
Edc Enhancer of decapping 
eIF eukaryotic Initiation Factor 
FUS Fused in Sarcoma 
GDP/GMP Guanosine di/monophosphate 
GST Glutathion-S-transferase 
HEPES 2-(4-(2-Hydroxyethyl)-1-
piperazinyl)- ethanesulfonic acid  
HLM Helical leucine-rich motif 
HMQC Heteronuclear multiple quantum 
coherence 
hn  Heterogeneous nuclear  
HSQC Heteronuclear single quantum 
coherence 
IDR Intrinsically disordered region 
IPTG Isopropyl β-D-1-
thiogalactopyranoside 
ITC Isothermal titration calorimetry 
LLPS Liquid-liquid phase separation 
LSm Like Smith  
MAGIC Methyl assignment by graphing 
inference construct 
MBP Maltose binding protein 
MES 2-(N-morpholino)-ethanesulfonic 
acid 
(ss)NMR (solid-state) Nuclear magnetic 
resonance 
NOE(SY) Nuclear Overhauser effect 
(spectroscopy) 
PAGE Polyacrylamide gel 
electrophoresis 
PABP Poly(A) binding protein 
Pat Protein associated with 
topoisomerase II 
P-body Processing body 
RecA Recombinase A 
(m)RNA (messenger) Ribonucleic acid 
RNP Ribonucleoprotein 
Scd Suppressor of clathrin deficiency 
SDS Sodium dodecylsulfate 
SEC Size exclusion chromatography 
SH Src-homology 
SUMO Small ubiquitin-related modifier 
TEV Tobacco etch virus 
TROSY Transverse relaxation optimized 
spectroscopy 
Xrn  Exoribonuclease 
Amino acids are abbreviated by their one- or 
three-letter code. Nucleobases are 
abbreviated by their one-letter code.  
- 10 - 
 
CHAPTER 1 General Introduction 
1.1 A SHORT VIEW ON THE LIFE OF AN mRNA 
Eukaryotic messenger RNA (mRNA) is transcribed from its DNA template in the 5’ to 3’ 
direction by RNA polymerase II (Pol II) in the nucleus1. Immediately after the first nucleotides emerge 
from the polymerase, the nascent transcript is protected at its 5’ end by a cap structure2–4  
(Figure 1.2 A). Binding of the capping enzyme to the C-terminal domain of Pol II ensures that only Pol 
II transcripts are capped5–7.  
The simplest eukaryotic 5’ cap structure, the so-called cap 0, consists of an N7-methylated 
guanosine (m7G) that is linked to the first transcribed nucleotide via a 5’-5’ triphosphate bridge  
(Figure 1.1)2. This unusual linkage results in a free 3’ OH group at the m7G, which confers stability of 
the nascent transcript against 5’-3’ exonucleases8,9. In higher eukaryotes, additional methylation at the  
2’-O ribose position of the first and second transcribed nucleotide result in cap 1 and cap 2 structures, 
respectively10. Higher methylated cap structures exist for minor RNA species and trypanosomal 
mRNAs10. Notably, Pol II has been shown to accept nicotinamide adenine dinucleotide (NAD) and 
3’-dephospho coenzyme A as non-canonical nucleotides for transcription initiation in vitro11. Recent 
evidence confirms the existence of NAD caps for a subset of yeast mRNAs and underscores the 
potential that also other adenine-containing nucleotide caps could exist12. 
Figure 1.1: Cap structures protect the mRNA from premature 5’-3’ exonucleolytic degradation. The cap 0 is characterized 
by an N7-methylated guanosine that is linked via a triphosphate to the first transcribed nucleotide, while the cap 1 has an 
additional methyl group at the 2’-O ribose position of the first transcribed nucleotide. Higher order cap structures exist for 
minor RNA species and in higher eukaryotes. The cleavage sites of the decapping enzymes DcpS and Dcp2 are indicated. 
Notably, DcpS is inhibited by the Dcp2 decapping product m7GDP. 
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The capped, premature mRNA is further processed by splicing events that remove introns13,14 
and by protecting the 3’ end by polyadenylation (Figure 1.2 A)15. The length of the polyadenosine 
(poly(A)) tail differs among species: in yeast, the poly(A) tails reach lengths of around 50-80 nucleotides 
while in mammals they can be up to 250 nucleotides long16–18. Thereby, long poly(A) tails are usually 
associated with high mRNA stability19. Notably, mRNAs with (not too) short poly(A)-tails can have 
higher translation rates than long-tailed mRNAs20. Replication-dependent histone mRNA is the only 
eukaryotic mRNA species that lacks a poly(A) tail; instead, these histone mRNAs contain a protective 
3’ stemloop structure21.  
The cap and the poly(A) tail are parts of the 5’ and 3’ untranslated regions (UTRs), respectively, 
that flank the protein coding region of a mature mRNA (Figure 1.2 A)22. The UTRs function in the control 
of mRNA maturation, localization, stability, translation efficiency and also plays a role in various 
disease23–27. Stable secondary structures that are found in the UTRs can interfere with translation by 
preventing the ribosome from scanning for the start codon28. Additionally, they provide internal 
ribosome entry sites (IRES)29,30 or serve as binding sites for regulatory proteins31,32. In higher 
eukaryotes, small RNA species like short interfering RNAs (siRNAs) or micro RNAs (miRNAs) can bind 
to the 3’ UTR, which provides an additional level to regulate gene expression33–35. 
  
Figure 1.2: Characteristics of mRNA. (A) Structural features of a mature mRNA. The transcript is protected at its 5’ end by an 
N7-methyl guanosine cap that is linked via a triphosphate to the first transcribed nucleotide. The 3’ end of an mRNA is 
protected by a polyadenosine (poly(A)) tail. The coding region starts with the initiation codon AUG and terminates with one 
of three possible stop codons. The 5’ and 3’ untranslated regions (UTRs) can contain highly structured segments and regulate 
mRNA maturation, translation and degradation. (B)-(D) Schematic representation of closed-loop messenger ribonucleo-
protein (mRNP) complexes during translation initiation (B), decapping by Dcp2 (C) and 5’-3’ degradation by Xrn1 (D). These 
three processes are assumed to be enhanced by bridging the 5’ and 3’ end of the mRNA, which is shown in a simplified manner 
compared to A. Closed-loop structures of translational repressed mRNPs are not shown.  
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The 5’ cap and the 3’ poly(A) tail mediate nuclear export of the mature mRNA36,37. In the 
cytosol, the eukaryotic translation initiation factor (eIF) 4E binds to the m7G cap38, while the poly(A) 
tail is bound by the poly(A) binding protein (PABP1 in human and Pab1 in yeast)39. Both proteins are 
bridged by eIF4G, which leads to a closed-loop structure of the messenger ribonucleoprotein (mRNP) 
complex (Figure 1.2 B)40. The circular closed-loop is associated with efficient translation41–43 and 
protection of the mRNA against decapping and subsequent degradation44. Further, the circularization  
serves as a quality control mechanism to ensure that only properly transcribed and processed mRNAs 
are translated, as a missing cap or poly(A) tail would prohibit circularization30. Notably, closed-loop 
structures are supposed to exist not only for actively translated mRNAs45, but also for repressed 
mRNAs46,47 or during mRNA degradation (Figure 1.2 C and D)48,49.  
1.2 mRNA DEGRADATION IN EUKARYOTES  
Cellular mRNA levels depend on the equilibrium between transcription and mRNA 
degradation. The amount of actively translated mRNA in a cell must be tightly regulated in a 
spatiotemporal manner to allow for adaption to environmental changes and to different stages in cell 
cycle or development. Thus, some mRNA species are turned over rapidly, while others are kept for 
longer periods50. The half-life of mRNAs varies considerably among different species, between minutes 
and a few hours in yeast51 and up to several days in mammals52,53. 
Degradation is the final step in the life of an RNA and provides the last possibility for a cell to 
control gene expression on the RNA level. mRNA degradation not only serves the purpose of routine 
mRNA turnover but also of differential gene expression. Additionally, aberrant transcripts must be 
removed from the cell to prevent their potentially dangerous accumulation. Dedicated quality control 
pathways exist for the degradation of mRNAs that contain premature stop codons (nonsense-
mediated decay, NMD)54, that lack a stop codon (non-stop decay, NSD)55,56 or that are trapped in stalled 
ribosomes (no-go decay, NGD)57,58. Besides these minor surveillance mechanisms two major mRNA 
decay pathways exist, a 5’ to 3’ and a 3’ to 5’ degradation pathway (Figure 1.3)59,60. 
Both pathways rely on the shortening of the poly(A) tail by deadenylation complexes61,62, 
whereby deadenylation is the rate-limiting step in mRNA turnover61. Deadenylation occurs in a biphasic 
manner62, where the Pan2/Pan3 complex trims initially very long poly(A) tails of mature mRNAs63–65, 
while further deadenylation by the CCR4-NOT complex leaves only a few adenines on the mRNA 
(Figure 1.3, top)65–67. In many eukaryotes, a stretch of uridine nucleotides is attached to the oligo(A) 
remnant, which finally marks the mRNA for degradation68–70. 
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Interestingly, the poly(A)-binding protein PABP plays an ambivalent role by not only promoting 
translation, but also by recruiting the deadenylation machinery that finally displaces PABP from the 
mRNA when the poly(A) tail is shortened below a critical length71,72. It was found that poly(A) tails with 
a high occupancy of PABP are deadenylated slowly by Ccr472.  
On the contrary, poly(A) tails free of PABP are rapidly deadenylated by Ccr4 and Caf1, another 
deadenylase of the CCR4-NOT complex72. Remarkably, low PAPB occupancy on the poly(A) tails was 
found to correlate with a high degree of sub-optimal codon usage in the coding region of the mRNA72. 
Moreover, mRNAs with poor codon optimality were reported to be occupied also with Dhh1,  
a DEAD-box RNA helicase involved in translational repression and mRNA degradation73–75. Thus, PABP 
and Dhh1 link codon optimality to mRNA turnover: efficiently translated mRNAs are protected against 
deadenylation and degradation, while slow translation triggers mRNA decay76.  
Figure 1.3: Schematic representation of the two major eukaryotic mRNA degradation pathways. Most mRNAs are turned 
over in a deadenylation-dependent manner. The poly(A) tail is removed in a biphasic process by the Pan2/Pan3 and CCR4-
NOT deadenylation complexes. Subsequently, the deadenylated mRNA is subjected to one of two different decay pathways: 
in 5’-3’ decay, irreversible decapping is followed by exoribonucleolytic degradation, while in 3’-5’ decay the mRNA is first 
degraded from its 3’ end before the short remnants are decapped. The decapping enzymes Dcp2 and DcpS produce m7GDP 
and m7GMP respectively. The cellular fate of the methylated nucleotides is unknown. The monophosphorylated nucleosides 
produced by Xrn1 and exosome activity can be recycled in the cell to transcribe new RNA molecules. 
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1.2.1 3´-5´ decay 
In 3’-5’ decay (Figure 1.3, bottom right), the cytosolic exosome complex degrades 
deadenylated mRNA in a processive, hydrolytic manner into monophosphorylated nucleosides 
(NMPs)77–80. In the cytosol, the exosome is accompanied by the Ski-complex that assists in mRNA 
recruitment and possesses helicase activity80,81. The short mRNA remnants of exosome activity are 
subsequently decapped by the scavenger decapping protein DcpS82–84. Thereby, hydrolysis of the 
triphosphate linkage between the cap structure and the first transcribed nucleotide releases  
N7-methyl GMP (m7GMP) as a product (Figure 1.1)85.  
1.2.2 5´-3´ decay and the mRNA degradation machinery 
In 5’-3’ mRNA decay (Figure 1.3, bottom left), deadenylation-dependent decapping by the 
Dcp1/Dcp2 complex precedes exonucleolytic degradation86. Removal of the cap interferes with 
translation initiation, which usually requires the recognition of the m7G-cap by the eukaryotic initiation 
factor 4E (eIF4E)87,88. As decapping is irreversible, Dcp2 activity inevitably leads to complete 
degradation of the mRNA. It is thus crucial for a cell to tightly regulate decapping factors to prevent 
premature mRNA degradation. Dcp2 hydrolyses the cap structure to release 5’ monophosphorylated 
mRNA and m7GDP89,90, in contrast to m7GMP that is produced by DcpS in 3’-5’ decay (Figure 1.1). 
Subsequently, the decapped mRNA is hydrolyzed to NMPs in a processive manner by the conserved 
exoribonuclease Xrn191–93. Notably, DcpS is inhibited by the Dcp2 decapping product m7GDP, which 
provides a means to down-regulate the 3’-5’ decay pathway if degradation in the 5’-3’ direction is 
highly active94. 
Dcp2 is part of a larger mRNA degradation machinery, whose components increase the low 
intrinsic decapping activity of Dcp295,96. This degradation machinery arises from a plethora of 
protein:RNA and protein:protein interactions. Although individual components of the mRNA 
degradation machinery and their specific interactions are not strictly conserved among different 
species, the basic principles of mRNA decapping and degradation are found to be similar from yeast to 
humans.   
The Dcp1 protein is the main decapping activator and forms a tight complex with Dcp2 in 
yeast97,98. Dcp1 recruits other decapping factors such as the enhancer of decapping 1 (Edc1), Dhh1 
(human DDX6) and Pat1 as well as Xrn199,100. Further, it could be shown that Dcp2 directly interacts 
with the decapping activators Edc3 and Scd6 (human LSm14)101–104. In turn, Edc3 and Scd6 as well as 
Pat1 are bound via conserved peptide motifs by the DEAD-box helicase Dhh1105–108.  
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In yeast, the 5’ cap-recognizing Dcp2 enzyme binds directly to the scaffolding protein Pat149. 
In turn, Pat1 interacts strongly with the LSm1-7 complex that binds at the 3’ end of the mRNA with a 
strong preference for oligo(A) over poly(A) sequences109,110. Thus, the Pat-LSm complex specifically 
recognizes deadenylated mRNA and links deadenylation to decapping48.  
The Dcp2:Pat1:LSm1-7 interaction bridges the 5’ and the 3’ end of the mRNA to form a closed-
loop structure, which is thought to further enhance decapping (Figure 1.2 C)59,111. As Pat1 also binds 
the exoribonuclease Xrn1, Dcp2 can be replaced by Xrn1 after decapping succeeded, thereby 
maintaining the closed-loop structure to facilitate 5’-3’ degradation (Figure 1.2 D)49. In human, the 
scaffolding protein Edc4 adopts the role of yeast Pat1 by mediating the contact between Dcp2 and 
Xrn1112, but leaving the closed-loop mechanism untouched49. 
1.3 LIQUID-LIQUID PHASE SEPARATION 
Given the many interactions between mRNA degradation factors, it is not surprising that they 
were found to co-localize in the cytosol. These foci that are enriched in mRNA degradation factors 
were named processing bodies (P-bodies) and appeared to be membrane-less compartments113,114.  
P-bodies or other cytosolic and nuclear foci are thought to arise from a process referred to as liquid-
liquid phase separation (LLPS)115–117. Over the recent years, LLPS evolved into a widely accepted 
mechanism for subcellular compartmentalization118. Concepts from polymer physics have been used 
and extended to provide the theoretical framework to describe cellular and reconstituted phase 
separation processes involving very heterogeneous biological polymers such as proteins and RNA119. 
The physical properties of phase-separated cellular bodies have first been described for  
P granules, germ line-specific RNPs in Caenorhabditis elegans117. P granules exhibit properties of liquid 
droplets. As such, they are spherical in shape, they fuse, and deform under shear stress117. 
Fluorescence recovery within seconds revealed highly dynamic granule components and a viscosity 
similar to that of glycerol117. Additionally, the surface tension between the P granules and the 
cytoplasm was found to be quite small, which facilitates rapid and reversible dissolution and 
condensation of P granules that is required for proper C. elegans embryo development117. In the last 
years, liquid-like behavior has been demonstrated for a variety of phase separated droplets103,120–124.  
RNP containing cellular foci can be grouped into nuclear and cytosolic granules118,125. The first 
group comprises for example nucleoli126, Cajal bodies127, Para speckles128, Histone locus bodies129, PML 
bodies130 and nuclear pore complexes131, while P-bodies113, stress granules132, germ (P) granules117 and 
Balbiani bodies133 are in the cytosol. Additionally, signaling complexes134–136 and biosynthetic clusters 
such as purinosomes137 can also form by phase separation processes. 
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Cellular phase transitions are a result of supersaturation of proteins and nucleic acids119. In a 
cell, this can be achieved for example by regulating gene expression or the charge state of proteins. 
Indeed, methylation, acetylation and phosphorylation interfere with LLPS120,138–141. Changes in 
temperature do not only influence gene expression but also have direct effects on phase separation, 
as some RNPs undergo phase separation at elevated temperatures while others phase separate in the 
cold142. Additionally, a cell reacts to environmental stress factors such as osmotic or pH shocks with 
phase transitions that result in compartmentalization of specific proteins and RNAs. Besides that,  
in vitro phase separations are influenced directly by changes in salt or proton concentration (pH). 
Three main driving forces for liquid-liquid phase transitions have been determined for 
proteins: (1) interactions within low complexity regions, (2) multivalent interactions involving folded 
domains and (3) protein:RNA interactions118. Thereby, different interaction modes can act 
simultaneously in phase separated droplets to give rise to the high redundancy observed for many 
LLPS processes103,143.  
Low complexity regions are unfolded protein segments with limited compositional diversity 
that are often enriched in glycine, polar, aromatic or charged residues. These intrinsically disordered 
regions (IDRs) are found frequently in proteins undergoing LLPS. Thereby, the IDRs mediate 
intermolecular contacts via charge-charge, cation-π, dipole-dipole and π-π interactions: For example, 
the P granule protein LAF-1 undergoes homotypic phase separation due to interacting clusters of 
positive and negative charges. For the DEAD-box RNA helicase DDX4, phase separation is dependent 
on an overrepresentation of aromatic FG/GF repeats within clusters of positive charge120. Dipole-dipole 
interactions dominate phase separation of prion-like IDRs in LSm4, huntingtin, Whi3 and a set of mRNA 
degradation factors that harbor stretches of poly-glutamine or -asparagine122,144–146. Lastly, proteins 
related to amyotrophic lateral sclerosis (ALS) such as FUS, hnRNPA1 and hnRNPA2 form amyloid-like 
fibrils that are stabilized by ladders of aromatic side chains123,147–149. Along these lines, phenylalanine-
to-serine mutations within the FG-repeat containing nuclear pore protein Nsp1p interfere with the 
formation of hydrogel-like assemblies, highlighting the importance of π-π interactions for cellular 
phase transitions131. Notably, phase separations that involve ionic interactions rely on the clustering of 
charge, while a more equal charge distribution was found to disfavor intermolecular interactions120,143. 
Multivalency is an instrumental aspect of cellular and in vitro reconstituted liquid-liquid phase 
separation. Many phase separations rely on weak but multivalent interactions between the involved 
binding partners. For example, the tripartite system of nephrin, NCK and N-WASP associates via a set 
of multivalent interactions that manifests in phase separation. First, nephrin contains three phospho-
tyrosine sites, which are recognized by the NCK SH2 domain. And second, the three SH3 domains in 
NCK can be bridged by N-WASP that contains six proline-rich motifs (PRMs).  
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The importance of multivalency has also been demonstrated for artificial two-component LLPS 
systems. One such system consists of multiple SH3 and PRM repeats on two separate polypeptide 
chains, where the degree of in vitro phase separation is directly dependent on the number of SH3 and 
PRM modules within the two proteins134. Additionally, (SH3)5 and (PRM)5 proteins were found to co-
localize in liquid-like compartments in living cells, indicating that multivalent interactions are sufficient 
to induce cellular phase transitions134. In another multivalent two-component LLPS system, that has 
been engineered from multiple copies of SUMO and SUMO-interaction motifs (SIMs), phase separation 
and the strength of interaction also scaled with the number of compatible modules150. Other 
multivalent interactions important for physiological LLPS processes are found between the Edc3 LSm 
domain and several helical-leucine rich motifs (HLMs) in Dcp2103 or between multiple RNA-recognition 
motifs (RRMs) in the polypyrimidine tract binding protein (PTB) and UCUCU repeats in RNA134. 
RNA is a key component of many cellular granules125. Interactions between RNA and IDRs of 
several proteins such as FUS, hnRNPA1 or LSm4 have been shown to promote LLPS in vitro151. 
Analogously, mRNA binding to a folded RRM enhances poly(Q)-driven phase separation of 
recombinant Whi3122. In hnRNPA1, RNA-binding to the two RRMs induces phase separation even in 
the absence of the low complexity region123 and in the case of PTB, binding of pyrimidine-rich clusters 
to the four RRMs is essential for LLPS134. Thus, disruption of RNA-binding can result in decreased phase 
separation and cellular foci formation, as has been shown exemplarily for Pat1, where phosphorylation 
of the C-terminus interferes with RNA-binding in vitro and P-body formation in vivo152,153.  
It has been observed frequently that liquid-liquid phase separated proteins and RNPs can 
undergo a second phase transition to a more solid- or gel-like state145,154–156. This second transition, 
also referred to as maturation, can result in the formation of dissolution- and salt-resistant structures 
with non-spherical morphology122,151,157. In some cases, droplet maturation was found to be driven by 
the formation of amyloid-like fibrils that are associated with neurodegenerative disorders such as 
frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS) and disease-related mutants 
often show enhanced fiber formation121,123,148. Notably, in vivo maturation processes can also lead to 
functional instead of pathological states. For example, Balbiani bodies in Xenopus leavis oocytes, yeast 
stress granules or nuclear pore complexes behave more like solids or hydrogels than like 
liquids116,133,158.  
Remarkably, high concentrations of RNA were found to prevent fibrillization and to slow down 
phase transitions in some cases121,122,159, although lower RNA concentrations frequently promote LLPS 
(see above). The RNA-dependent reduction in fiber formation has been linked to the charge screening 
properties of the polyanionic RNA122.  
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Similarly, sub-physiological ATP levels facilitate phase separation of FUS, while physiological 
ATP concentrations between 5 and 10 mM  result in droplet dissolution and frequently in protein 
solubilization and stabilization160–162. The effect of ATP on LLPS has been attributed to its hydrotropic 
properties160. These results hint at cellular mechanisms beyond posttranslational modifications (see 
above), autophagy-mediated clearance163 or ATP-dependent chaperone and Dhh1 activity12,164 to 
control LLPS and RNP homeostasis and to prevent pathological fibrilization.  
In this thesis, I used the conserved decapping factors and P-body components Edc3  
(CHAPTER 2 and CHAPTER 3) and Dhh1 (CHAPTER 4) to study LLPS mechanisms at an atomic level. 
1.4 NMR SPECTROSCOPY 
This chapter contains parts written for a review that I co-authored which has been accepted by 
“Progress in Nuclear Magnetic Resonance Spectroscopy” for publication and which is currently in press. 
Until recently, biomolecular NMR spectroscopy studies of proteins with a molecular weight 
over 40 kDa were challenging and rare. For these systems rapid spin relaxation rates prevented the 
routine recording of high-quality NMR spectra165. Currently, this molecular weight limit of solution-
state NMR spectroscopy has been shifted significantly and numerous reports demonstrated that 
complexes that are (far) over 100 kDa in size are amenable to detailed NMR studies. These advances 
can be ascribed to two important technological advances. On the one hand, sample preparation and 
isotope labeling methods have been established, where partial or complete deuteration has resulted 
in significant decreases in transverse relaxation rates by eliminating 1H-1H dipole-dipole  
coupling166–173. On the other hand, the exploitation of transverse relaxation optimized spectroscopy 
(TROSY) effects174–177 has resulted in additional and significant sensitivity gains in protein NMR 
spectroscopy178,179. These TROSY approaches were initially introduced for 1H,15N-labeled proteins, and 
later adapted to aromatic 1H-13C spin systems180 and 13CH3-labeled methyl groups181. 
1.4.1 The TROSY experiment 
The amide 1H-15N spin system possesses four different energy levels arising from the 
combination of α and β spin states of the 1H and 15N spins. The four energy levels can be described as 
magnetization terms (coherences), which are created by the pulse sequence of an NMR experiment. 
The four coherences each have an individual relaxation rate, whereof some coherences relax 
significantly slower than others due to the destructive interference of different relaxation mechanisms. 
For the amide 1H-15N spin system, transverse relaxation receives strong contributions from dipole-
dipole coupling (DD) and chemical shift anisotropy (CSA).  
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1H-15N DD and 15N CSA where found to interfere destructively for one of the four 1H-15N 
coherences in an heteronuclear single quantum correlation (HSQC) experiment, which leads to slow 
relaxation of this magnetization term176.  
In a traditional 1H-15N HSQC experiment182, all four magnetization terms are mixed, which 
results in an averaged relaxation rate and a relatively broad resonance of medium intensity. Contrarily, 
NMR experiments that exploit the TROSY effect select the slowly relaxing coherence and keep it 
separated from fast relaxing terms throughout the pulse sequence176. Due to its slow relaxation, this 
magnetization term leads to a sharp and intense signal in the spectrum. As only one fourth of the 
equilibrium magnetization is finally used to record the NMR spectrum, TROSY-type experiments are 
preferably applied to large proteins and complexes, where relaxation is a severe issue. For small 
proteins with slow relaxation rates the sensitivity gains due to the TROSY effect do not compensate for 
the loss of three quarters of the initial magnetization.  
In contrast to DD, the CSA for 1H and 15N nuclei in amide groups is dependent on the strength 
of the external magnetic field. For amide groups, optimal cancellation of DD and CSA and thus the most 
efficient TROSY effect was found to occur at field strengths of about 21 T, corresponding to a proton 
Larmor frequency of 900 MHz176,183. Due to the different CSA of 13C and 15N, aromatic CH-groups show 
an optimal TROSY effect at about 14 T (600 MHz proton frequency)180. The largest possible peak 
heights, in contrast to slowest transverse relaxation rates, are obtained with spectrometers operating 
at even higher proton frequencies of 900 MHz for 13C-detected TROSY on aromatic CH-moieties and, 
theoretically, 1.5 GHz for 1H-detected TROSY on amide groups183. Notably, the most powerful NMR 
spectrometers that are currently being developed will operate at a proton frequency of “only” 1.2 GHz.  
1.4.2 Methyl TROSY 
It has turned out that the combination of specialized methyl group labeling schemes and 
application of the methyl TROSY technique is one of the most successful approaches to make solution-
state NMR spectroscopy amenable to assemblies that are far over 200 kDa184. Notably, amide TROSY 
and methyl TROSY rely on different principles as the former is effective on AX spin systems such as 
amide 15N-1H moieties (or aromatic CH-groups), while the latter requires an AX3 spin system as found 
in 13CH3-labeled methyl groups. In contrast to the amide 15N or aromatic 13C chemical shift anisotropy, 
the methyl 13C CSA is very small and can thus not interfere with the large dipole-dipole couplings. 
Instead, proton-carbon and proton-proton dipolar interactions interfere destructively in the isolated 
1H-13C spin system of methyl groups in high molecular weight proteins. As transverse relaxation in 
methyl groups is dominated solely by dipolar interactions, the methyl TROSY effect is independent on 
the magnetic field strength. 
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In methyl groups, the carbon atom is connected to three protons. As each 1H and 13C spin either 
adopts an α or a β spin state, the combination of all possible spin states results in 16 different energy 
levels. The energy levels are connected by 28 fast and slowly relaxing single-quantum proton, single-
quantum carbon and heteronuclear double-/zero-quantum transitions. The group of Lewis Kay could 
show that the fast and slowly relaxing coherences never interconvert in a 1H-13C heteronuclear multiple 
quantum correlation (HMQC) experiment, which thus is an intrinsic TROSY experiment for methyl 
groups in high molecular weight proteins181. 
The 1H-13C HMQC experiment was found to be up to three-times more sensitive for methyl 
groups than the standard 1H-13C HSQC experiment181. In the 1H-13C HSQC pulse sequence, several 90° 
1H pulses interconvert fast and slowly relaxing methyl coherences multiple times, which results in 
broader and weaker signals for large proteins. Contrarily, the application of only a single 90° 1H pulse 
in the 1H-13C HMQC pulse sequence prevents mixing of the differentially relaxing methyl coherences, 
which is essential for the gain in sensitivity. As a result, methyl resonances of large proteins are 
comparably sharp and intense, especially relative to amide resonances of the same protein.  
1.4.3 Methyl labeling 
Methyl groups occur in around one third of the proteinogenic amino acids (alanine, threonine, 
valine, leucine, isoleucine and methionine) and are thus abundant probes to study protein structure, 
function and dynamics. Routine experiments that exploit the methyl TROSY effect are most efficient 
on fully protonated and 13C-labeled methyl groups (13CH3) that are embedded in an otherwise 
uniformly deuterated background181. Deuteration eliminates dipolar interactions with non-methyl 
protons that would lead to additional relaxation mechanisms. However, as 13C has a natural abundance 
of only 1.1 %, methyl TROSY experiments require the enrichment with NMR-active nuclei by either 
providing appropriate isotope sources during protein expression (see below) or by posttranslational 
modifications with isotope-labeled tags185,186.  
During cell-based protein expression in Escherichia coli (E. coli), natural metabolic pathways of 
the expression host are utilized to selectively channel 13CH3-labeled methyl groups into specific 
residues. To that end, isotope labeled amino acids or amino acid precursors are added to the growth 
medium of the cells. To ensure that these labeled compounds only end up in the target sites and are 
not “scrambled” into other amino acids, it might be required to add additional unlabeled 
metabolites187 or to genetically modify the expression host188,189.  
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Most of the commonly applied labeling schemes work well in growth media that are based on 
D2O as a solvent and glucose as the main carbon source. In case other carbon sources such as glycerol 
are used, the dominant cellular metabolic pathways change, which can result in a situation where 
specific precursors are no longer solely used in the corresponding amino acid synthesis pathway. 
Methyl labeling strategies have been developed for Ala-β190,191, Ile-γ2192,193, Ile-δ1165,181,194–196, 
Met-ε197–200 and Thr-γ2188,201–203 methyl groups as well as for the simultaneous labeling of the Leu-δ and 
Val-γ positions194,204–207. To reduce spectral overlap in the crowded region of Leu and Val methyl 
resonances, Leu208 or Val188,189,209 can be labeled separately or stereo-specific labeling of the pro-(S)  
(Leu-δ2 and Val-γ2)210,211 or pro-(R) (Leu-δ1 and Val-γ1)211 methyl groups can be applied.   
  
Figure 1.4: Schematic biosynthetic pathways of the methyl-bearing amino acids (Ala, Ile, Leu, Met, Thr and Val) in E. coli. 
Amino acids and key metabolites, that can be used as precursors for methyl labeling, are depicted with their structural 
formulas. Full arrows indicate one-step reactions, while dashed arrows resemble multiple reactions, double-headed arrows 
indicate reversible reactions. The scrambling pathways of the Ala-β methyl group (red) into leucine, valine and isoleucine-γ2 
and of the Thr-γ2 methyl group (blue) into isoleucine-δ1 are indicated. The methionine methyl group (green) does not 
scramble. The enzymes or enzyme complexes that catalyze the biosynthetic reactions are abbreviated with their EC number 
and gene names. EC 1.1.1.85: 3-isopropylmalate dehydrogenase, EC 1.1.1.86: ketol-acid reductoisomerase (KARI), EC 2.2.1.6: 
aceto-hydroxy-acid synthase (AHAS), EC 2.3.3.13: 2-isopropylmalate synthase, EC 2.6.1.1: aspartate aminotransferase,  
EC 2.6.1.2: glutamate-pyruvate aminotransferase, EC 2.6.1.42: branched-chain amino acid aminotransferase (BCAT),  
EC 2.6.1.57: aromatic-amino-acid transaminase, EC 2.6.1.66: alanine-valine transaminase, EC 2.7.1.39: homoserine kinase,  
EC 4.2.1.9: dihydroxyacid dehydratase, EC 4.2.1.35: 3-isopropylmalate dehydratase, EC 4.2.3.1: threonine synthase,  
EC 4.3.1.19: threonine deaminase. Further information on the biosynthetic pathways can be found online: 
https://www.genome.jp/kegg/  
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Usually, a combination of methyl groups is labeled184,196,200,206,212. Choosing the correct 
precursors and supplements, all possible combinations of methyl-labeling can be achieved. Although 
not done frequently, methyl labeling of all methyl-bearing amino acids (ILVMAT) has been shown203,213. 
In our group, we exploit advanced labeling schemes such as IM-214,215, ILVM- (Damman, Schütz, 
et al., under revision) or ILVMA-labeling96 (Schütz et al., in preparation). We also label subsets of amino 
acids such as IA and IV, if residue-type specific assignments are required, for example as a prerequisite 
for automated assignment algorithms. In the case of IA- and IV-labeling, label scrambling to Leu/Val 
and Leu methyl groups is suppressed by supplementing unlabeled α-ketoisovalerate and  
α-ketoisocaproate, respectively. Whenever feasible, we make use of D2O with a deuteration level of 
less than 100% and of protonated supplements for suppression of label scrambling, without 
compromising the information content of our experiments. This strategy works well for proteins and 
complexes with a molecular weight of up to 100 kDa. However, we frequently observe that methyl-
methyl NOE and protein dynamics experiments such as relaxation dispersion require the highest 
possible level of deuteration.     
In this thesis, I applied ILVM-labeling to the Edc3 YjeF domain (see CHAPTER 3) and ILVMA-
labeling to the helicase core or isolated RecA-like domains of Dhh1 (see CHAPTER 4). For residue-type 
specific assignments of the Dhh1 RecA-like domains, I also used IA-, IV-, IMV- and IMA-labeling (see 
CHAPTER 4).  
1.4.4 Methyl resonance assignment 
The assignment of methyl resonances to specific methyl groups in the protein is a prerequisite 
for the analysis of methyl TROSY NMR data. For methyl groups in large proteins and complexes, this 
process can be time-consuming and challenging, especially when traditional methyl resonance 
assignment strategies that rely on assigned backbone resonances fail.  
Methyl assignment via through-bond correlations  
For small proteins,  it is usually possible to assign the backbone resonances through traditional 
methods216. In case the spectral quality allows, the methyl resonances can subsequently be assigned 
by correlating the methyl chemical shifts with assigned backbone and/or side chain resonances based 
on total correlated spectroscopy (TOCSY) transfer methods. Due to fast signal relaxation processes, 
this assignment approach will fail for larger proteins. We observe that proteins and complexes with a 
molecular weight exceeding 25 kDa require full deuteration and special methyl labeling schemes to 
assign methyl groups in this manner217,218. 
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Significant magnetization losses, that occur during the TOSCY transfer times, can be prevented 
by using a series of correlated spectroscopy (COSY)-type magnetization transfer steps as these ensure 
that magnetization from the methyl groups is solely transferred to one or a few specific backbone 
nuclei219. The complete magnetization transfer via COSY is, however, insensitive due to the large 
number of transfer steps. Thus, more sensitive methyl-detected “out-and-back” experiments have 
been introduced.  
In those experiments, the magnetization is transferred from the methyl groups to side chain 
or carbonyl carbons with known chemical shifts and subsequently back to the methyl protons for 
detection206,220,221.  
The assignment of methionine methyl resonances by 
spectroscopic methods is challenging as the methyl group is an 
isolated spin system that is separated from the other side chain 
atoms by an NMR-inactive sulfur atom. Nevertheless, for low 
molecular weight proteins, small 13C-13C and 1H-13C long-range  
J-couplings have been exploited to link the methyl group to the 
rest of the side chain222. For large proteins (> 20 kDa), this 
strategy will most likely not be of the required efficiency to 
provide any assignment information. 
In this thesis, I initially aimed for an assignment of methyl 
resonances of the Dhh1 RecA-like domains based on through-
bond correlations with backbone amide and side chain Cα and Cβ 
chemical shifts. However, the triple-resonance experiments 
required for the assignment of backbone resonances were of 
insufficient quality to assign methyl groups with this strategy.  
I thus turned to alternative assignment strategies that are 
discussed below. 
Divide-and-conquer 
For most proteins that have a molecular weight over 50 kDa, the assignment of the backbone 
becomes challenging223. This often prevents the assignment of methyl group resonances based on the 
backbone assignment. In the divide-and-conquer approach, a large complex or multi-domain protein 
is dissected into smaller building blocks. In case the fold of the building blocks is preserved in isolation, 
it is possible to transfer the traditionally obtained assignments from the small part onto the larger 
assembly (Figure 1.6).  
Figure 1.5: Methyl resonance assignment 
strategy based on J-couplings. Chemical 
shifts of methyl proton and carbon atoms 
are correlated with assigned backbone or 
side chain chemical shifts. Blue arrows 
indicate magnetization transfer pathways 
from the methyl groups to the backbone 
amide protons for detection. Red arrows 
indicate the flow of magnetization in “out-
and-back” experiments, where magneti-
zation is transferred from the methyl 
protons via the methyl carbon atoms to 
side chain and backbone carbons with 
known chemical shifts and back to the 
methyl protons for detection. 
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This approach has turned out to be useful for symmetric multi-subunit assemblies, in case the 
individual subunits can be prepared in a monomeric form184. Changes in the chemical shifts between 
the monomer and the fully assembled complex are often limited, especially in the core of the protein 
building block. Hence, a straightforward transfer of the assignments from the subunit to the complex 
is possible. In addition, the divide-and-conquer approach has been successfully applied to complexes 
that contain more than one unique subunit224 and to large multi-domain proteins200,214,225,226. 
After the transfer of the resonance assignments from the building block to the large assembly, 
it is required to validate that these are indeed transferred correctly. To that end, additional information 
is required that can, for example, be derived from the comparison of the chemical shifts of additional 
side chain carbon atoms through “out-and-back” J-based experiments (see above), or from NOE based 
experiments (see below). 
In this thesis, the divide-and-conquer approach has been applied to assign the Edc3 YjeF 
methyl resonances in the Edc3 ΔLSm construct, that comprises the IDR and the YjeF-domain (see 
CHAPTER 3), and to assign the ILVMA-methyl resonances of Dhh1 based on methyl resonance 
assignments of the isolated RecA1 and RecA2 domains (see CHAPTER 4).  
Figure 1.6: The divide-and-conquer approach is used to assign multi-domain proteins or multi-subunit complexes.  
(A) Schematic 1H-13C correlation spectrum of a hypothetical protein (black) and of one of its domains in isolation (red). 
Assignments from the isolated domain are easily transferred to the full-length protein due to limited chemical shift 
perturbations. Resonances corresponding to residues that experience a similar chemical environment in the isolated domain 
and in the full-length protein do not show chemical shift perturbations (see for example the resonance of Ile12 in A; Ile12 is 
remote from the domain interface in the full-length protein (B)). However, residues that experience a different chemical 
environment in the isolated domain compared to the full-length protein give rise to resonances that exhibit (small) chemical 
shift perturbations (see for example the Ile234 resonance in A; Ile234 is in the interface of the two domains in the full-length 
protein (B)). (B) Schematic representation of an isolated domain (red), whose assignments are transferred to the hypothetical 
full-length protein (black).  
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Methyl assignment via site-directed mutagenesis 
For very large or challenging protein complexes the assignment strategies mentioned above 
might not be applicable. In addition, in many cases, a full methyl group assignment might not be 
required to address the question at hand. In those cases, a limited or full methyl group assignment can 
be obtained through a mutagenesis approach. In this approach, a methyl-bearing residue of interest is 
mutated into a (closely related) other amino acid, without distorting the fold of the protein. Methyl 
TROSY spectra are subsequently recorded for the wild-type and for the mutant protein227. In the ideal 
case, both spectra are identical apart from one (alanine, methionine, threonine, isoleucine) or two 
(valine, leucine) resonances that are absent in the spectrum of the mutated protein. These 
resonance(s) then correspond to the methyl group(s) of the mutated residue (Figure 1.7). 
In several cases, the mutagenesis approach has proven to be successful for obtaining methyl 
group assignments of large complexes214,215,228,229. In addition, the mutagenesis approach complements 
other assignment strategies, for example those that are based on the divide-and-conquer approach or 
the NOE-based approach for residues with other methyl groups in spatial proximity (see below). In 
practice, this assignment procedure can be complicated in case the introduced mutation results in 
severe chemical shift perturbations (CSPs) of other resonances so that the peak reporting on the 
mutation can no longer be unambiguously identified184. In that case, it might be necessary to include 
a large number of mutations to be able to distinguish between primary and secondary CSPs228. 
Figure 1.7: Methyl group assignment based on a mutagenesis approach. (A) Schematic 1H-13C correlation spectra of the 
hypothetical protein (black) and of a mutant (green), where one Ile residue (Ile345) has been mutated into another amino 
acid X. The Ile345 resonance is thus missing in the spectrum of the mutant protein, while the resonances of all other Ile methyl 
groups superpose well in the wild-type protein (black) and in the mutant (green). An exemption is the Ile234 resonance, which 
experiences a small chemical shift perturbation. This is due to the proximity of Ile234 to the mutation site at position 345 that 
results in a different chemical environment for Ile234 in the wild-type compared to the mutant protein. (B) Schematic 
representation of the hypothetical protein (black), where Ile345 is mutated to another amino acid X (green). 
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Here, I utilized the mutagenesis-driven assignment approach to assign several methyl groups 
in the Edc3 YjeF domain as a prerequisite to apply the methionine scanning methodology (see 1.4.6 
and CHAPTER 3). 
Assignments based on NOEs 
Even for very large complexes, it is possible to obtain methyl-methyl NOE contacts with high 
sensitivity184. Methyl-methyl NOE spectra reveal methyl resonances that are derived from methyl 
groups close in space. This data can be used to validate assignments obtained by the divide-and-
conquer approach through comparison of NOE patterns (Figure 1.8). In case high resolution structural 
information of the complex is available, it is possible to directly compare experimental NOE cross-peak 
patterns with expected, back-calculated NOE patterns. Based on that, assignments of residues that are 
close in space to already assigned residues can be accomplished.  
Experimentally, inter-methyl NOEs are readily obtained with the use of 3D HMQC-NOESY230 or 
4D HMQC-NOESY-HMQC231,232 experiments. Due to the lower dispersion of the proton chemical shifts 
in methyl groups, H-C-H correlations are usually less informative than C-C-H correlations.  
Figure 1.8: Methyl group assignment based on NOEs. (A) Schematic 2D methyl TROSY spectrum of a hypothetical protein 
labeled at the Ile-δ1 methyl groups (left) and three exemplary NOESY “strips” from a C-C-H experiment (right). Dashed lines 
indicate matching resonances in the 2D spectrum and the NOESY strip of Ile234. The NOESY strips show one intense peak for 
the respective Ile-δ1 methyl group and less intense cross-peaks for each Ile-δ1 methyl group that is close in space. Notably, 
the cross-peak intensity decreases with the distance between the methyl groups (r-6 dependence). For example, Ile234 (red, 
left strip) is in close proximity of Ile345 (green; see B and C) and the Ile345 cross-peak is thus quite intense. Compared to 
Ile345, Ile256 (blue) is more distant to Ile234 and its cross-peak is weaker. Above an inter-methyl distance of approximately 
7 Å, NOE cross-peaks are no longer detectable using routine NOESY-experiments (see also panel B). For example, Ile345 shows 
an NOE to Ile234, but not to Ile256 (see A, right NOESY strip). In practice, the NOE transfer between two methyl groups can 
be more efficient in one than in the other direction, giving rise to cross-peaks of different intensity. For example, the cross-
peak of Ile234 to Ile256 is more intense than the cross-peak of Ile256 to Ile234 (compare left and middle NOESY strip in A). 
(B) Schematic drawing of the three Ile side chains discussed above. Black dashed lines indicate observable NOEs, while a gray 
dashed line indicates an inter-methyl distance that is too large to detect NOEs. (C) Schematic representation of the 
hypothetical protein, where the assignment for Ile345, that has been obtained by a mutagenesis approach (see above), can 
be confirmed by an NOE to the proximal Ile234. The dashed ellipse indicates the area that is enlarged in B. 
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The recent development of non-uniform sampling (NUS)-based experiments233,234 allow for the 
relatively fast recording of 4D H-C-C-H correlations that provide unambiguous information on methyl 
resonances that are close in space231,232,235,236. 
Computational methods for methyl assignments 
Automated strategies try to facilitate the tedious processes that accompany the methyl group 
assignment process. These programs use experimental NMR data and a protein structure as input and 
ideally result in a complete and reliable assignment of all methyl group resonances. The programs 
MAP-XS237 and FLAMEnGO238 use a swapping procedure to reach convergence between measured and 
predicted NOEs. Both programs can include additional data such as paramagnetic relaxation 
enhancements (PREs), residual dipolar couplings (RDCs), and pseudo-contact shifts (PCS) as well as 
assignments from mutagenesis or chemical shift predictions. The programs MAGMA239 and MAGIC240 
exploit graph theory to correlate experimental and back-calculated NOE patterns. Software to map 
experimental PRE- or PCS-based data onto known structures have also been introduced241,242. 
In this work, I used the NOE-based MAGIC algorithm for the computational assignment of 
ILVMA methyl resonances in the isolated Dhh1 RecA1 and RecA2 domains (see CHAPTER 4).  
1.4.5 CSP experiments 
The strength of NMR spectroscopy is its ability to pick up the subtle differences in the chemical 
environment of individual spins. Hence, in an NMR spectrum, each spin gives rise to a resonance with 
a characteristic chemical shift. Chemical shift perturbation (CSP) experiments exploit the sensitivity of 
a spin to changes in the chemical environment. CSP experiments are most frequently performed as 2D 
heteronuclear correlation experiments, either on amide (in 1H-15N correlations) or on methyl groups 
(in 1H-13C correlations) as NMR probes. In the latter case, each isotopically labeled methyl group within 
a protein gives rise to a resonance in 1H-13C correlation experiments such as the HMQC experiment 
which exploits the methyl TROSY effect181. Figure 1.9 A schematically shows the resonances of Ile 
methyl groups in a ligand-binding protein. Ligands include but are not limited to ions, small molecules 
such as drugs, metabolites or other proteins.  
In presence of a ligand, the chemical environment of methyl groups in or close to the ligand 
binding site (Figure 1.9 B, e.g. Ile234 and Ile345) changes. This change results in a shift (or perturbation) 
of the respective methyl resonances in the ligand-bound state relative to the ligand-free state of the 
protein (Figure 1.9 A, compare black and magenta spectra).  
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On the contrary, methyl groups remote from the ligand binding site (Figure 1.9 B, e.g. Ile12 or 
Ile89) exhibit the same chemical environment in the ligand-bound and in the ligand-free protein. 
Consequently, the corresponding resonances in both states are the same (Figure 1.9 A, compare black 
and magenta spectra). 
CSP experiments are a versatile tool to study protein:ligand interactions since structural, 
thermodynamic and kinetic aspects of binding can be addressed. First, by comparing protein spectra 
in the absence and presence of a ligand, it is possible to determine if a ligand binds to a protein and in 
case resonance assignments are available, it is also possible to locate the ligand binding site. Second, 
analysis of CSP experiments that were recorded at different ligand concentrations enables the 
extraction of thermodynamic parameters including the ligand affinity (KD). And third, determination of 
association (kon), dissociation (koff) and exchange rates (kex = kon + koff) between the ligand-free and 
ligand-bound state allow insights into the binding kinetics. The exchange rate between the ligand-free 
and the ligand-bound state (kex) as well as the chemical shift difference between these two states (Δω) 
determine the appearance of NMR resonances in a titration experiment. In the fast exchange regime 
(kex >> Δω), a ligand-sensitive resonance progresses with increasing ligand concentration in a linear 
direction from its position in the ligand-free state to its position in the saturated ligand-bound state. 
Notably, only one resonance is observed at every titration step for each ligand-sensing NMR probe.  
Figure 1.9 The principle of chemical shift perturbation (CSP) experiments. (A) Methyl groups in a hypothetical protein give 
rise to distinct resonances in a schematic 1H-13C-correlation spectrum (black) due to the unique chemical environment of each 
methyl group. Resonances of methyl groups that sense ligand binding undergo CSPs in the presence of a ligand (e.g. Ile234 
and Ile345, magenta versus black), while resonances of methyl groups that are outside of the binding interface superpose 
perfectly in the apo (black) and in the ligand-bound state (magenta). (B) Schematic representation of a hypothetical protein, 
where a ligand (magenta shape) binds at an interface that comprises Ile234 and Ile345. All other Ile residues (black dots) are 
outside of the binding pocket. 
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Contrarily, if ligand binding is in slow exchange (kex << Δω), in every titration step two 
resonances per ligand-sensing probe are observed: one corresponds to the ligand-free and the other 
corresponds to the ligand-bound form. The intensities of both resonances then depend on the 
population of both states. Between the extreme cases of slow and fast exchange, intermediate 
exchange regimes show a more complex relation between changes in chemical shift and peak intensity. 
Thus, depending on the exchange regime of a protein:ligand interaction, resonances that report on 
ligand binding in CSP experiments are identified either by a peak shift or by a decrease in peak intensity 
(or a combination of both).  
In this thesis, CSP experiments have been used to map binding sites for the Edc3 YjeF domain, 
RNA and the Dhh1 helicase on the Edc3 IDR (see CHAPTER 2), for the Edc3 IDR on the Edc3 YjeF 
domain (see CHAPTER 3) and to detect Dhh1 residues that are affected by LLPS (see CHAPTER 4). In 
the latter case, the “ligands” are other Dhh1 molecules.  
1.4.6 Methionine scanning 
The above-mentioned CSP experiments to investigate biomolecular interactions via methyl 
TROSY NMR spectroscopy rely on the natural occurrence of methyl-bearing side chains within the 
binding site. However, NMR is “blind” to areas devoid of appropriate probes and interaction surfaces 
may not harbor methyl groups in the quantity and distribution required for a detailed binding site 
mapping. To overcome this bottleneck, Stoffregen et al. proposed the methionine scanning 
approach243, which extends the applicability, information content, and spatial resolution of standard 
methyl CSP experiments.  
Methionine scanning involves the systematic, serial substitution of solvent-exposed residues 
with reporter methionines. This strategy is comparable to alanine-scanning244,245, as it identifies 
functional epitopes via a mutagenesis-driven approach, but is highly advantageous in many ways. Since 
methionine is on average under-represented in proteins246–248, the methionine region in a methyl 
TROSY spectrum is usually only sparsely populated and introduced methionines are instantaneously 
assigned by the appearance of a new resonance (Figure 1.10, bottom panels). Endogeneous methyl 
groups serve as internal probes for proper folding of methionine mutants (M456 in Figure 1.10). In 
addition, methionine labeling provides further advantages: First, the label can be stably incorporated 
during bacterial growth such that no post-translational modification is required. Second, label 
scrambling from methionine to other amino acids is not observed, which results in excellent 
incorporation rates249,250. 
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Third, the high degree of rotational freedom on the long, unbranched methionine side chain 
results in very favorable NMR relaxation properties. This allows for the investigation of high-molecular 
weight complexes, unstable or dilute samples and can be combined with fast pulsing methods249,250. 
And fourth, methionine scanning can be applied to systems which are invisible in traditional HSQC-
based backbone experiments or where backbone assignments are unavailable. 
  
Figure 1.10: Schematic representation of the methionine scanning approach. (A) Top panel: The residue mutated to 
methionine (blue, R369M) is located inside the binding pocket. An endogenous methionine (blue, M456) reports on proper 
folding of the mutant. I234 is used as an internal reference for the ligand binding properties of the mutant protein. Middle 
and bottom panels: overlay of representative regions of 1H-13C correlation spectra in the presence (magenta) and absence 
(black and blue, respectively) of ligand (magenta shape in top panel). Binding of the internal reference is not affected by the 
mutation (middle panel). (B) The methionine mutant (blue, N357M) is located outside the binding pocket (top). No CSPs are 
observed for the introduced methionine (bottom), while the internal reference reports on ligand binding as in the WT protein 
(middle). (C) The methionine mutant (blue, W347M) impairs binding of the ligand (indicated by the transparent magenta 
shape in the top panel). In this case, no CSPs are observed for the resonances corresponding to the methionine mutant 
(bottom panel) and to the internal reference (middle panel).  
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The methionine scanning approach consists of two steps. First, residues of interest are 
mutated to methionine and the new methyl resonance is assigned (Figure 1.10, bottom panels). In a 
second step, the ligand of interest is added to the methionine mutant (Figure 1.10, compare magenta 
with black and blue spectra in middle and bottom panels, respectively). There are three possible 
outcomes of this CSP experiment. First, if CSPs are observed for the reporter methionine, this residue 
is inside the binding pocket (Figure 1.10 A). Second, if the reporter is outside of the interface there are 
no CSPs observed for the mutated methionine probe (Figure 1.10 B). The same is true for the third 
scenario when the mutation hits a “hotspot” residue whose mutation abolishes binding  
(Figure 1.10 C). To differentiate between the latter two options, CSPs of an intrinsic indicator of binding 
are analyzed (Figure 1.10, middle panels). The intrinsic indicator of binding (internal reference) is a 
methyl-bearing residue whose resonance is not perturbed due to the introduced mutation and which 
reports on ligand binding of the protein (I234 in Figure 1.10; see also Figure 1.9). If the methionine 
mutation is outside the binding pocket, the internal reference still shows CSPs upon ligand binding 
(Figure 1.10 B, middle panel), while in case the mutation hits a “hotspot”, disruption of the binding 
interface by the introduced methionine also abrogates CSPs of the internal reference (Figure 1.10 C, 
middle panel)243. 
Applicability of the methionine scanning method was showcased for the interaction of the E3 
ubiquitin ligase Rsp5 HECT-domain with its cognate E2 ubiquitin conjugating enzyme, Ubc4, resulting 
in a 62 kDa complex243. Mutations at 19 positions allowed a detailed binding site mapping, whereby 
five hotspots and eight more residues involved in binding have been identified. Importantly, 
methionine scanning is not restricted to protein:protein interfaces but can be extended to protein:RNA 
interaction and complexes far beyond 100 kDa as has been impressively demonstrated by  
Cvetkovic et al.214 for the archaeal exosome complex, an exoribonuclease that is involved in 3´-5´ mRNA 
decay77,251.  
In this thesis, I applied a slightly modified version of the methionine scanning approach to map 
the binding surface of the Edc3 IDR on the dimeric Edc3 YjeF domain (see CHAPTER 3). 
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1.5 AIMS OF THIS THESIS 
Liquid-liquid phase separation (LLPS) is increasingly recognized as a process involved in the 
cellular organization of proteins and RNA into membrane-less compartments. One of these 
compartments are so-called processing bodies (P-bodies) which are cytosolic foci containing 
translationally repressed mRNA as well as proteins and enzymes involved in mRNA degradation. The 
cellular function of P-bodies is a matter of debate, as some results point to P-bodies as sites for active 
mRNA degradation, while other studies associate them with mRNA storage. In this thesis, I aim at 
elucidating the cellular role of P-bodies by performing enzymatic assays under phase separation and 
non-phase separation conditions. 
In vivo and in vitro LLPS processes are often studied using fluorescence microscopy techniques. 
However, we observe some disadvantages when using light microscopy to study in vitro LLPS of 
proteins involved in P-body formation. We found that light microscopy experiments required high 
amounts of protein and RNA and that they are extremely time-consuming. One aim of this thesis was 
to develop a robust assay that allows for the rapid and reliable analysis of in vitro LLPS. With this assay 
at hand, I analyzed the molecular mechanisms that underly LLPS and the formation of in vitro P-bodies. 
Importantly, I aimed for a more quantitative analysis of the molecular contributions that lead to LLPS 
relative to what is achieved with microscopy-based approaches. 
I focused on the conserved Edc3 and Dhh1 proteins that are tightly embedded in the mRNA 
degradation machinery. Edc3 is a scaffolding protein that interacts with the decapping enzyme Dcp2 
and other decapping factors to undergo phase separation, while Dhh1 is a DEAD-box RNA helicase that 
has been reported to undergo in vitro LLPS in the presence of ATP and RNA. Although both proteins 
are important for P-body formation and some interactions facilitating LLPS of these proteins have been 
described, little is known about the intra- and intermolecular interactions at an atomic level. I aimed 
to shed light on these interactions by employing NMR spectroscopy that enables the detection of 
interactions with atomic resolution.   
Many intrinsically disordered proteins that undergo LLPS are observed to form insoluble 
aggregates over time. These aggregates were found to contain amyloid-like fibers which are associated 
with neurodegenerative diseases. Here, I aim to investigate if Edc3 liquid droplets also undergo a 
second phase transition from a liquid-like to a solid-like state and which interactions mediate this 
maturation process. As structural data on phase-separated proteins that contain folded domains is 
scarce, we aim to reveal structural features of Edc3 after LLPS in collaboration with the group of Marc 
Baldus at Utrecht University (The Netherlands) by combining solid-state NMR spectroscopy with state-
of-the-art labeling schemes and solution-state methyl TROSY NMR techniques. 
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CHAPTER 2 A synergistic network of interactions promotes the  
  formation of in vitro processing bodies and  
  protects mRNA against decapping 
This chapter was published in Nucleic Acids Research252. Large parts of the text and figures are 
thus identical to the published manuscript. Remco Sprangers conceived the project. Experiments were 
designed by all authors. Stefan Schütz and Erik Nöldeke performed molecular cloning, protein 
expression and purification. E.N. established fluorescence microscopy and small scale, high-
throughput liquid-liquid phase separation (LLPS) assays. S.S. and E.N. performed fluorescence 
microscopy experiments and LLPS assays. S.S. prepared samples for NMR spectroscopy and acquired 
NMR data with help from R.S. Isothermal titration calorimetry (ITC), RNA in vitro transcription and 
purification were done by S.S., who also performed RNA protection and decapping assays. All authors 
analyzed and interpreted data. R.S. wrote the paper with contributions from S.S. All authors 
commented on the manuscript. 
2.1  INTRODUCTION 
To facilitate and regulate biological reactions the intracellular space is partitioned into distinct 
compartments253. These compartments can be divided in those that are encapsulated in a lipid 
membrane and those that are devoid of a lipid membrane125,254. Membrane-less compartments, also 
referred to as intracellular bodies or granules, are dynamic cellular sub-structures that arise from a 
spontaneous liquid-liquid phase separation (LLPS) process, which results in a very high local 
concentration of specific components119. Both the nucleus and the cytoplasm of eukaryotic cells 
contain a number of functionally distinct granules, each of them typically harboring tens to hundreds 
of specific proteins and RNA. Examples of nuclear ribonucleoprotein (RNP) bodies include Cajal bodies, 
nucleoli and PML bodies, whereas cytoplasmic RNPs include stress granules, germ granules and 
processing bodies (P-bodies)125. The large number of RNA granules reflects the involvement of these 
assemblies in central cellular processes including mRNA translation, processing, localization, and 
turnover. Membrane-less compartments display a liquid-like behavior, where smaller granules can 
fuse together into larger assemblies116,117,126. The viscosity inside these cellular droplets has been 
determined to be three to six orders of magnitude above that of pure water, which can impact on the 
enzymatic processes taking place inside these foci. Interestingly, it has been shown that functionally 
different RNP granules, like P-bodies and stress granules, share certain components and that these foci 
can fuse or dock together132,255. 
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Several in vivo and in vitro approaches have revealed insights into the molecular details that 
lead to cellular phase transition. Currently, three mechanisms have been shown to be important for 
the self-assembly process. First, intrinsically disordered regions (IDRs) are highly abundant in proteins 
that segregate into cellular foci256. These IDRs are characterized by the lack of tertiary structure and 
are sparse in hydrophobic amino acids. Indeed, interactions between the IDRs in DDX4, have been 
shown to be important for the self-assembly of the protein into germ granules120. In addition, an IDR 
in hnRNPA1 is important for the phase separation of the protein into stress granules123,151, IDRs in  
LAF-1 have been shown to promote P-granule assembly124 and a glutamine/ asparagine-rich domain in 
yeast LSm4 stimulates P-body formation144. The IDRs in these proteins are able to associate into large 
networks due to a combination of charge-charge, cation-pi, dipole-dipole and pi-pi stacking 
interactions119. The distribution of charged residues has been shown to be important for self-assembly, 
where an unequal distribution of charges stimulates intermolecular contacts120,143. Secondly, 
interactions between folded protein domains and short linear motifs in disordered regions are found 
in interaction networks that result in phase separations. Examples include the interactions between 
SH3 domains and proline-rich motifs134 and those between the Edc3 LSm domain and helical leucine-
rich motifs (HLMs) in Dcp2 and Pdc1101,103 (Figure 2.1 A). Finally, interactions between folded RNA 
recognition motifs (RRMs) in granule proteins and RNA stimulate the formation of mRNP granules, 
which has been shown for hnRNPA1123, PTB134 and Whi3122. In addition, non-translating mRNAs have 
been shown to increase the number of cellular P-bodies114. On the other hand, RNA does not 
contribute to the phase separation of the P-granule protein LAF-1124, indicating that RNA is not a 
general component important for RNP formation. Importantly, it has been shown that different 
intermolecular interaction modes can simultaneously take place within phase-separated 
granules103,143, illustrating the high level of redundancy within LLPS processes.  
The integrity of cellular granules is regulated and cellular foci can be disassembled by a number 
of processes, including phosphorylation by the DYRK3 kinase139, the activity of the Hsp70 and Hsp40 
chaperones257, through autophagy and Cdc48/VCP function163 and the activity of the helicase Dhh1164. 
As the cellular environment appears to be close to the phase separation boundary, small perturbations 
to the interaction network that underlies granule formation allow for a rapid formation and 
disassembly of cellular foci. Proteins in cellular foci can undergo further transitions to form fiber-like 
structures. Interestingly, the mechanisms that result in cellular phase transitions and those that are 
important for fibrillization are different123. The formation of fibers appears to be enhanced in cellular 
foci due to the high local protein concentration, which can result in pathological inclusions115,121,151,258. 
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Processing bodies are dynamic cytoplasmic RNP granules that contain proteins that are 
involved in translational repression and mRNA degradation114. The main constituents are mRNA259 and 
the mRNA decay machinery, including the Dcp1:Dcp2 mRNA decapping complex, the enhancer of 
decapping 3 (Edc3), the RNA helicase Dhh1, the Pat-Lsm1-7 complex and the exonuclease 
XrnI89,113,144,260. The composition and the mechanism of assembly of P-bodies varies between different 
organisms, as an example, the protein Pdc1261 plays a central scaffolding role in Schizosaccharomyces 
pombe (S. pombe), but this factor appears to be absent in Saccharomyces cerevisiae (S. cerevisiae). 
Despite the ubiquitous presence of P-bodies in eukaryotes their biological role remains a matter of 
debate. Based on the protein composition, they have been implicated in mRNA decapping and 
degradation. However, mRNA can leave processing bodies to re-engage in translation262, which points 
towards a role of P-bodies in the temporary storage of non-translating mRNAs, e.g. during cellular 
stress conditions.  
Here, we address the cooperative intermolecular interactions in the formation of processing 
bodies and maturation of these foci into a gel-like phase. To that end, we exploit an automated, fast 
and reliable in vitro bottom-up approach103,134 using purified processing body components (Dcp1, 
Dcp2, Pdc1, Edc3, Dhh1 (Ste13) and RNA) and assess their ability to undergo LLPS and subsequent 
formation of gel-like structures. Using mRNA enzymatic assays, we reveal the first insights into the 
activity of the mRNA decapping complex within processing body-like foci that support a role for 
processing bodies in the storage of translationally inactive mRNA. 
2.2  MATERIALS AND METHODS 
2.2.1 Protein expression and purification 
The genes for full-length Pdc1 and Edc3 proteins as well as for the isolated Edc3 LSm and 
YjeF_N domains and for the first RecA-like domain of Ste13 from S. pombe were cloned into modified 
pET vectors that carried an N-terminal TEV-cleavable His6-tag. The genes for the intrinsically disordered 
region (IDR) of Edc3 and the second RecA domain of Ste13 (Dhh1 in S. cerevisiae) were cloned into 
modified pET vectors that carried an N-terminal TEV-cleavable His6-GST- or His6-GB1-tag, respectively. 
Dcp1:Dcp2 complexes were cloned in a modified pET vector, where only the Dcp1 protein carried an 
N-terminal TEV- cleavable His6-tag. Point mutations, insertions and deletions were introduced into the 
genes using standard site-directed mutagenesis methods (Table 2.1).  
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Table 2.1: Protein constructs used in this study 
Protein / complex Residues Purification tag Internal reference 
Edc3 1-454 N-His6-TEV #180 
Edc3 1-71 (LSm) N-His6-TEV #1380 
Edc3 72-194 (IDR) N-His6-GST-TEV #1293 
Edc3 195-454 (YjeF_N) N-His6-TEV #196 
Edc3 1-194 (ΔYjeF_N) N-His6-TEV #244 
Edc3 1-454, Δ72-194 (ΔIDR) N-His6-TEV #1291 
Edc3 72-454 (ΔLSm) N-His6-TEV #1301 
Edc3 72-194, Δ90-110 (IDRΔ1) N-His6-GST-TEV #1514 
Edc3 72-194, Δ158-171 (IDRΔ2) N-His6-GST-TEV #1512 
Edc3 72-194, Δ90-110 + Δ158-171 (IDRΔ12) N-His6-GST-TEV #1516 
Edc3 72-194, F108A (FDK-to-ADK) N-His6-GST-TEV #1688 
Edc3 72-194, F99A, F101A (FDF-to-ADA) N-His6-GST-TEV #1689 
Dcp1:Dcp2 ΔMid 1-127 (Dcp1), 1-741 Δ290-554 (Dcp2) N-His6-TEV on Dcp1 #264 
Pdc1 1-105 (Pdc1) – GST – 880-1076 (Pdc1) N-His6-TEV #928 
Ste13 43-249 (RecA1) N-His6-TEV #183 
Ste13 250-421 (RecA2) N-His6-GB1-TEV #1675 
Chemical competent E. coli BL21 (DE3) Codon Plus RIL (Stratagene) cells were transformed with 
the appropriate plasmid and grown at 37 °C to an OD595 of 0.8 in lysogeny broth (LB) medium, after 
which protein overexpression was induced with 0.5 mM IPTG at 20 °C. After expression overnight, cells 
were pelleted by centrifugation and lysed in buffer A (25 mM sodium phosphate, pH 7.4, 250 mM NaCl, 
1 mM DTT) complemented with 10 mM imidazole, lysozyme, 0.1 % Triton X-100, 5 mM MgCl2 and  
0.2 U/mL DNase I. The cell lysate was cleared from insoluble debris by centrifugation and the 
supernatant was loaded on Ni2+-nitrilotriacetic acid (NTA) resin. The resin was washed with buffer A 
that was complemented with 10 mM imidazole. The protein bound to the resin was eluted with buffer 
A complemented with 300 mM imidazole. 1 mg TEV protease was added to the eluted proteins to 
cleave the purification tag from the target protein. 
Proteins carrying an N-terminal TEV cleavable GST- or GB1-tag were dialyzed overnight at 4 °C 
into buffer B (25 mM HEPES, 50 mM NaCl, 1 mM DTT) supplemented with 0.5 mM EDTA. The dialyzed 
proteins were applied to a HiTrap 5mL SP FF column (GE Healthcare) to separate the protein of interest 
from the cleaved solubility-tags using appropriate gradients from buffer B to buffer C (25 mM HEPES, 
1 M NaCl, 1 mM DTT) over 100 mL. The pH of the ion exchange buffers varied depending on the used 
solubility tag (pH 7.3 for GB1 and pH 8.0 for GST). The buffer of the pooled fractions was exchanged to 
SEC buffer (25 mM HEPES, pH 7.3, 125 mM NaCl, 1 mM DTT) using centrifugal filters.  
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Proteins carrying an N-terminal His6-tag were dialyzed overnight at 4 °C into SEC buffer 
supplemented with 0.5 mM EDTA. Purification to homogeneity was achieved by size exclusion 
chromatography on Superdex 75 or Superdex 200 columns (GE Healthcare) in SEC buffer.  
Labeling of proteins with NMR-active nuclei was achieved by over-expression of the gene in 
M9 minimal medium. The growth medium was supplemented with 0.5 g/L 15NH4Cl as the sole nitrogen 
source and either 2 g/L 1H13C-glucose for resonance assignment purposes or 4 g/L 1H12C-glucose for 
NMR binding experiments.  
2.2.2 Protein fluorescence labeling 
For fluorescence microscopy studies that assess droplet maturation, the Edc3 protein was 
labeled with Oregon Green 488 (OG). Therefore, the protein was prepared in SEC buffer free of any 
reducing agent. A few micro grams of OG-maleimide were dissolved in DMSO and added in a two- to 
three-fold excess to the protein solution. The labeling reaction was allowed to proceed for up to two 
hours at room temperature in the dark. The reaction was stopped by addition of DTT to a final 
concentration of 4 mM. Unreacted dye was removed using a PD10 desalting column (GE Healthcare) 
in SEC buffer. The concentration of the labeled protein was determined photometrically at 280 and 
492 nm, whereby the lower concentration was used for further calculations. The fluorescently labeled 
protein was mixed with non-labeled protein to obtain an appropriate signal-to-noise ratio in the 
fluorescence microscopy experiments. 
2.2.3 RNA in vitro transcription, purification and capping 
RNA was prepared using in vitro transcription with in-house purified T7 polymerase263. The 
DNA template was obtained from one of two different sources (Table 2.2). In the first case, two DNA 
primers were mixed, where the forward primer encodes for the T7 promoter and the reverse primer 
encodes for the desired RNA sequence plus the T7 promoter. In the second case, the DNA template 
was cloned into a vector that coded for the target RNA sequence followed by a 3´ HDV ribozyme that 
cleaves at the end of the target RNA sequence and results in a 3´ cyclic phosphate.  
In vitro transcribed RNA was purified under denaturing conditions at 80 °C using anion 
exchange chromatography with a DNAPac PA100 column (22 x 250 mm, Dionex) (Buffer D: 20 mM Tris, 
pH 8, 5 M urea; Buffer E: as D, supplemented with 2 M NaCl)99,263,264. The target RNA was precipitated 
from the pooled fractions by addition of 0.7 volumes isopropanol and incubation at -20 °C. The 
precipitate was collected by centrifugation, washed with 70 % ethanol and resuspended in water.  
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Complete desalting was achieved using a PD10 column, followed by vacuum concentration to 
obtain pure dry RNA product. RNA was resuspended at concentrations required for subsequent 
experiments. The quality of the RNA was assessed using urea-PAGE with 1x TBE (89 mM Tris, pH 8.0, 
89 mM boric acid, 2 mM EDTA) as a running buffer. RNA was visualized by methylene blue staining. 
5mer RNA was produced from a purified GA-containing 30mer RNA with a single uracil 
nucleotide at position 5 that was subjected to preparative RNase A cleavage263. After phenol-
chloroform extraction, the different RNA species were separated by anion exchange chromatography 
as described above. Fractions containing the 5mer RNA were pooled and supplemented with  
3.5 volumes ethanol and 0.2 M NaCl. After incubation at -20 °C for at least 12 hours, the precipitate 
was treated further as described above.  
Capped RNA was prepared as previously published by Fuchs et al.263. For a 21mer RNA the 
capping efficiency was directly analyzed by Urea-PAGE, while a 100mer RNA (single uridine at position 
15) was treated with RNase A before gel analysis as described263. For labeling of RNA with a fluorescent 
dye, a GA-containing 30mer RNA with a single uridine at position 15 was transcribed in the presence 
of 4-thiouridine triphosphate instead of UTP. The transcript was purified and capped as described 
above. Fluorescence labeling was achieved using 5-(iodoacetamido)-fluorescein following published 
protocols99,265. 
Table 2.2: RNA used in this study 
RNA Properties Sequence 
Internal 
reference 
15mer GA-only GGAGAAGAGAAGGAG #4, primer 
21mer GA-only GGAAGGAGAGGAAGGAAAGGA #40, plasmid 
30U5mer 
GA-only, but single 
U at position 5 
GGAGUGAGAGGAAGGAAGGGAAGAAAGAAG #8, primer 
30U10mer 
GA-only, but single 
U at position 10 
GGAGGAGAGUGAAGGAAGGGAAGAAAGAAG #9, primer 
30U15mer 
GA-only, but single 
U at position 15 
GGAGGAGAGGAAGGUAAGGGAAGAAAGAAG #10, primer 
63mer GA-only 
GGAAGGAGAGGAAGGAAGGGAAGAAAGAAGAGGA
GAGGAAGGAAGGGAAGAAAGAAGGGAAGA 
#5, primer 
100U15mer 
GA-only, but single 
U at position 15 
GGGAAGGAAGGGAAUAAAGAAGGGAAGAGGAAGG
AGAGGAGGGAAGAAAGAAGAGGAGAGGAAGGAAG
GGAAGAAAGAAGAGGGAAGAGGAAGGAGAGGA 
#6 
primer 
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2.2.4 Liquid-liquid phase separation experiments 
For in vitro phase separation experiments, samples were prepared in glass-bottom 1536-well 
plates (Greiner). Stock solutions of RNA, DNA, proteins and different buffer conditions were prepared 
in 96-well V-bottom plates (Greiner). A Mosquito pipetting robot (TTP Labtech) was used for 
transferring liquids from the 96-well source plates to the 1536-well assay plates. The general pipetting 
order was (1) buffer, (2) RNA or DNA and (3) proteins (Dcp1:Dcp2, Pdc1, Edc3). Automated pipetting 
routines were applied for a thoroughly mixing of the samples prior to analysis. The total sample volume 
in the 1536-well plates was 5 µL. Unless indicated otherwise, the salt concentration used was 125 mM. 
1536-well plates were analyzed immediately after preparation in a Synergy Mx plate reader 
(BioTek) at 30 °C. To avoid droplet maturation during prolonged pipetting routines, only four out of  
48 columns of the 1536-well plates were prepared in parallel. The absorption at 630 nm (as a good 
estimate of the OD600) was used as a quantitative measure for phase separation. 
For LLPS maturation experiments, Edc3 samples were prepared at 150 µM in 25 mM HEPES, 
pH 7.3 and 20, 30, 40, 50, 60, 70, 80, 90, 100 or 125 mM NaCl. At each time-point, the solution was 
mixed by pipetting and the absorption at 600 nm (OD600) was measured. Subsequently, 8 µL of the 
sample were collected and mixed with 2 µL 2.5 M NaCl to dissolve liquid-like droplets. The protein 
concentration of this clear solution was measured, and the concentration of the sample was calculated, 
thereby considering the dilution factor. The fraction of insoluble protein (gel) was determined as the 
loss in the protein concentration.  
2.2.5 Microscopy 
Fluorescent droplets were observed at room temperature with a Zeiss Axio Observer Z1 
equipped with an AxioCam MRM imaging system. Micrographs were processed with Fiji266. 
2.2.6 NMR 
All NMR samples were in SEC buffer and contained 5 % D2O. NMR spectra were recorded at 
283 K on Bruker AVIII-600 and AVIII-800 spectrometers with room temperature probe-heads. 
Backbone and side chain resonances were assigned using HSQC-based HNCACB, HN(CO)CACB, 
HNCACO, HNCO and CC(CO)NH experiments216. NMR titration experiments were carried out with 0.01 
to 0.1 mM 15N-labeled protein (Edc3 IDR) and a 4-fold excess of unlabeled protein (Edc3 YjeF_N or 
Ste13 RecA2 domain) or an equimolar amount of RNA or DNA. NMR spectra were processed using the 
NMRPipe/NMRDraw software suite267. Figures displaying NMR spectra were prepared using NMRview 
(onemoonscientific.com). 
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2.2.7 Decapping assays 
RNA decapping assays were performed as triplicates at 30 °C in 20 µL SEC buffer 
(supplemented with 0.1 mM EDTA) containing 1 µM Dcp1:Dcp2, 20 µM capped RNA and 15 µM BSA. 
The reaction mixture was complemented with 15 µM of either full-length Edc3, Edc3 LSm, Edc3 IDR or 
Edc3 YjeF_N or 15 µM of each Edc3 LSm, IDR and YjeF_N. The decapping reaction was started by 
addition of MgCl2 to a final concentration of 5 mM. At different time-points 4 µL samples were 
collected and the reaction was quenched by addition of 26 µL stop solution (10 mM EDTA, pH 8.0,  
500 mM NaCl) and 15 µL phenol-chloroform-isoamylalcohol. Depending on the length of the used RNA, 
the upper aqueous RNA-containing phase was either directly subjected to HPLC analysis or was treated 
with RNase A first, followed by another phenol-chloroform extraction step to remove the enzyme 
before HPLC analysis. 
2.2.8 HPLC analysis  
10 µL of the quenched reaction were automatically injected onto an analytical DNAPac PA200 
RS column (4.6 x 250 mM, Dionex). Capped and decapped RNA were separated by anion exchange 
HPLC at 50 °C using appropriate gradients (buffer F: 25 mM Tris, pH 8; buffer G: as buffer F, 
supplemented with 1.5 M NaCl) at a flow rate of 0.45 mL/min. Eluting RNA was detected using the 
absorption at 260 nm (Figure 2.4 D).  
2.2.9 Analysis of degradation data 
Substrate and product peaks were integrated and corrected for different absorption 
coefficients of capped and decapped RNA to calculate the ratio of the two RNA species in the sample. 
The fractions of decapped RNA at different time-points were fitted to a first order curve using in-house 
written Matlab scripts. Based on the known concentrations of Dcp2 and RNA in the reaction mixture, 
the decapping rates (kcat in min-1) were derived. 
2.2.10 RNase A protection assays 
RNase A protection assays were performed at 37 °C in 50 µL SEC buffer containing 25 µM of a 
30mer GA-containing RNA with a single uracil nucleotide at position 10. The reaction was 
complemented with 15 µM Dcp1:Dcp2 and/or 30 µM full-length Edc3 or 30 µM of each Edc3 LSm, IDR 
and YjeF_N. A sample that only contained RNA, but no additional proteins, served as a control. The 
reaction was started by addition of 10 nmol RNase A per nmol RNA.  
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After ten minutes, 4 µL 5M NaCl were added to dissolve any liquid-like droplets and the 
reaction was quenched by addition of 54 µL phenol-chloroform-isoamylalcohol. 10 µL of the upper 
aqueous RNA-containing phase were mixed with an equal volume of 2x RNA loading dye. RNA species 
were separated on a 15 % urea-polyacrylamide gel and band intensities were analyzed with Fiji266 to 
determine the fraction of cleaved RNA. A protection factor was calculated by dividing the fraction of 
cleaved RNA for each sample by the fraction of cleaved RNA for the control sample.  
2.3 RESULTS 
2.3.1 High throughput approach for LLPS determination 
In previous work103, we studied the LLPS process of the Dcp1:Dcp2 decapping complex and the 
Edc3 adaptor protein (Figure 2.1 A). In those experiments purified proteins were manually mixed in 
96-well plates and the presence of phase separations was assessed using a wide field microscope. For 
each condition we used 80 μL protein solution and for a small phase diagram with 30 conditions we 
required tens of mg protein. Due to the long time it takes to manually prepare these grids and due to 
the high amount of required protein this approach is not feasible for larger LLPS screens. To be able to 
probe LLPS in a fast, reliable and high throughput manner, we reduced the volume per condition by a 
factor of 16. To pipette small volumes, we used a pipetting robot and 1536-well plates. Importantly, 
this process also increased the speed and accuracy of the pipetting procedure.  
After mixing the individual protein components, the LLPS process results in the formation of 
droplets that fuse over time and then settle on the bottom of the well as a homogeneous layer. In our 
previous setup, it took on the order of hours to record stacked images of 30 conditions, during which 
the appearance of the droplets gradually changed. On a macroscopic level, LLPS is visible as a turbidity 
of the solution134. In our new setup, we measure this turbidity directly in a plate reader. Importantly, 
this turbidity correlates directly with the amount of LLPS as judged from manually interpreted 
microscopy images (Figure 2.1 B, Figure 2.2). From that we conclude that the turbidity provides an 
unbiased and quantitative measure of the LLPS process. The determination of the turbidity of hundreds 
of conditions takes under a minute in a plate reader, which ensures that all conditions are assessed at 
the same stage. In summary, we here established a fast method by which large phase separation 
diagrams can be reliably and quantitatively measured with minimal amounts of material. To test our 
novel strategy, we assessed how salt influences the LLPS potential of Dcp1:Dcp2 and Edc3. 
- 42 - 
 
 
Figure 2.1: High throughput LLPS diagrams. (A) Schematic diagram of the proteins used in this study. Lines indicate the intra- 
and intermolecular interactions that are important for the LLPS process. (B) Comparison of LLPS diagrams for the Dcp1:Dcp2 
(y-axis) and Edc3 (x-axis) protein that are constructed based on the visual inspection of microscopy images (left) or direct and 
quantitative turbidity measurements (right). Both methods provide highly similar phase diagrams, underlining that our high 
throughput approach provides rapid and reliable data. The degree of phase separation is indicated in a white (no LLPS), 
yellow, orange, red (high degree of LLPS) color scale. See also Figure 2.2. (C) The effect of salt on the LLPS process. Salt inhibits 
LLPS of Dcp1:Dcp2:Edc3. Note the few outliers in the phase diagrams (at e.g. 150 mM salt, 5 µM Edc3 and 30 µM Dcp1:Dcp2) 
are likely due to the presence of small air bubbles in these conditions. (D) Addition of Pdc1 significantly enhances the LLPS of 
Dcp1:Dcp2 and Edc3. The effect is due to specific interactions between Pdc1 and Dcp1:Dcp2:Edc3 and is not due to indirect 
effects of e.g. molecular crowding, as BSA (bottom left) has no effect on the LLPS process. A very high amount of the crowding 
agent Ficoll70 (bottom right) only has a minor effect on the Dcp1:Dcp2:Edc3 phase separation process 
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Previous studies have shown that salt can either inhibit120,124,151 or enhance268,269 the LLPS 
process, indicating the formation of cellular foci does not always follow the same molecular principles. 
Here, we used phase separation diagrams with 15x8 conditions and prepared six grids with salt 
concentrations between 50 and 200 mM (720 unique conditions; Figure 2.1 C). These data clearly show 
that an increase in the salt concentration results in a gradual shift of the phase separation boundary 
towards higher protein concentrations. From these data we conclude that electrostatic interactions 
play a role in the clustering of Dcp1:Dcp2 and Edc3. In addition, these data reveal that the increase in 
the number of in vivo cytosolic processing bodies upon increased extra-cellular salt concentrations259 
is not a direct effect. 
2.3.2 Pdc1 stimulates LLPS  
In vitro, LLPS has only been addressed for systems with a limited number (two to three) of 
components. In a cellular setting, LLPS foci, including processing bodies, contain tens of proteins and 
nucleic acids. Based on our novel high throughput approach, we set out to assess the effect the 
addition of proteins has on the phase diagram boundaries.  
Figure 2.2: Interpretation of LLPS diagram based on fluorescence microscopy images. Phase separation diagram of 
Dcp1:Dcp2 and Edc3 in the absence (A) and presence (B) of 15 μM Pdc1. The degree of phase separation was visually classified 
as strong (red), intermediate (orange) or weak (yellow). See also Figure 2.1. 
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First, we complemented the Dcp1:Dcp2:Edc3 in vitro system103 with the processing body 
protein Pdc1261 (Figure 2.1 A) and observe that the presence of Pdc1 reduces the amounts of 
Dcp1:Dcp2 and Edc3 that are required to induce phase separations (Figure 2.1 D). In the extreme case, 
the absence of Dcp1:Dcp2 can be compensated for by the presence of Pdc1, clearly illustrating the 
redundancy of the interactions that lead to phase separation and processing body formation. 
Importantly, the addition of the unrelated protein BSA does not influence the phase separation 
boundary, indicating that the Pdc1 effect is not due to molecular crowding (Figure 2.1 D). In agreement 
with that, also the addition of a crowding agent has no significant effect on the LLPS boundaries  
(Figure 2.1 D), although crowding agents are reported to increase LLPS in other systems123,151. As 
mentioned above in the salt-dependent LLPS experiments, there thus appears to be no general rules 
that can describe the mechanisms underlying the spontaneous clustering of proteins. 
2.3.3 RNA strongly stimulates LLPS  
In a second set of experiments, we investigated the effect of RNA on the phase separation 
diagram. To that end, we complemented Dcp1:Dcp2:Edc3 grids with 5 μM RNA of increasing length 
(Figure 2.3 A). Interestingly, we observe that a small RNA with 15 nucleotides has no effect on the 
phase diagrams. This is most likely due to the inability of this RNA to cross-link between different 
proteins. Longer RNAs, especially RNA with 30 or more nucleotides, have a strong impact on the phase 
diagrams and significantly shift those towards lower Edc3 and Dcp1:Dcp2 concentrations. Remarkably, 
we observe that Edc3 alone as well as Dcp1:Dcp2 alone can undergo efficient phase separation in the 
presence of RNA (e.g. Figure 2.3 A, bottom middle panel at zero Edc3 or Dcp1:Dcp2 concentrations). 
As for Pdc1, this underlines the redundancy in the phase separation systems. Noteworthy, the addition 
of DNA does not have an influence on the LLPS process, indicating that the Dcp1:Dcp2:Edc3 system is 
selective for RNA. 
In the experiments above, we kept the molar RNA concentration constant and increased the 
length of the oligonucleotide. To directly address how the length of the RNA influences the phase 
separation process, we performed complementary experiments where we kept the number of 
nucleotides constant. In those experiments, we added a higher molar amount of a short RNA and a 
lower molar amount of the long RNAs. These experiments show that RNA substrates of 15 nucleotides 
or less have no or only a weak effect on the phase diagrams, whereas substrates of 30 or more 
nucleotides have a similarly strong effect (Figure 2.3 B). This shows that three 30mer RNAs have the 
same effect as one 100mer RNA, which provides strong evidence that the individual protein:RNA 
interactions are independent. In addition, our data indicate that the RNA length that is required to 
efficiently link into the interaction network is around 30 nucleotides. 
- 45 - 
 
To experimentally validate that the RNA directly engages into the protein:protein interaction 
network we coupled the transcript to a fluorescence dye. Based on fluorescence microscopy images, 
we can unambiguously observe a strong enrichment of the labeled RNA in the droplet phase  
(Figure 2.3 C). Importantly, we observe that the size and the number of the liquid-like droplets depend 
on the order in which the components are mixed.  
Figure 2.3: RNA strongly enhances LLPS. (A) Phase diagrams of Dcp1:Dcp2:Edc3 supplemented with 5 µM RNA of different 
length. RNA of 30 bases or more significantly moves the phase separation boundaries to lower concentrations, whereas DNA 
has no effect on the phase diagram. (B) Phase diagrams of Dcp1:Dcp2:Edc3 supplemented with RNA, however, as opposed 
to panel A, the total amount of nucleotides is kept constant. The phase diagrams show that one 100mer RNA has the same 
effect as three 30mer RNAs and indicate that the RNA binding events with Dcp1:Dcp2:Edc3 are fully independent. Shorter 
RNAs have no influence on the phase separation diagrams, indicating that the minimal length of an RNA that can efficiently 
be incorporated into the interaction network is around 30 bases. (C) Fluorescence microscopy images of Dcp1:Dcp2:Edc3 that 
is complemented with fluorescently labeled RNA. The RNA is highly enriched in the droplet phase. Addition of Dcp1:Dcp2 and 
Edc3 (no preformed Dcp1:Dcp2:Edc3 foci) to RNA (top) results in larger foci as when the RNA is added to Dcp1:Dcp2:Edc3 foci 
(middle), indicating that RNA is a highly efficient nucleation factor. No fluorescent signal is detected in the droplet phase in 
the absence of RNA (bottom), demonstrating that the fluorescent signal observed in the top and middle panels is due to 
fluorescently labelled RNA. The experimental conditions and the brightness and contrast are the same for all images. The 
size/ number of LLPS droplets in the bottom images is less than in the top/middle images due to the absence of RNA. 
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Addition of Edc3 and Dcp1:Dcp2 to the RNA resulted in larger and fewer droplets  
(Figure 2.3 C, top), whereas addition of RNA to preformed Edc3:Dcp1:Dcp2 droplets resulted in more 
and smaller droplets (Figure 2.3 C, middle). This indicates that RNA plays an important role in the 
nucleation dynamics of the LLPS process and that it can act as a strong nucleation factor270 around 
which fast growing processing bodies are formed.  
2.3.4 RNA is protected against degradation by LLPS 
Inside the droplet phase the RNA is engaged in a tight network of protein:RNA interactions. 
This can provide advantages as it can potentially protect the transcript from exo- and endonucleolytic 
degradation. To test this hypothesis experimentally, we prepared an RNA substrate with  
30 nucleotides that contains a single uridine at position 10. This site is a target for the enzyme RNase 
A that can cleave the substrate into 10mer and 20mer products (Figure 2.4). We then complemented 
the system with combinations of Dcp1:Dcp2 and Edc3. At the concentrations that we used, addition of 
Dcp1:Dcp2 resulted in weak phase separations (Figure 2.3 A, B) and a small degree of protection of 
the RNA (less cleavage). Addition of Edc3 resulted in intermediate phase separations and intermediate 
protection of the substrate. This protection is not due to direct interactions between the RNA and Edc3 
as addition of the individual domains of Edc3 does not result in LLPS and does not protect the RNA 
from RNase A cleavage. Addition of both Dcp1:Dcp2 and Edc3 results in significant phase separations 
as well as in a significant protection of the RNA substrate. From these data we conclude that the LLPS 
process is able to protect the RNA substrate from enzymatic cleavages and degradation.  
2.3.5 LLPS reduces the catalytic activity of Dcp2 
One of the central components of processing bodies is the decapping complex Dcp1:Dcp2. To 
address how the activity of this enzyme complex is influenced by the inclusion into processing bodies 
we performed mRNA decapping experiments under multiple turnover conditions in the presence and 
absence of in vitro processing bodies. In these experiments we kept the concentration of the 
Dcp1:Dcp2 decapping complex constant and supplemented this with full-length Edc3 (to induce phase 
separation) or with exactly the same concentration of the isolated Edc3 domains (LSm, IDR and YjeF_N; 
Figure 2.1 A) that cannot induce LLPS. This ensures that the protein content in the different 
experiments is identical and thereby prevents indirect effects. Interestingly, we find that a small 
capped RNA with 21 nucleotides is decapped in the presence and absence of in vitro processing bodies 
with the same efficiency (Figure 2.4 B). This correlates with the limited effect that this short RNA has 
on LLPS (Figure 2.3 B).  
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In agreement with previous findings, we do, however, observe a modest stimulating effect of 
the Edc3 LSm domain on the decapping activity101,104. Interestingly, for a longer substrate with an RNA 
body of 100 nucleotides, which efficiently induces LLPS, we observe a significantly slower decapping 
activity under phase separation conditions (Figure 2.4 C). These in vitro results suggest that mRNA 
which is tightly embedded in in vivo processing bodies could be protected against decapping.  
Figure 2.4: RNA is protected within LLPS foci. (A) RNase cleavage of a 30mer RNA (that contains a single RNaseA cleavage 
site at position 10) is reduced upon phase separation. This shows that the RNA within in vitro processing bodies is protected 
against RNase activity. This protection is not due to direct interaction between Edc3, Dcp1 or Dcp2 with RNA as addition of 
the same amount of the individual Edc3 domains (LSm, IDR and YjeF_N) does not result in RNase protection (and LLPS). The 
amount of LLPS is indicated on top, where the colour scheme of Figure 1B is used. (B) The Dcp2 activity on a short RNA of  
20 nucleotides is independent of LLPS. (C) The Dcp2 activity on a longer RNA of 100 nucleotides is significantly reduced upon 
LLPS. This is not due to direct interactions, as the addition of the individual Edc3 domains has no influence on the decapping 
activity (see also A). The long RNA is efficiently embedded in the intermolecular interaction network that lead to LLPS  
(Figure 2.3), whereas the short RNA is not able to enhance phase separations of Dcp1:Dcp2:Edc3. It should be noted that the 
measured decapping activity is a weighted average of the activity of Dcp2 inside and outside the in vitro processing bodies, 
due to the exchange of components between the two phases. The activity of the decapping complex that is purely within the 
in vitro processing bodies is thus likely even lower than what we observe here. (D+E) Representative mRNA decapping 
experiment. 20 µM capped RNA substrate were supplemented with 1 µM Dcp1:Dcp2. At different time-points during the 
decapping reaction, a part of the sample was removed for analysis as described in the Methods section (2.2.7 and 2.2.8). (D) 
HPLC trace (DNAPac PA200 RS column (4.6 x 250 mM, Dionex) of an mRNA decapping experiment. The substrate (capped 
RNA) and the product (uncapped RNA) are indicated. (E) Time course of a decapping reaction, the best fit to the data is 
indicated. Note that the reaction is no longer linear after 2 minutes, due to product inhibition of the decapping enzyme. 
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2.3.6 The IDR in Edc3 specifically interacts with RNA 
Edc3 contains an IDR region that links the N-terminal LSm domain and the C-terminal YjeF_N 
dimerization domain (Figure 2.1 A, Figure 2.6 A). To elucidate the importance of this IDR for LLPS, we 
deleted it from the Edc3 protein and prepared LLPS grids in the presence of Dcp1:Dcp2 (Figure 2.5 A). 
In the absence of RNA, we observe that deletion of the IDR moves the phase separation boundary 
slightly towards higher concentrations. More importantly, the addition of RNA to Edc3 lacking the IDR 
does not result in the strong shift of the phase separation boundary towards lower protein 
concentrations as observed for full-length Edc3 (Figure 2.5 A). This effect is even more prominent in 
RNA:Edc3 phase diagrams, where the removal of the IDR results in the almost complete loss of LLPS 
(Figure 2.5 B). This data indicates that the IDR in Edc3 is an important RNA interaction site. 
Figure 2.5: The Edc3 IDR specifically interacts with RNA. (A) Phase separation diagrams of Dcp1:Dcp2 and Edc3 in the absence 
(top) and presence (bottom) of a 30mer RNA. RNA significantly shifts the phase separation boundary for the wild-type (WT) 
Edc3 protein (left). Upon deletion of the IDR the effect of RNA on the phase diagrams is reduced (right). (B) Phase separation 
diagrams of Edc3 and a 30mer RNA. Edc3 and RNA are sufficient to induce LLPS (left). A version of Edc3 that lacks the IDR is 
no longer able to undergo phase separations in the presence of RNA only. (C) 1H-15N NMR spectra of the Edc3 IDR in the 
absence (black) and presence (red) of an equimolar amount of RNA of 15 nucleotides. Many resonances are significantly 
weaker or undergo CSPs, indicating a direct interaction between the RNA and the IDR. Several assignments are indicated.  
(D) The extent of the CSPs that are induced by the RNA correlate with the length of the RNA. This indicates that one RNA can 
interact with multiple IDRs. (E) Plot of the loss of intensity of the NMR signals in the Edc3 IDR upon addition of a 30mer RNA. 
Three regions in the Edc3 IDR interact with RNA: a region around residue 80, a region around residue 130 and a region around 
residue 180. (F) ITC binding experiments reveal a micromolar affinity between a 30mer RNA and the Edc3 IDR. The exact 
affinity cannot be extracted due to the unknown stoichiometry of the interaction. 
 
- 49 - 
 
To assess which residues in the Edc3 IDR interact with RNA, we used NMR spectroscopy. NMR 
spectra of the Edc3 IDR in the absence and presence of RNA show clear chemical shift perturbations 
(CSPs) that are restricted to a subset of the resonances (Figure 2.5 C). This indicates that a specific part 
of the IDR directly contacts the RNA. Interestingly, the extent of the observed CSPs correlates with the 
length of the added RNA (Figure 2.5 D), which shows that multiple IDRs can interact with a single RNA, 
in agreement with the phase separation diagrams of Edc3:Dcp1:Dcp2 and RNA (Figure 2.3 A, B). Based 
on the assignments of the Edc3 IDR resonances, there are three RNA interaction sites that are centered 
around residues 80, 130 and 180 (Figure 2.5 E). Notably, the region between residues 155 and 175, 
which is devoid of any positively charged residues, does not interact with RNA. 
Figure 2.6: The Edc3 IDR does not interact with DNA, but with the second RecA domain of the helicase Dhh1 (Ste13).  
(A) Sequence of the Edc3 IDR. The residues are colored according to charge and hydrophobicity. The regions that interact 
with RNA (Figure 2.5), the Edc3 YjeF_N domain (Figure 2.8) and the helicase Ste13 (Figure 2.7) are indicated. (B) 1H-15N NMR 
spectra of the Edc3 IDR region in the absence (black) and presence (orange) of DNA. The lack of clear CSPs reveals that the 
Edc3 IDR does not interact with single-stranded DNA. (C) The intensity ratio of the NMR signals in the presence and absence 
of DNA is close to unity for all residues (top). As a comparison, the intensity ratio of the NMR resonances in the absence and 
presence of a 30mer RNA (middle) or the second RecA domain of Ste13 (bottom) is shown. The region in the Edc3 IDR that is 
affected by binding of Ste13 is around the conserved FDF motif. The binding sites of Ste13 and the Edc3 YjeF_N on the Edc3 
IDR thus partially overlap. (D) 1H-15N NMR spectra of the Edc3 IDR region in the absence (black) and presence (hot pink) of 
the second RecA domain of Ste13.  
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 ITC measurements reveal that the affinity between the RNA and the Edc3 IDR is in the 
micromolar range (Figure 2.5 F), although exact affinities cannot be extracted due to the unknown and 
dynamic stoichiometry of the Edc3 IDR:RNA interaction. The micromolar affinity is, however, in full 
agreement with other interactions that play a role in LLPS and allows for rapid readjustments within 
the interaction network103,134. Noteworthy, NMR titration experiments do not reveal an interaction of 
DNA with the Edc3 IDR (Figure 2.6 B, C). This is in agreement with our finding that DNA has no 
significant effect on the Edc3:Dcp1:Dcp2 phase diagram (Figure 2.3 A). Thus, the unstructured Edc3 
IDR appears to be able to discriminate between RNA and DNA. 
Figure 2.7: The Edc3 IDR interacts with Ste13 in a conserved manner. (A) 1H-15N NMR spectra of free (black) and bound 
(magenta) Edc3 IDR. Many resonances are significantly weaker or undergo CSPs in the presence of the second RecA2 domain 
of Ste13, indicating a direct interaction between the two proteins. (B, C) 1H-15N NMR spectra of mutant Edc3 IDR protein in 
the absence (B: red; C: green) and presence (B: cyan; C: blue) of the Ste13 RecA2 domain. The lack of CSPs indicate that either 
of the two mutants ADA (B) or ADK (C) abolishes binding of the Edc3 IDR to Ste13. (D) The first RecA1 domain does not 
interact with the Edc3 IDR as no CSPs are observed in the presence (orange) of Ste13 RecA1 compared to apo Edc3 IDR (black). 
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2.3.7 Interactions of the Edc3 IDR and the RNA-helicase Dhh1 are conserved 
from yeast to human 
Major processing body components and decapping factors are conserved in all higher 
eukaryotes271. Additionally, orthologs of the Dhh1 helicase were found to interact with the Edc3 
protein in a similar manner, where the second but not the first RecA-like domain of the helicase binds 
to conserved FDF and FDK peptide motifs in an intrinsically disordered region of Edc3106,107,144.  
We performed chemical shift perturbation experiment to test whether the interaction 
between Edc3 and the Dhh1 ortholog Ste13 is also conserved in S. pombe. We could identify residues 
in the Edc3 IDR that are perturbed upon binding of the second RecA2 domain of Ste13 (Figure 2.6 D). 
These residues span a region of around 40 amino acids (residues 90-130) and contain the conserved 
FDF and FDK motifs (Figure 2.6 A, C). Mutating either the FDF motif (to ADA) or the FDK motif (to ADK) 
completely abolishes Ste13 binding to Edc3. Notably, the Edc3 IDR does not interact with the RecA1 
domain of Ste13. These results are in line with previous findings and argue for a conserved mode of 
interaction between Edc3 and Dhh1 in different yeast species and from lower to higher eukaryotes. 
2.3.8  Maturation of processing bodies 
Previous work has shown that cellular LLPS can undergo maturation and form more solid-like 
structures that, in specific cases, correlated with human disease123. Interestingly, we observe that 
fused Edc3:Dcp1:Dcp2 droplets also form a gel-like film over time that can be scratched from the 
bottom of the well of a 96-well plate with a tip of a pipette (Figure 2.8). In addition, as opposed to 
freshly formed LLPS droplets, this film does not rapidly dissolve upon dilution and is resistant to high 
salt concentrations (Figure 2.8). We therefore conclude that droplets that are formed from processing 
body components also undergo maturation. To unravel interactions contributing to the maturation 
effect, we focused on the Edc3 protein. Edc3 in isolation undergoes phase separations at high 
concentrations in a temperature- and salt-dependent manner, even in the absence of RNA and 
Dcp1:Dcp2 (Figure 2.1 C at zero Dcp1:Dcp2 concentration). Maturation occurs over time and to assess 
the underlying mechanisms of this process we measured both turbidity (as a measure of the phase 
separation) and the soluble protein concentration (as a measure of the amount of protein that engages 
in the insoluble mature phase) at different timepoints. To modulate the amount of LLPS we performed 
these measurements at ten salt concentrations between 20 and 125 mM. 
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Figure 2.8: Maturation of in vitro processing bodies into a dilution-resistant phase. (A) Successive fluorescence microscopy 
images that were taken of Dcp1:Dcp2:Edc3 phase separated proteins after incubation for 12 hours. The proteins formed a 
gel-like film on the bottom of the well that could be scratched off using a pipette tip. (B) LLPS (left panels) and maturation 
(right panels) of the Edc3 protein at different salt concentrations (y-axis) were monitored over time (x-axis). Full-length Edc3 
(top panel) undergoes phase separation at low salt concentrations. The formed foci (left) merge and subsequently form a 
gel-like film (right). Deletion of the IDR or the YjeF_N domain in Edc3 inhibited the phase separation and maturation 
processes, indicating that the interaction between these domains plays an important role in the maturation of Edc3- 
containing foci. (C+D) Dcp1:Dcp2 and fluorescently labeled Edc3 were mixed. (C) Top: Widefield and fluorescent images after 
5 minutes incubation. Bottom: images of the same condition, after 1:5 dilution and 10 minutes incubation. The LLPS droplets 
largely disappeared. A small degree of matured droplets is visible in the fluorescent images. These have formed during the 
incubation times. (D) Liquid droplets matured for 90 minutes. During this time, they merge as a homogeneous layer on the 
bottom of the well. Subsequent dilution does not result in the disappearance of the homogeneous gel-like structure, 
indicating that the intermolecular interactions in the early (C) and late (D) in vitro processing bodies are significantly different. 
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At salt concentrations between 20 and 80 mM, the Edc3 wild-type protein undergoes LLPS and 
liquid-like droplets form (Figure 2.8 B, top left). Over time, these droplets disappear and in parallel a 
gel-like mature phase forms (Figure 2.8 B, top right). At salt concentrations above 80 mM, Edc3 does 
not undergo LLPS and no mature phase is formed. This indicates that the formation of the gel-like 
structure is a direct result of the formation of liquid-like droplets and that the LLPS is required for the 
aggregation process. Next, we repeated these experiments for Edc3 proteins lacking the LSm domain 
(Figure 2.8 B, second row), the IDR (third row) or the YjeF_N domain (bottom row) and observe that 
removal of either the IDR or the YjeF_N domain prevents the formation of mature droplets. Our data 
thus suggests that an interaction between the Edc3 IDR and YjeF_N domain underlies the maturation 
of in vitro processing bodies. To confirm an interaction between the Edc3 LSm and YjeF_N domains, 
we performed NMR titration experiments and identified two regions in the Edc3 IDR that directly and 
independently interact with the YjeF_N domain (Figure 2.9 A, B). Only upon deletion of both regions, 
the interaction between the Edc3 IDR and the Edc3 YjeF_N domain is abolished, while the ability of 
RNA binding persists (Figure 2.9 C), indicating that both interactions are not competing. 
  
Figure 2.9: Two regions in the Edc3 IDR interact independently with the Edc3 YjeF_N domain. (A) 1H-15N NMR spectra of the 
Edc3 IDR region in the absence (black) and presence (green) of the Edc3 YjeF_N domain. (B) Intensity ratios of the 1H-15N 
resonances of the Edc3 IDR in the presence and absence of the Edc3 YjeF_N domain. Two regions in the Edc3 IDR are 
prominently influenced by this interaction: a region around residue 100 and a region around residue 165. Deletion of one of 
these regions does not influence the interaction with the other region (middle two panels, the deleted region is indicated in 
gray). Deletion of both regions (lower panel) abolishes the interaction between the Edc3 IDR and the Edc3 YjeF_N domain. 
(C) The Edc3 IDR double-deletion mutant, which is no longer able to interact with the YjeF_N domain, still binds RNA. 
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2.4 DISCUSSION 
Processing bodies are ubiquitous in eukaryotic cells. Nevertheless, their function remains a 
matter of debate. Therefore, we here address the formation and subsequent maturation of processing 
bodies. In addition, we examine how the activity of the decapping enzyme is modulated by the 
incorporation into highly densely packed cellular foci.  
The formation of cellular foci is governed by a redundant set of intermolecular interactions 
that initially result in the appearance of liquid-like droplet that spontaneously separate from the 
surrounding. In vivo, this LLPS process is counteracted by processes that can disintegrate these cellular 
foci into individual soluble proteins139,163,164,257. In an in vitro setting, however, liquid droplets 
continuously flow and fuse into larger assemblies that eventually settle as a homogeneous layer on 
the bottom of a test-tube103. To study the mechanisms behind LLPS processes in an in vitro setting, it 
is thus important to assess the formation of liquid droplets rapidly, before the proteins that are 
involved are irreversibly aggregating into gel-like structures. To that end, we here introduce an 
approach where hundreds of conditions can be screened rapidly, such that the irreversible aggregation 
of proteins can be neglected. Our approach is based on the use of small volume pipetting robotics and 
the assessment of the LLPS through turbidity measurements. These quantitative turbidity 
measurements on 5 μL volumes quantitatively correlate very well with the LLPS experiments on 80 μL 
volume samples using microscopic techniques (Figure 2.1 B). The small volume turbidity 
measurements, however, require significantly less time (factor of 100) and sample (factor of 16) and 
thus allow for the reliable assessment of LLPS screens that report only on the initial clustering process 
without interference from the maturation/aggregation process.  
Based on the above methodology we assessed how incorporation of processing body proteins 
and RNA in in vitro assays influences the phase separation boundary. Pdc1 significantly reduces the 
required concentrations of Dcp1:Dcp2 and Edc3 to induce LLPS (Figure 2.1 D). Mechanistically this can 
be explained by the interactions between the Pdc1 HLMs and the Edc3 LSm domain that reduce the 
requirement of the Dcp2 HLMs to form indefinite interaction networks103. Importantly, RNA is also able 
to significantly reduce the concentrations that are required for the LLPS process of Dcp1:Dcp2 and 
Edc3 (Figure 2.3 A, B). To that end, the RNA needs to be longer than 20-30 bases. Shorter RNAs are 
most likely not able to bridge between different RNA binding sites in Dcp2 and Edc3 and can therefore 
not enhance the clustering process. RNA that is longer than 30 bases is efficient in influencing the LLPS 
process, where three 30mer RNAs have the same effect as one 100mer RNA has. This indicates that 
the multiple protein:RNA interactions in long RNAs are independent. 
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Cellular phase separation processes are modulated by interactions between folded protein 
domains (e.g. the interaction between Dcp1 and Dcp2, or the interaction between Dcp1:Dcp2 and the 
Ge1 domain in Pdc1103; Figure 2.1 A), interactions between disordered regions and folded protein 
domains (e.g. Edc3 LSm domain and the Dcp2 and Pdc1 HLMs99,103; Figure 2.1 A), interactions between 
folded protein domains and RNA (e.g. Dcp2 and RNA; Figure 2.1 A). Here, we add a fourth type 
interaction and show that the disordered region in Edc3 efficiently interacts with RNA (Figure 2.1 A, 
Figure 2.5 C-F). These IDR:RNA interactions are functionally important as removal of the IDR results in 
a reduction of the LLPS processes (Figure 2.5 A, B). We show that the collaborative sum of all these 
interaction types can move the LLPS boundary to significantly lower concentrations. Within a cellular 
setting the concentrations of the Dcp1, Dcp2, Pdc1 and Edc3 proteins are approximately between  
20 and 200 nM272. Our phase diagrams now show clear LLPS close to these concentrations, despite the 
fact our used RNAs are significantly shorter than the average of cellular mRNAs and that many 
processing body components are still absent from our in vitro setup. Based on the additive effect that 
we describe here we confidently predict that addition of more P-body proteins will result in the 
formation of foci at cellular concentrations. In that light, it is important to note that the proteins Pat, 
Lsm1-7, Dhh1 (Ste13), Xrn1 (Exo2), Scd6 and Edc1 are all reported to interact with Dcp1, Dcp2, Edc3, 
Pdc1 and/or RNA99,101 and that they can thus be efficiently embedded into the intermolecular 
interaction network that drives the LLPS process.  
Maturation of cellular foci is implicated with medical disorders273. Due to the high local protein 
concentration in cellular foci the phase-separated proteins are likely prone to aggregation that can 
lead to the formation of amyloid like structures. Here, we observe that in vitro processing bodies also 
evolve into highly insoluble aggregates. This maturation is driven by interactions between the Edc3 IDR 
and the Edc3 YjeF_N domain (Figure 2.8). To what degree the maturation of processing bodies in an  
in vivo setting is correlated with medical disorders will be an exciting question for future studies.  
Based on our data, the 120 amino acid long IDR of Edc3 plays multiple roles (Figure 2.1 A, 
Figure 2.6 A), in agreement with the previously reported importance of Edc3 in processing body 
formation144. First, it directly interacts with RNA and thereby enhances LLPS. Second, an FDF motif in 
this region can recruit the helicase Dhh1 (Ste13) through interactions with the second RecA domain. 
This interaction was previously shown for the human homologues106 and is conserved in S. pombe 
(Figure 2.6 C, D). Finally, the Edc3 IDR directly interacts with the Edc3 YjeF_N dimerization domain, 
which is involved in the irreversible maturation process. Interestingly, the Dhh1 (Ste13), RNA and 
YjeF_N binding sites in the Edc3 IDR partially overlap (Figure 2.6 A, C and Figure 2.9 B). Whether the 
interaction of RNA with Edc3 influences the maturation process in processing bodies, as was recently 
shown for Whi3 droplets122, remains to be determined.  
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Here, we define the intrinsically disordered region in Edc3 as a multivalent interaction platform 
for proteins and RNA, which underscores the importance of disordered regions in proteins for 
function274.  
To address the functional implication of processing bodies we assessed the mRNA decapping 
activity within these foci (Figure 2.4 B, C). Interestingly, the mRNA decapping activity is reduced within 
processing body-like structures for RNA substrates longer than 20 nucleotides. These longer RNAs are 
tightly incorporated within the network of interactions that drives processing body formation, which 
will restrict their local diffusion rates. The reduction in decapping activity within our in vitro processing 
bodies correlates well with the proposed role of processing bodies in temporary mRNA 
storage114,259,262,275, where mRNA is temporarily taken out of the translational pool such that the cell 
can react efficiently to stress situations. In agreement with that, the RNA inside droplets is also 
protected against RNase activity (Figure 2.4 A).  
 In summary, our data reveal a highly intertwined network of intermolecular interactions that 
is responsible for the formation and maturation of processing bodies. Interestingly, this network of 
interactions is able to significantly reduce the mRNA decapping activity. Our studies thereby provide 
unique insights into the mechanisms of formation and the functional implication of processing bodies. 
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CHAPTER 3 Atomic level insight into the maturated state of  
  mRNA processing bodies by combining solid- and  
  solution-state NMR spectroscopy 
 
This chapter was published in Nature Communications. Large parts of the text and figures are 
thus identical to the published manuscript. The project was supervised by Remco Sprangers and Marc 
Baldus. Experiments were designed by all authors. Stefan Schütz performed molecular cloning, protein 
labeling, expression and purification and prepared samples for NMR. Reinier Daman, Yanzhang Luo 
and Markus Weingarth acquired solid-state NMR data, while S.S. acquired solution-state NMR data. 
M.W. performed molecular dynamics simulations. All authors contributed to the analysis and 
interpretation of data. M.B. and R.S. wrote the manuscript and all authors commented on it.  
3.1 INTRODUCTION 
Increasing evidence shows that cells develop intra-cellular protein-rich organelles that grow 
and fuse, allowing certain molecules to become locally enriched while excluding others118. Such 
intracellular liquid–liquid phase separation (LLPS) processes seem to be a common approach to achieve 
spatial organization of cellular components into dynamic, membrane-less compartments. While 
physical models have helped to understand the formation of membrane-less protein compartments119, 
studying such networks at atomic resolution has been challenging due to their intrinsic mobility and 
heterogeneous nature276,277 and because genetic approaches in a cellular context are complicated by 
the highly redundant nature of the clustering process. 
NMR spectroscopy has been shown to provide unique structural insights into heterogeneous 
and dynamical systems at atomic resolution278–281. Previously, solution-state NMR has been used to 
decipher molecular interactions among LLPS components under in vitro conditions using titration 
studies103,269 and determined 3D structures of fast tumbling folded subdomains282. However, studying 
the structural organization of liquid-like droplets using solution-state NMR methods is complicated by 
the reduced diffusion of the liquid-liquid phase separated molecules283. Hence, direct insights into the 
structural and dynamical organization of liquid-like droplets has been limited283. Instead, solid-state 
NMR (ssNMR) has been employed to study the formation158,284 and structural organization158,285–288 of 
protein hydrogels and fibrillar assemblies that may be closely related to LLPS276,289.  
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For example, we have previously used ssNMR to investigate the hydrogel state of the FG repeat 
domain of the nucleoporin Nsp1p related to the nuclear pore complex, revealing that transient 
amyloid-like β-sheet interactions among NTQS-rich protein regions are responsible for gelation and 
network formation158,286. Such on-pathway amyloid interactions were also recently proposed for 
hydrogel-forming peptides that contain GSY-amino acid rich  stretches and, in isolation, form 
crystalline needles that shared essential features of amyloid fibrils147. Indeed, ssNMR revealed charac-
teristic β-strand arrangements in fibrils formed by the low complexity domain of the FUS RNA-binding 
protein148. A relationship between LLPS and fibril-like protein states and their relevance for human 
disease has also been examined in stress granules, cytosolic membrane-less organelles composed of 
RNA-binding proteins (RBPs) and RNA123, and, more recently, for huntingtin exon1 assemblies in 
mammalian cells and yeast145. While LLPS and fibrillization may represent two mechanistically distinct 
processes, models that connect these two processes have been developed123,151,289. For example, 
Molliex et al. have depicted the relationship between phase separation, fibrillization, and pathological 
inclusions by three steps with an intermediate maturation regime where two phases coexist in the 
granule state, which ultimately connects LLPS to disease123. However, the structural relationship 
between liquid-liquid phase separation and maturation has remained elusive.  
In the following, we combined solid- and solution-state NMR experiments to directly study the 
LLPS and maturation of processing bodies (P-bodies) that are dynamic cytoplasmic ribonucleoprotein 
(RNP) granules containing proteins involved in translational repression and RNA degradation89,113,252,290. 
Their main constituents are mRNA and the mRNA decay machinery, including the Dcp1:Dcp2 mRNA 
decapping complex, the RNA helicase Dhh1, the Pat–LSm1-7 complex, the exonuclease Xrn1 and Edc3 
(enhancer of decapping 3)144,252. The Edc3 protein is a central hub for processing body formation in 
yeast. The 50 kDa protein (Figure 3.1) comprises an N-terminal LSm domain that directly interacts with 
helical leucine-rich motifs (HLMs) in the P-body proteins Dcp2101 and Pdc1103. C-terminal to the LSm 
domain, the Edc3 protein contains a 120 amino acid long intrinsically disordered region (IDR). This IDR 
is an interaction platform for RNA252, the RNA helicase Dhh1105 and the C-terminal Edc3 YjeF_N 
dimerization domain252,291.  
Previously, we showed the in vitro reconstitution of processing body-like assemblies using 
purified components103,252. These Edc3-containing in vitro foci undergo a maturation process, which 
over time results in the irreversible formation of an insoluble gel-like state. Based on solution-state 
NMR spectroscopy and phase separation diagrams, we identified key interactions in this sequential 
two-step process and found that interactions between the Edc3 LSm domain and HLMs in Dcp2 and 
interactions between the Edc3 IDR and RNA are required for LLPS103,252.  
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Recently, we noticed that the isolated Edc3 protein is also able to undergo LLPS and we have 
shown that the IDR and the YjeF_N domain are key for this process252. Moreover, the ability of Edc3 to 
mediate phase transitions is significantly enhanced by RNA which can bridges between Edc3 protomers 
through interactions with the Edc3 IDR.  
Solution-state NMR spectroscopy is ideally suited to study the proteins and protein:RNA 
complexes before they undergo LLPS, however, it is less optimal to study full-length processing body 
components after they have undergone phase separation. This is due to the limited diffusion within 
the high-density phase and due to the fact that these in vitro processing bodies mature into a more 
solid-like phase that does not spontaneously dissolve into a liquid phase upon dilution252. To study the 
structure, dynamics and RNA interactions of the Edc3 protein in the matured high-density protein state 
we here turned to solid-state (ss) NMR.  
In the following, we conducted 13C/15N- as well as 1H-detected ssNMR experiments using a 
combination of scalar- and dipolar-based correlation methods that, as we have shown 
previously158,286,292, provide a powerful tool to separate ssNMR protein signals of mobile and rigid 
protein regions. For 1H-detected ssNMR experiments, we furthermore made use of proton dilution 
approaches293,294 to increase spectral resolution under high-field/high-speed magic angle spinning 
(MAS) conditions. We applied our strategy to the full-length Edc3 protein as well as to  the matured 
state of an Edc3 construct that lacks the N-terminal LSm domain (ΔLSm, Figure 3.1 A) representing the 
minimal Edc3 construct that can undergo LLPS252. In addition, we examined the C-terminal YjeF_N 
domain by both solid- and solution-state NMR and conducted ssNMR experiments of Edc3 samples 
after the addition of RNA, which significantly enhances the LLPS process of Edc3.  
Our studies reveal that the intra- and intermolecular contacts that are present between the 
Edc3 protein and RNA before LLPS are also present in the matured granule state of processing bodies. 
These interactions are diverse and range from weak electrostatic to strong hydrophobic contacts and 
include folded protein domains as well as IDRs.  
3.2 MATERIALS AND METHODS 
3.2.1 Protein expression and purification 
The genes for the full-length Edc3 protein, for Edc3 lacking the LSm domain (Edc3-∆LSm) and 
for the Edc3 YjeF-N domain from Schizosaccharomyces pombe were cloned into modified pET vectors 
that carried an N-terminal TEV-cleavable His6-tag.  
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The gene for the IDR of Edc3 was cloned into a modified pET vector that carried an N-terminal 
TEV-cleavable His6-GST-tag. Point mutations and deletions were introduced using standard site-
directed mutagenesis methods (Table 3.1).  
Chemical competent Escherichia coli BL21 (DE3) Codon Plus RIL cells (Stratagene) were 
transformed with the appropriate plasmid and grown at 37 °C to an OD600 of 0.8 in lysogeny broth (LB) 
medium. Overexpression was induced with 0.5 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). 
After overnight expression at 20 °C cells were pelleted by centrifugation and resuspended in buffer 1 
(25 mM sodium phosphate, pH 7.4, 250 mM NaCl, 1 mM DTT) complemented with 10 mM imidazole, 
5 mM MgCl2, 0.1 % Triton X-100, lysozyme and 0.2 U/mL DNase I. Cells were lysed with ultrasound and 
insoluble cell debris were removed from the lysate by centrifugation. The supernatant was bound to 
equilibrated Ni-NTA resin, which was washed subsequently with buffer 1 complemented with 10 mM 
imidazole. Bound protein was eluted from the resin with buffer 1 complemented with 300 mM 
imidazole. Tobacco etch virus (TEV) protease was added to the elution fractions to cleave the 
purification tag from the target proteins.  
The Edc3 IDR was dialyzed overnight at 4 °C into buffer 2 (25 mM HEPES, pH 8.0, 50 mM NaCl, 
1 mM DTT) supplemented with 0.5 mM EDTA. The dialysate was applied to a cation exchange column 
(HiTrap 5mL SP FF, GE Healthcare) equilibrated with buffer 2. To separate the protein of interest from 
the cleaved GST-tag, a gradient from 0 to 35 % buffer 3 (25 mM HEPES, pH 8.0, 2 M NaCl, 1 mM DTT) 
was applied over a volume of 100 mL. Fractions containing the target protein were pooled and the 
buffer was exchanged to buffer 4 (25 mM HEPES, pH 7.3, 125 mM NaCl, 1 mM DTT) using centrifugal 
filters. Proteins carrying only an N-terminal His6-tag were directly dialyzed into buffer 4 supplemented 
with 0.5 mM EDTA. Purification to homogeneity was achieved by size exclusion chromatography on 
HiLoad 16/600 Superdex 75 (Edc3 IDR, Edc3 YjeF_N) or Superdex 200 (Edc3-FL and Edc3-∆LSm) 
columns (GE Healthcare) in buffer 4.  
NMR-active proteins were obtained by overexpression in (50-100%) D2O-based M9 minimal 
medium supplemented with 0.5 g/L 15NH4Cl as the sole nitrogen source and either 2 g/L 1H13C-glucose 
for solid-state NMR samples or 4 g/L 1H12C-glucose for solution-state NMR samples. For labeling of the 
Ile-δ1, Met-ε, Val-γ1/γ2 and Leu-δ1/δ2 methyl groups within a U-[2H12C]-background, the medium was 
supplemented with α-ketobutyrate (3-2H2-4-13CH3; 60 mg/L), methionine (methyl-13CH3; 100 mg/L),  
α-ketoisovalerate (3-2H-3-(methyl-13CH3)-4-13CH3; 100 mg/L) one hour prior to induction. For 
simultaneous labeling of Ala-β methyl groups, 2-2H-3-13C-L-alanine was added to the medium  
20 minutes prior to induction. 
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Table 3.1: Edc3 constructs used in this study  
Residue number / domain / mutations Solubility / 
purification tag 
Internal 
reference 
1-454 N-His6-TEV #180 
72-194 (IDR) N-His6-GST-TEV #1293 
195-454 (YjeF_N) N-His6-TEV #196 
YjeF_N (M-2G, L254I) N-His6-TEV #1797 
YjeF_N (M-2G, K258M) N-His6-TEV #1798 
YjeF_N (M-2G, L390M) N-His6-TEV #1799 
YjeF_N (M-2G, K392M) N-His6-TEV #1800 
YjeF_N (M-2G, W393M) N-His6-TEV #1776 
YjeF_N (M-2G, L445I) N-His6-TEV #1801 
YjeF_N (M-2G, Q447I) N-His6-TEV #1802 
YjeF_N (V253I) N-His6-TEV #1786 
YjeF_N (L370M) N-His6-TEV #1787 
YjeF_N (V416M) N-His6-TEV #1788 
72-454 (ΔLSm) N-His6-TEV #1301 
72-454, Δ90-110 (IDRΔ1 – YjeF_N) N-His6-TEV #1515 
72-454, Δ158-171 (IDRΔ2 – YjeF_N) N-His6-TEV #1513 
1-454 N-MBP-TEV #259 
195-454 (Yjef_N) N-MBP-TEV #258 
3.2.2 RNA in vitro transcription and purification 
RNA in vitro transcription and purification was carried out as described before252. In vitro 
transcription of a 30mer RNA was accomplished using in-house purified T7 polymerase263 and a DNA 
primer as the template (Table 3.2). Transcribed RNA was purified under denaturing conditions using 
anion exchange chromatography, followed by isopropanol precipitation, desalting and vacuum 
concentration. The obtained pure dry RNA product was resuspended at concentrations required for 
subsequent experiments. The quality of the RNA was assessed using urea-polyacrylamide gel 
electrophoresis (PAGE) in 1× TBE (89 mM Tris, pH 8.0, 89 mM boric acid, 2 mM EDTA). RNA was 
visualized by methylene blue staining. 
Table 3.2: RNA used in this study 
RNA Properties Sequence Internal reference 
30U15mer GA-only, but single U at 
position 15 
GGAGGAGAGGAAGGUAAGGGAAGAAAGAAG #10 primer 
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3.2.3 Liquid-liquid phase separation assays 
LLPS maturation experiments were carried out as described previously252. In brief, Edc3-∆LSm 
samples were prepared at 150 µM in 25 mM HEPES, pH 7.3 and different salt concentrations. At each 
time-point, the solution was mixed by pipetting and the turbidity (OD600) was measured. 8 µL of the 
sample were collected, liquid droplets were dissolved by adding 2 µL 2.5 M NaCl and the protein 
concentration was determined by absorption measurements at 280 nm. Based on the dilution factor 
the concentration of soluble protein within the sample was obtained. The decrease in the protein 
concentration over time was used as a measure of the fraction of insoluble protein (matured state). 
3.2.4 Solution-state NMR experiments 
All solution-state NMR samples were prepared in buffer 4 and contained 5 % D2O. NMR spectra 
were recorded at 298 K on Bruker AVIII-500 and AVIII-800 spectrometers equipped with room 
temperature and cryogenic probe-heads, respectively. NMR titration experiments were carried out 
with 0.05-0.1 mM 15N- and ILVM methyl-labeled protein (Edc3 YjeF) and a 4- to 6-fold excess of 
unlabeled protein (Edc3 IDR). NMR spectra were processed using the NMRPipe/NMRDraw software 
suite267. Figures displaying NMR spectra and protein structures were prepared using NMRview 
(onemoonscientific.com) and Pymol (pymol.org), respectively. 
3.2.5 Solid-state NMR experiments 
Phase-separated Edc3 samples for solid-state NMR measurements were obtained by lowering 
the salt concentration of concentrated protein from 125 mM to 25 mM by dilution with buffer 5  
(25 mM HEPES, pH 7.3, 1 mM DTT). For samples to contain RNA, the protein was supplemented with 
a 2.5-fold molar excess of 30mer RNA in buffer 5. Protein and protein:RNA samples were incubated for 
30 minutes at room temperature and droplets were pelleted by centrifugation at 15.000 g for  
15 minutes. The supernatant was discarded, and the gel was transferred to the solid-state NMR rotors. 
Solid-state NMR experiments were conducted using 3.2 mm and 1.3 mm triple-resonance (1H, 
13C, and 15N) magic-angle-spinning (MAS) probe heads in static magnetic fields of 9.4, 16.4, 18.8 and 
22.2 T, corresponding to proton resonance frequencies of 400, 700, 800 and 950 MHz, respectively. 
Scalar-based correlation experiments utilized HC INEPT295 and 6 ms mixing C-C TOBSY296 transfer steps. 
Samples were chilled to approximately 278 K sample temperature and spun at a MAS rate of 9 kHz. 1H-
detected experiments were performed at a MAS rate of 60 kHz and a sample temperature of 
approximately 310 K. Dipolar-based sequences were used with cross-polarization (CP) steps with an 
amplitude ramp of 80-100% on 1H and 15 kHz PISSARRO297 decoupling during detection periods. 
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For J-based experiments, decoupled HSQC182 sequences were used with a 4 and 3.35 ms INEPT 
transfer time for NH and CH transfers, respectively. NHHC experiments298 were performed on 
[12C,15N]/[13C,14N]-mixed labeled samples in the matured state. Dipolar-based CP steps were used for 
magnetization transfer from 13C to 1H and from 1H to 15N. Proton-mixing times were 0, 1 and 2 ms.  
3.2.6 Molecular Dynamics Simulations 
Molecular dynamics (MD) simulations to probe the interaction between the YjeF_N domain and the 
Edc3 IDR were run with the g54a7 force field299 and the GROMOS simulation package version 4.6.3.300. 
A 3D model of the dimeric YjeF_N domain was obtained using homology modelling301 based on the 
structure of the human protein (PDB:3D3K)291. A linear 14-meric peptide corresponding to the IDR 
stretch M93-E106 was built in Pymol (pymol.org). For the starting state, peptides were placed within 
approximately 1 nm distance from the dimeric YjeF_N domain in a cubic aqueous box. The system was 
first energy minimized, afterwards equilibrated in an NVT ensemble for 100 ps with position restraints, 
then further equilibrated in an NPT ensemble for 100 ps with position restraints, and eventually freely 
evolved for 100 ns. In total, six replicates of 100 ns duration each with randomized initial peptide 
positions were run. Contacts between IDR segment M93-E106 and the YjeF_N domain were quantified 
with the g-mindist tool of the GROMACS simulation package using a contact cut-off of 8 Å. Contacts 
were counted over the last 50 ns of the trajectory. Since the YjeF_N domain is symmetric, the contacts 
for both monomers were added together. The final analysis is the summation of the intermolecular 
IDR - YjeF_N domain contacts from three replicas. 
 
3.3 RESULTS 
3.3.1 The LSm domain of Edc3 is mobile in the matured state  
We initially examined the global dynamics of the matured state of full-length Edc3 (Edc3-FL) 
using scalar-based ssNMR experiments158,286,292. To this end, we recorded HC INEPT295 (Figure 3.1 B) 
and C-C TOBSY296 (Figure 3.1 C) spectra that reveal regions of the protein that are highly mobile. These 
spectra indicate that at least one subdomain of the full-length Edc3 protein remains mobile, even in 
the matured state. As we previously showed that the Edc3 LSm domain is not essential for the LLPS 
process of isolated Edc3252, we speculated that this domain might remain flexible in the matured 
processing body state. To test this hypothesis, we repeated the scalar-based ssNMR experiments on 
matured processing bodies that were prepared from Edc3 protein lacking the LSm domain (Edc3-
∆LSm).  
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In these spectra (Figure 3.1 B and C; blue), we observed a near complete reduction of the 
dynamics that were visible for the wild-type Edc3 protein. In particular, backbone correlations were 
strongly reduced in two-dimensional CC TOBSY spectra of the matured states of the Edc3-∆LSm protein 
compared to Edc3-FL (Figure 3.1 C). Many of these disappearing correlations in Figure 3.1 C matched 
with previous solution-state NMR assignments of the isolated LSm domain and the corresponding 
residues are indicated in Figure 3.1 D in green. Deletion of the LSm domain removes two proline 
residues from the amino acid sequence. Yet, for Edc3-∆LSm a total of four proline resonances 
disappeared (Figure 3.1 E), suggesting that the presence of the highly mobile LSm domain increases 
the flexibility of a part of the IDR. From these data, we conclude that the Edc3 LSm domain remains 
highly flexible in the matured state of the Edc3 protein. This notion also implies that the LSm domain 
is accessible for interactions with other processing body proteins and that it can thus engage in 
interactions with Dcp2, as we previously showed101.  
Figure 3.1: The LSm domain of Edc3 remains mobile after LLPS. (A) Overview of the Edc3 constructs used in this study. 
Residue numbers are indicated on top. (B) HC INEPT spectra highlighting dynamic regions in the full-length phase-separated 
Edc3 protein (Edc3-FL, red) and in the phase-separated Edc3 protein that lacks the N-terminal LSm domain (Edc3-∆LSm, blue). 
(C) 2D CC TOBSY spectra of the phase separated Edc3-FL (red) and Edc3-∆LSm (blue) proteins. The crosses indicate the 
solution chemical shifts of the LSm domain101. (D) The NMR structure of the LSm domain color-coded for residues where the 
solution state chemical shifts match with resonances in the CC TOBSY spectrum (green) and for residues where the solution 
state chemical shifts are not in a region where there are resonances observed in the CC TOBSY spectrum (gray). (E) Zoom on 
the proline region highlighted by the black dashed box in panel C, indicating four unique proline spin systems. 
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3.3.2 The YjeF_N domain forms a rigid core in the matured state  
The C-terminal YjeF_N domain of Edc3 forms a strong dimer interface291 (Figure 3.2) that does 
not dissociate over time and that is essential for the LLPS behavior of Edc3252. Solution-state NMR 1H-
15N TROSY spectra of the isolated and soluble YjeF_N domain display a well-folded protein (Figure 3.3 
A, green). To assess if the fold of the YjeF_N domain changes upon maturation of the phase-separated 
Edc3 protein, we recorded 1H-detected dipolar NH ssNMR spectra on the matured state of the Edc3-
∆LSm protein (Figure 3.3 A, black). These spectra display Edc3 regions that are rigid on the time scale 
of our ssNMR experiment. As the Yjef_N domain comprised the majority of the Edc3-∆LSm protein, we 
thus expected to observe mainly resonances from the dimerization domain.  
Indeed, we found a remarkable overall 
agreement between the NH correlation spectrum of the 
isolated Yjef_N domain in solution and the matured 
form of the Edc3-∆LSm construct (Figure 3.3 A, green 
versus black). The same agreement was observed for  
1H-13C methyl TROSY181 spectra recorded on the soluble 
YjeF_N domain as compared to a 1H-detected dipolar CH 
ssNMR spectra recorded on the matured state of  
Edc3-∆LSm (Figure 3.3 B, green versus black). Note that 
the solution-state NMR spectrum in Figure 3.3 B only 
comprises signals of methyl groups from Ala-β, Ile-δ1, 
Met-ε, Val-γ and Leu-δ positions, as the other carbon 
and proton atoms are NMR-inactive. 
Even in the absence of residue-specific 
assignments, this strong resemblance of solution- and 
solid-state NMR data suggests that the fold of the YjeF_N 
domain is largely conserved in the matured state of the 
Edc3 protein without major structural rearrangements. 
This notion rules out a scenario where the Yjef_N domain 
forms β-sheet-rich fibril-like structures after phase 
separation and maturation and is further supported by 
the strong correlation between ssNMR spectra of the 
matured phase separated Edc3-∆LSm protein and of the 
lyophilized Yjef_N domain (Figure 3.4). 
Figure 3.2: Edc3 forms a stable dimer in solution. 
His6-tagged full-length Edc3 was co-expressed in  
E. coli with either the MBP-tagged Edc3 Yjef_N 
domain (I) or with MBP-tagged full-length Edc3 (II). 
The expressed proteins were purified in two steps. In 
step one, all His-tagged Edc3 complexes (dimers) 
were selected for using Ni-NTA chromatography. In 
step two, all MBP-tagged Edc3 complexes (dimers) 
were selected for using amylose affinity 
chromatography. Edc3 complexes that were purified 
this way contain at least one His-tag and at least one 
MBP-tag. The purified complexes were analyzed by 
SDS-PAGE and show a 1:1 ratio of a His-tagged and an 
MBP-tagged Edc3 monomer. This clearly shows that 
the Edc3 protein forms a stable dimer in solution 
through the Yjef_N domain. Mw: molecular weight 
marker in kDa. 
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Despite the strong correlation between the ssNMR spectrum of the Edc3 protein in the phase-
separated state and the solution-state NMR spectrum of the isolated Yjef_N domain, there are some 
notable differences. This is mainly caused by the fact that the ssNMR spectrum was recorded on a 
protein construct that contains the IDR and the Yjef_N regions, whereas the solution-state NMR 
spectrum was obtained on a sample that only contains the Yjef_N domain. Note that it is not possible 
to record solution-state NMR spectra on an Edc3 construct that includes the IDR, as both Edc3-FL and 
Edc3-ΔLSm undergo LLPS and will transition into a matured state over time, which is incompatible with 
solution-state NMR methods. Due to the presence of the IDR in the sample that was used to record 
the ssNMR spectra, additional NMR resonances are expected and observed (Figure 3.3, compare black 
and green spectra). In addition, the IDR is known to interact with the Yjef_N domain in the phase 
separated protein (see below). This will result in chemical shift perturbations of a set of the Yjef_N 
resonances and thus in differences between the solution and ssNMR spectra. In addition, as the YjeF_N 
domain was expressed in D2O for the solution-state NMR experiments, not all backbone NH protons 
might have back-exchanged during the purification process, which could result in absence of 
resonances in the solution-state 1H-15N NMR spectrum. 
 
Figure 3.3: The fold of the YjeF_N dimerization domain is conserved after LLPS. Comparison of dipolar ssNMR NH spectra 
recorded on Edc3-∆LSm (black) with (1H-15N or methyl 1H-13C) TROSY-based spectra recorded in solution on the YjeF_N 
domain (green). (A) 1H-15N region of the spectrum and (B) methyl region of the spectrum. The overall similarity between the 
spectra shows that the Edc3 Yjef_N domain is folded similarly in solution and in the matured state. As a reference, average 
13C chemical shifts for methyl-containing residues are indicated next to 1H-13C spectrum (note that Thr-γ, Ile- γ2 methyl groups 
and CH2 groups are not NMR-active in the solution-state sample).  
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 Moreover, Ile-γ2 and Thr-γ methyl groups were not labeled for the solution-state NMR 
experiments and the corresponding resonances are thus not visible in the 1H-13C methyl TROSY 
spectrum. Finally, changes between the solution- and solid-state NMR spectra can result from 
differences in the measurement temperature (solid: 277 K, solution: 298 K) and sample preparation. 
Based on our experience on globular proteins, we however judge that these temperature effects only 
cause minor changes in the NMR spectra. In summary, based on a comparison of Yjef_N spectra of the 
Edc3 protein in solution and spectra in the matured state, we conclude that the structure of the Yjef_N 
domain is largely maintained after undergoing LLPS.  
3.3.3 Interactions between the IDR and the Yjef_N domain are important for 
phase separation of Edc3 
Previously, we have shown that the interaction between the Edc3 IDR and the Edc3 
dimerization domain is important for the LLPS process of Edc3. In particular, we have identified two 
regions in the IDR that can interact with the Yjef_N domain252. These regions comprise two amino acid 
segments: K90-K111 (termed IDR1, Figure 3.5 A) and L159-L172 (termed IDR2, Figure 3.5 A). To assess 
the relative importance of these segments for the self-assembly process of Edc3, we performed LLPS 
assays with versions of the protein that lack either the first (IDR1) or the second (IDR2) disordered 
segment that interacts with the Yjef_N domain (Figure 3.5 B). We found that both segments in the IDR 
enhance LLPS.  
Figure 3.4: The fold of the YjeF_N domain in 
isolation is conserved in the matured state. 
Comparison of 1H-detected dipolar NH spectra 
recorded on Edc3-∆LSm in the matured state 
(red) and lyophilized YjeF_N domain (cyan) 
highlighting the conservation of the fold of the 
YjeF_N domain as seen by ssNMR. Differences 
between the two spectra can result from the IDR 
that interacts with the Yjef_N domain in the  
Edc3-∆LSm construct. 
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The first segment has a stronger influence on LLPS than the second one, as removing IDR1 from 
the protein reduces LLPS to a larger degree than removing IDR2. These results underscore the 
degeneracy in the interaction networks that are responsible for cellular phase transitions and identify 
IDR1 and 2 as important interaction sites for LLPS. In support of this data, [13C, 14N] and [12C, 15N] mixed-
labeled Edc3-∆LSm samples were prepared in the matured state to probe intermolecular contacts 
between dimers. We observed intermolecular contacts between HN and HC atom pairs in NHHC 
experiments298 verifying intermolecular contacts between the IDR and YjeF_N during LLPS (Figure 3.6). 
Figure 3.5: Two distinct regions in the IDR are important for phase separation. (A) Edc3 IDR sequence with highlighted 
residues that interact with the YjeF_N domain and RNA. (B) Assays that report on the LLPS (top panels) and maturation 
(bottom panels) of the Edc3 ΔLSm protein. The behavior of the protein was monitored over time (x-axis) at different salt 
concentrations (y-axis). The wild-type Edc3-ΔLSm construct exhibits a high degree of LLPS at low salt concentrations (top left 
panel). The droplets merge over time and form an insoluble gel-like matured phase (bottom left panel). Deletion of YjeF-
interacting segments (middle and right panels) from the IDR results in a decrease of phase separation (top panels) and thus 
also of maturation (bottom panels). These data thus show that the IDR:YjeF_N interaction is important for Edc3 foci formation 
and maturation. IDR1 that contains residues 90-110 has a larger impact on LLPS than IDR2, that comprises residues 158-171. 
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3.3.4 Details of the IDR and Yjef_N domain interactions 
To address the interaction between the IDR and the Yjef_N domain with atomic detail, we 
turned to solution-state NMR techniques. In titration experiments we observed clear chemical shift 
perturbations in 1H-15N TROSY and 1H-13C methyl TROSY NMR spectra of the Yjef_N dimerization 
domain when the IDR is added in trans (Figure 3.7 A and B).  
To identify where the IDR interacts with the YjeF_N domain, we assigned several resonances 
in the 1H-15N and 1H-13C spectra through a mutational approach (Figure 3.8 A). In particular, we were 
able to identify that W393 (based on 1H-15N data) and V253 (based on methyl TROSY data) in the 
dimerization domain are both part of the interface with the Edc3 IDR.  
Figure 3.6: Edc3 dimers show inter-
molecular interactions during LLPS. 
NHHC spectra recorded on mixed 
13C-only labeled and 15N-only 
labeled Edc3-∆LSm with different 
proton mixing times shows the 
intermolecular interactions of  
Edc3-∆LSm dimers in the matured 
state. 
Figure 3.7: The Edc3 IDR interacts with the YjeF_N domain in solution. (A) Solution-state 1H-15N TROSY and (B) 1H-13C HMQC 
spectra of the YjeF_N domain in the absence (black) and presence (green) of the unlabeled IDR. The assignment of W393 and 
V253 are highlighted as these residues show a significant chemical shift perturbation upon interaction with the IDR. 
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Figure 3.8: The IDR interacts directly with the YjeF_N domain. (A) The binding site of the Edc3 IDR on the Edc3 Yjef_N domain 
was mapped using methyl TROSY NMR spectra. Specific residues (W393M (cyan), V253I (blue), K392M (green), L445I (orange) 
and Q447I (magenta)) on the Yjef_N surface were mutated into methyl group containing amino acids to add NMR-active 
probes. These mutant proteins were subsequently used in titration experiments were the NMR-inactive Edc3 IDR was added 
in a 4- to 6-fold molar excess. Chemical shift perturbations of the introduced methyl groups indicate if the corresponding 
residue is part of the Edc3 IDR binding site on the Edc3 Yjef_N domain. Mapping of binding sites in this manner has proven 
to be highly sensitive and accurate214,243. (B) The identified IDR binding site is highlighted on the Yjef_N homology model. 
Residues of the YjeF_N domain that interact with the IDR are colored red while non-interacting residues are colored yellow. 
M315 is located at the back of the YjeF_N dimer in the represented orientation, outside of the binding site of the IDR. 
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As W393 and V253 are close in space on the surface of the Yjef_N domain, they are part of the 
same binding pocket. To define additional residues that are part of this pocket, we took advantage of 
a slightly modified version of the methionine scanning approach214,243. In this method, methyl group-
containing residues were introduced in the spatial vicinity to W393 and V253. These methyl groups 
were subsequently used as probes for the interaction of the YjeF_N domain with the IDR. Based on 
this strategy, we were able to identify K392, L445 and Q447 as part of the IDR binding pocket (Figure 
3.8 A). The introduced methyl groups did not alter the interaction mode between the Yjef_N domain 
and the IDR as the naturally occurring methyl groups of V253 underwent the same CSPs in the WT 
protein and the mutants. At the same time, we showed that L254, K258, L370, L390 and V416 are 
located outside the IDR binding interface (Figure 3.8 B), as these reporter methyl resonances are 
insensitive to the IDR, while the methyl groups of V253 remain effected by the IDR:Yjef_N interaction. 
In short, we find that the Edc3 IDR interacts with the dimerization domain at two specific pockets on 
the surface, one on each protomer.  
To shed further light on how the IDR interacts with the YjeF_N domain, we used atomistic 
molecular dynamics (MD) simulations (Figure 3.9 A). To this end, we used a homology model of the 
YjeF_N domain and performed six simulations of the complex formation between the YjeF_N domain 
and a short peptide that corresponds to IDR segment M93-E106 (IDR1). For each MD simulation, two 
‘IDR peptides’ were randomly placed in the aqueous phase above the YjeF_N domain, shortly 
minimized and equilibrated with position restraints, and the system was freely evolved for 100 ns.  
  
Figure 3.9: Molecular dynamics (MD) simulations confirm a 
direct interaction between the Edc3 IDR and the YjeF_N domain.  
(A) MD simulations on the complex formation between the 
YjeF_N dimer (in white) and peptides corresponding to the first 
YjeF_N-interacting segment of the IDR M93-E106 (IDR 1; red). In 
the MD simulation, for three out of six replicas, the IDR peptides 
directly interacted with the residues V253 (cyan) and W393 
(blue), that were identified as YjeF_N-interacting hotspots in our 
solution-state NMR data. The figure shows the endpoints of the 
simulations after 100 ns.  
(B) The analysis of molecular dynamics simulations results in the 
identification of the binding epitope that was also determined 
based on solution-state NMR experiments. For the simulations 
where the IDR bound in agreement with the solution-state data 
(in red in A), the contacts between the IDR and the Yjef_N domain 
were summed up over the last 50 ns of the MD simulations. 
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Interestingly, in three of the six runs, we observed that the peptides (in red, Figure 3.9 A) 
bound the YjeF_N domain in direct proximity of V253 and W393 (in cyan and blue), corroborating the 
solution-state NMR data. Peptides that bound in proximity of these residues also remained stably 
associated with the YjeF_N domain (Figure 3.9 B). 
3.3.5 RNA interacts with the IDR and thereby increases rigidity  
Previously, we observed that RNA significantly enhances the LLPS tendency of the Edc3 protein 
as three distinct regions on the IDR can directly interact with RNA252  (Figure 3.5 A). To obtain insights 
into the molecular mechanism by which RNA is embedded into the matured state of phase-separated 
Edc3, we conducted ssNMR experiments on Edc3-ΔLSm protein in the presence of RNA. Interestingly, 
based on scalar-based CH and NH spectra we observed that the incorporation of RNA into the protein-
rich Edc3 phase results in a significant loss in ssNMR signals, consistent with a reduction of the internal 
dynamics in the matured phase (Figure 3.10 A and B; compare blue and green spectra). In particular, 
we observe that many resonances that are typical for unstructured backbone and side chain regions 
disappear upon interaction with RNA (Figure 3.10 B, green). These data thus directly report on the 
interaction between RNA and the IDR which results in a loss of mobility of the IDR (Figure 3.10 B).  
Figure 3.10: RNA interacts with the IDR and results in reduced dynamics in the matured state. (A, B) Scalar-based CH 
and NH spectra that detect molecular elements with fast nanosecond motions recorded on Edc3-∆LSm in the absence 
(blue) and presence (green) of RNA, respectively. In panel B, the solution-state 1H-15N assignments of the IDR are 
indicated with black crosses. Putative interaction sites with RNA (red labels) or the YjeF_N domain (black labels) are 
indicated.  
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Using assignments obtained from solution-state NMR252 (black crosses), the regions where 
signals disappear upon RNA incorporation (red labels) were identified to include S86, K127, S131, N137 
and G183. This confirms our previous solution-state NMR analysis on the putative IDR:RNA interaction 
site (Figure 3.5 A), as these residues were identified to directly interact with RNA. Furthermore, many 
resonances of the IDR that are known to interact with the Yjef_N domain are not observed in these 
ssNMR spectra, as these amino acids are rigid both in absence and in presence of the RNA.  
 
  
  
 
  
 
 
 
To independently confirm the rigidification of the IDR upon interaction with RNA, we recorded 
dipolar CH experiments on the matured state of the Edc3-ΔLSm protein in the absence and presence 
of RNA. In those experiments, we observe that several peaks appear upon addition of RNA, confirming 
the hypothesis that residues of the IDR are stabilized by the RNA (Figure 3.11, green). The 
corresponding correlations (for example at 5.39 ppm 1H and 59.9 13C ppm) are consistent with lysine 
side chain and serine/threonine backbone 1H-13Cα signals that are prominently present in the IDR 
segments that interact with RNA in solution (Table 3.4). In conclusion, our solid-state NMR data 
suggests that RNA is recruited to the dynamic and unstructured IDR in Edc3, which results in decreased 
internal mobility. 
 
YjeF IDR 
Ala 26 7 
Arg 6 3 
Asn 14 9 
Asp 10 9 
Cys 3 1 
Gln 16 3 
Glu 8 8 
Gly 18 6 
His 7 4 
Ile 18 2 
Leu 33 8 
Lys 10 20 
Met 1 1 
Phe 9 6 
Pro 11 6 
Ser 19 18 
Thr 21 5 
Trp 3 1 
Tyr 3 2 
Val 23 7 
Figure 3.11: Dipolar-based ssNMR experiments report on the 
rigidification of the Edc3 protein in the presence of RNA.  
(A) Dipolar CH spectra that detect rigid, immobile entities were 
recorded on Edc3-∆LSm in the absence (blue) and presence (green) 
of RNA. Several boxes indicate predicted chemical shifts for specific 
amino acids. (B-D), 1D slices of highlighted regions in A. 
 
Table 3.3: Amino acid distribution 
and occurrence for the Edc3 YjeF_N 
domain and IDR 
 
 
YjeF IDR 
Ala 26 7 
Arg 6 3 
Asn 14 9 
Asp 10 9 
Cys 3 1 
Gln 16 3 
Glu 8 8 
Gly 18 6 
His 7 4 
Ile 18 2 
Leu 33 8 
Lys 10 20 
Met 1 1 
Phe 9 6 
Pro 11 6 
Ser 19 18 
Thr 21 5 
Trp 3 1 
Tyr 3 2 
Val 23 7 
 Table 3.4: Amino acid distribution 
and occurrence for the Edc3 YjeF_N 
domain and IDR 
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3.4 DISCUSSION 
LLPS is increasingly recognized as a cellular process that allows for the organization of cellular 
compartments across different spatial and temporal scales. A prominent example of such systems are 
RNP granules that contain proteins involved in translational repression and mRNA degradation252.  
Currently, the mechanisms by which LLPS modulates cellular function is not understood in 
sufficient detail. One potential consequence of LLPS is that the  catalytic activity of the embedded 
enzymes is effected, potentially through changes in the local concentrations or accessibility of 
substrates252. To shed light on these aspects, it is essential to gain atomic-level insight into the 
structural organization of LLPS proteins. Here, we demonstrate the power of combining solid- and 
solution-state NMR to study the process of phase separation events on the structural and dynamical 
level and at atomic resolution.  
Our results on the central processing body protein Edc3 reveal that the different domains 
exhibit different levels of structural organization and dynamics after LLPS and a second transition into 
a matured phase. Firstly, we find that the N-terminal LSm domain remains largely dynamic in the 
matured state, which leaves this domain accessible for contacts with additional processing body 
proteins including the Dcp1:Dcp2 mRNA decapping complex. Secondly, we find that the C-terminal 
YjeF_N domain largely retains its structure when the Edc3 protein undergoes a transition from the 
soluble to the matured phase separated state. This is in strong contrast to other proteins that have 
been observed to form insoluble amyloidic fibril structures after phase separation148. The minor 
structural changes in the fold of the Edc3 protein reflects the fact that proteins that reside in cellular 
processing bodies can rapidly dissociate from these foci.   
Within the phase-separated state, the Edc3 Yjef_N domain interacts with the IDR of Edc3. This 
transient interaction is likely intermolecular as it increases the network of interactions leading to LLPS. 
Finally, we observe that the Edc3 IDR interacts with RNA in the matured state. These interactions 
involve distinct segments of the IDR and result in enhanced phase separation as the RNA extends and 
tightens the intermolecular interaction network. 
Based on our data, we can propose a model for the formation of the matured state of the Edc3 
protein (Figure 3.12). In this model, the dimeric soluble Edc3 protein engages in a number of 
intermolecular interactions that involve RNA. These contacts result in the formation of an infinite 
interaction network that drives the transition of the Edc3 protein from the dimeric soluble form into a 
dense protein state that then further matures into an insoluble state. 
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 Interestingly, our data clearly show that the interactions between Edc3 and RNA that take 
place between the soluble components are, to a large degree, preserved in the matured phase-
separated state. The structural differences upon LLPS are thus small, which facilitates the reversibility 
of the process and necessitates only small cellular perturbations to induce phase separations (Figure 
3.12).  
Our work paves the way for future studies that address the exact structural changes that take 
place upon LLPS and those that result in the formation of the irreversible assemblies. Based on our 
data, these latter changes are small, but they will, nevertheless, have a significant effect on cellular 
homeostasis, as the maturation of cellular condensed protein phases needs to be prevented. We 
envision that our approach to study the structure and dynamics of LLPS complexes will be able to 
provide important insights for the current context and will also be applicable for other LLPS systems 
where irreversible assemblies are closely linked to fibril formation and disease. 
  
Figure 3.12: Model of Edc3- and RNA-mediated processing body formation. The soluble dimeric Edc3 protein (blue and red) 
contains an N-terminal LSm domain that is linked through an IDR with the C-terminal dimeric Yjef_N domain (left). 
Intermolecular interactions between RNA (green), the IDR and the Yjef_N domains (solution-state NMR) result in the 
establishment of an infinite interaction network that leads to liquid-liquid phase separation of the RNP. The LLPS proteins 
mature over time to form a gel-like state. Within this matured phase of processing bodies, the LSm domains remain highly 
flexible (solid-state NMR) and can thus interact with other processing body proteins (top circle). Based on solution-state and 
solid-state NMR data, we have shown that the Edc3 YjeF_N dimerization domain remains dimeric and interacts specifically 
via a surface patch with an Edc3 IDR of another Edc3 dimer (middle circle). The RNA interacts with the Edc3 IDR, which results 
in a rigidification of the unstructured region (bottom circle). 
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CHAPTER 4 Deciphering the contributions of molecular inter- 
  actions that lead to liquid-liquid phase separation 
  of the conserved DEAD-box protein Dhh1 
Unpublished results. Remco Sprangers conceived the project. Experiments were designed 
by R.S. and Stefan Schütz. S.S. performed all experiments. R.S. and S.S. analyzed and interpreted data. 
S.S. prepared figures and drafted the manuscript, which has been revised by R.S. 
4.1 INTRODUCTION 
DEAD-box helicases302 belong to a large family of non-processive ATP-dependent RNA helicases 
that are conserved from bacteria to humans303. S. cerevisiae Dhh1 belongs to the Dhh1/DDX6  
sub-family of DEAD-box helicases304 and is involved in translational repression, processing body  
(P-body) formation and mRNA decay75,88,95,305–307. Orthologs of Dhh1 are found in all higher 
eukaryotes271 such as S. pombe (Ste13)308, Caenorhabditis elegans (CGH-1)309, Drosophila melanogaster 
(Me13B)310, Xenopus leavis (Xp54)311 and mammals (RCK/p54 or DDX6)312–314.  
Dhh1 contains two conserved central RecA-like315 domains that are connected via a short 
flexible linker sequence. The two RecA-like domains form the so-called helicase core, which is flanked 
by disordered N- and C-terminal extensions (NTE and CTE, respectively). The sequence of these 
extensions are not conserved among the members of the Dhh1/DDX6 sub-family of DEAD-box 
helicases303. In S. cerevisiae Dhh1, the protein discussed in this work, the NTE comprises about  
30 residues and is enriched in asparagine. The CTE contains about 80 residues and is highly enriched 
in proline and glutamine residues146, reminiscent of a prion-like domain316,317. 
The crystal structure of the apo Dhh1 helicase core reveals an open but compact conformation 
that is rigidified by contacts between the two RecA-like domains (Figure 4.1 A and B)318. It has been 
shown that RNA binding to Dhh1 requires domain interactions, as mutations of the interdomain 
contacts result in weaker RNA binding318. In the absence of ATP, RNA binding does not induce 
conformational changes in Dhh1 as has been concluded from tryptic digestion experiments318. 
Contrarily, ATP alone is sufficient to induce a conformational change and further compaction is 
achieved in the presence of both ATP and RNA318. Based on structures of other DEAD-box helicases, it 
has been suggested that the interaction of Dhh1 with RNA and ATP leads to the formation of a closed 
state of the enzyme (Figure 4.1 C)318.  
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Figure 4.1: Crystal structure of the S. cerevisiae Dhh1 helicase core. (A) In the apo form (pdb: 1s2m), Dhh1 adopts an open 
but compact conformation with several contacts between the RecA1 (dark grey) and RecA2 (light gray) domains. These 
contacts interfere with the formation of a continuous RNA-binding surface (green). Binding of the Pat1 protein (yellow) to 
the Dhh1 RecA2 domain does not interfere with the interdomain contacts, but with crystal packing. The position of Pat1 was 
obtained from a superposition of apo Dhh1 (pdb: 1s2m) with Dhh1 in complex with Pat1 (5-79) (pdb: 4brw). Residues involved 
in the interdomain contacts are indicated and depicted in stick representation. The DEAD-box motif is highlighted in magenta. 
(B) Same as (A) but rotated as indicated. (C) Model of Dhh1 in its RNA- and ATP-bound form. The model was obtained by a 
superposition of the RecA1 domain from apo Dhh1 and of the RecA2 domain from the Dhh1:Pat1 complex with the structure 
of D. melanogaster Vasa (pdb: 2db3) in complex with an oligo-U RNA (orange), magnesium (green sphere) and AMPPNP (hot 
pink sticks). The orientation of the Dhh1 RecA1 domain is as in (B). To highlight the domain reorientation in the closed 
conformation, the RecA2 domain is in light blue compared to light gray in apo Dhh1 (A and B). In the ATP- and RNA-bound 
form, Dhh1 residues involved in RNA-binding (as inferred from the Vasa:RNA:ATP complex structure) form a continuous 
interaction surface, while the interdomain contacts are disrupted. The DEAD-box motif is in proximity to the Mg2+-ion that 
coordinates the β- and γ-phosphate groups of ATP. Note that Pat1 clashes with the RNA in the closed conformation, which 
provides a rationale for the mutually exclusive interactions of Pat1, Edc3 and RNA with the Dhh1 RecA2 domain.   
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In the closed state, the ATPase activity and the affinity for single-stranded RNA is increased in 
other DEAD-box helicases such as D. melanogaster Vasa319–322. Consistently, the low intrinsic ATPase 
activity that is associated with the rigid open conformation of Dhh1 increases about 10-fold in the 
presence of RNA and about a further 2.5-fold when the interdomain contacts are disrupted323. On the 
other hand, the RNA-binding affinity was found to be independent of ATP323. Notably, helicase activity 
has never been demonstrated for the purified Dhh1 enzyme164,318,323. 
In vivo, members of the Dhh1/DDX6 subfamily of DEAD-box helicases have a general function 
in mRNA storage and translational control311,324–328. The role of Dhh1 in translational repression likely 
results from its interaction with the CCR4-Not deadenylation complex329,330 and by interfering with the 
assembly of the 48S preinitiation complex88. In addition, Dhh1 can interfere with translation elongation 
by binding to sub-optimal codons, which can trigger the degradation of the transcript74.  
Dhh1 interacts with a large number of proteins that are involved in mRNA turnover. First, Dhh1 
binds to the CCR4-Not deadenylation complex via a direct interaction with the Not1 MIF4G domain, 
that also serves as a scaffold to tether the Pop2/Caf1 and Ccr4 deadenylases331–334. Second, Dhh1 is 
recruited to the mRNA degradation machinery through interactions between the Dhh1 C-terminal 
extension and the main decapping activator Dcp199,330. Third, Dhh1 interacts directly with Dcp2, 
without influencing the activity of the mRNA decapping enzyme95. And fourth, the RecA2 domain of 
Dhh1 can recognize FDF, FDK and FG motifs that are present in the decapping factors Edc3, Pat1 and 
Scd6105–108. These motifs interact with specific, hydrophobic binding sites on the surface of the helicase 
(Figure 4.2). Notably, binding of Pat1 or Edc3 to Dhh1 was found to interfere with RNA binding due to 
overlapping binding sites on the surface of the RecA2 domain105. 
Dhh1 is a major component of cytosolic processing bodies113,259 and recruited to these foci 
through interactions with the Edc3 protein144. The Dhh1 protein is then able to recruit the 
deadenylases Pop2/Caf1 and Ccr4335. ATP- and RNA-binding is required for Dhh1 localization to  
P-bodies, as the disruption of either binding site significantly reduces P-body formation164. Notably, 
the ATPase activity of Dhh1 is required for the disassembly of in vivo P-bodies, as mutations in the 
active site result in a permanent presence of P-bodies164. 
The mechanisms that result in the formation of processing bodies have been extensively 
studied in vitro, based on bottom-up experiments that can detect the propensity of protein complexes 
to undergo spontaneous liquid-liquid demixing103,252. It was found that the in vitro phase separation of 
Dhh1 depends on the presence of ATP and single-stranded RNA164. Consistent with this notion, RNase 
treatment resulted in the dissolution of in vitro Dhh1 droplets164.  
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Several intermolecular interactions modulate the Dhh1 LLPS process. On the one hand, the 
Not1 MIF4G domain stimulates the disassembly of Dhh1 clusters in vitro and triggers disassembly of 
P-bodies in vivo164. In agreement with that, mutations in the Not1:Dhh1 interface lead to a constitutive 
assembly of cellular P-bodies164. On the other hand, the decapping factor Pat1 enhances in vitro Dhh1 
phase separation in the presence of ATP and RNA and promotes in vivo P-body formation through a 
direct interaction with the Dhh1 helicase core152.  
Here, we study the liquid-liquid phase separation process of Dhh1 at an atomic level. Based on 
a bottom-up approach with recombinant proteins and well-defined RNA, we quantify how specific 
intermolecular interactions contribute to the LLPS propensity of Dhh1. In summary, we establish that 
the isolated Dhh1 helicase core also undergoes liquid-liquid phase separation in a manner that is 
independent of ATP or RNA. Based on a large number of mutations in Dhh1 and on methyl TROSY NMR 
spectroscopy we identified residues in Dhh1 that are important for the phase separation process. In 
addition, we show that the LLPS of the Dhh1 core is enhanced by ATP, RNA and the N- and C-terminal 
extension of Dhh1. Our studies thus shed light on molecular principles that result in LLPS of proteins 
that contain both folded domains and intrinsically disordered regions.  
Figure 4.2: Decapping factors interact with the Dhh1 RecA2 domain. (A) Surface representation of the Dhh1 RecA2 domain 
(pdb: 4brw, light gray) in complex with peptides of Edc3 (orange), Pat1 (yellow) and LSm14/Scd6 (beige). For the model, the 
RecA2 domains of the Dhh1:Pat1 (pdb: 4brw) and DDX6:LSm14 (pdb: 6f9s) complexes were superposed on the RecA2 domain 
of the Dhh1:Edc3 complex (pdb: 4bru). In the DDX6:LSm14 crystal structure, LSm14 residues 209-254 (dashed line) are lacking 
electron density. This linker sequence connects the FG and FNK motifs. The superposition reveals a conserved binding mode 
of several mRNA decay factors and P-body components to the Dhh1 protein. (B, C) Zoom on the FDF (B) and FG/WQ motif 
(C) that bind to hydrophobic pockets on the RecA2 domain. Coloring of the peptides is as in A. The surface of Dhh1 is colored 
according to its electrostatic surface potential. Surface potentials were calculated in pymol 2.3 (Schrödinger, LLC; 
https://pymol.org/2/) and color-coded from red (negatively charged) to blue (positively charged). 
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4.2 MATERIALS AND METHODS 
4.2.1 Protein expression and purification 
The genes for full-length or truncated constructs of Dhh1 from Saccharomyces cerevisiae and 
Chaetomium thermophilum were cloned into modified pET vectors that carry an N-terminal TEV-
cleavable His6-tag. The genes for the first and second RecA-like domain of Dhh1 (RecA1 and RecA2, 
respectively), the N-terminus of Pat1 (Pat_N) and the intrinsically disordered region (IDR) of Edc3 from 
S. cerevisiae were cloned into modified pET vectors that carried an N-terminal TEV-cleavable His6-GST-
tag. Point mutations, deletions and insertions were introduced using standard site-directed 
mutagenesis or enzymatic assembly methods336,337 (Table 4.1).  
Table 4.1: Protein constructs used in this study 
Protein / Construct Residues / Mutations Solubility / 
Purification tag 
Internal 
reference 
S.c. Dhh1 1-506 N-His6-TEV #1872, #1906 
S.c. Dhh1 (Dhh1ΔN) 31-506  N-His6-TEV #1873 
S.c. Dhh1 (Dhh1ΔC) 1-425  N-His6-TEV #1883 
S.c. Dhh1 (ΔNC / core) 31-425  N-His6-TEV #47, #1907 
S.c. Dhh1 (RecA1) 31-251  N-His6-GST-TEV #1696 
S.c. Dhh1 (RecA2) 250-425  N-His6-GST-TEV #1697 
S.c. Dhh1 (stretch1) 31-425 (core), 316-KMPQAARNR-324 N-His6-TEV #1874 
S.c. Dhh1 (stretch1+2) 31-425 (core), 316-KMPQAARNR-324, 
328-DFRNGVCRN-336  
N-His6-TEV #1912 
S.c. Dhh1 (stretch1+3) 31-425 (core), 316-KMPQAARNR-324, 
407-HPIPAEIPKNLYVYENP-423 
N-His6-TEV #1914 
S.c. Dhh1 (stretch3) 31-425 (core),  
407-HPIPAEIPKNLYVYENP-423  
N-His6-TEV #1936, #1957 
S.c. Dhh1 (AAtoHP) 31-425 (core), A407H, A408P N-His6-TEV #1958 
S.c. Dhh1 (DDtoPP) 31-425 (core), D414P, D423P N-His6-TEV #1958 
S.c. Edc3_idr 86-125 N-His6-GST-TEV #1887 
S.c. Pat_N 5-79 N-His6-GST-TEV #1905 
C.t. Dhh1 27-421 (core) N-His6-TEV #1903 
S.c. RecA1 – C.t. RecA2 
(ScA1-CtA2) 
31-250 (S.c.) fused to 251- 421 (C.t.) 
 
N-His6-TEV #1911 
C.t. RecA1 – S.c. RecA2 
(CtA1-ScA2) 
17-250 (C.t.) fused to 251-425 (S.c.) 
 
N-His6-TEV #1803 
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Chemical competent E. coli BL21 (DE3) Codon Plus RIL (Stratagene) cells were transformed with 
the appropriate plasmid and grown in LB (lysogeny broth) medium at 37 °C. At an OD600 of 0.8, protein 
overexpression was induced with 0.5 mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) at 20 °C. 
Following overnight expression, cells were pelleted by centrifugation and lysed by ultrasound in  
buffer A (25 mM sodium phosphate, pH 7.4, 500 mM NaCl, 1 mM DTT) complemented with 10 mM 
imidazole, lysozyme, 0.1 % Triton X-100, 5 mM MgCl2 and 0.2 U/mL DNase. Insoluble debris were 
removed from the cell lysate by centrifugation and the supernatant was applied to Ni2+-nitrilotriacetic 
acid (NTA) resin equilibrated in buffer A. The resin was washed with 15 column volumes (CV) buffer A 
that was complemented with 10 mM imidazole. The protein bound to the resin was eluted with buffer 
A complemented with 300 mM imidazole. 1 mg TEV protease was added to the eluted proteins to 
cleave the purification tag from the target protein.  
Subsequently, proteins were dialyzed overnight at 20 °C into buffer B (20 mM MES, pH 6.0,  
125 mM NaCl, 1 mM DTT) supplemented with 0.5 mM EDTA. Solutions of dialyzed Dhh1 constructs 
that contain the helicase core (RecA1-RecA2) were adjusted to 250 mM NaCl and supplemented with 
4 % (v/v) 3 M sodium acetate, pH 5.3. Proteins were concentrated using centrifugal filters. Purification 
to homogeneity was achieved by size exclusion chromatography (SEC) on a HiLoad 16/600 Superdex 
75 column (GE Healthcare) in buffer C (20 mM MES, pH 6.0, 100 mM NaCl, 1 mM DTT).  
After SEC, pooled fractions of Pat_N (Pat1, residues 5-79) or Edc3 IDR (residues 86-125) still 
contained trace amounts of the His6-GST expression tag as assessed by SDS-PAGE. The impurities were 
removed by reverse affinity chromatography. In brief, the solution was applied to Ni2+-NTA resin 
equilibrated with buffer C that was supplemented with 10 mM imidazole. The resin was washed with 
two CV buffer C complemented with 10 mM imidazole. The flow-through and wash fractions, that 
contained only the target protein, were pooled and concentrated for a second size exclusion 
chromatography step, after which pure and homogenous target protein was obtained.    
4.2.2 Complex reconstitution 
Dhh1:Pat_N and Dhh1:Edc3_idr complexes were reconstituted following published 
protocols105. In brief, purified components were mixed in a 1:1.5 molar ratio, whereby the peptide was 
in excess over the Dhh1 protein. After incubation for 1 hour at 30 °C, unbound protein was separated 
from the complex on a HiLoad 26/600 Superdex 75 column (GE Healthcare) in buffer C. Fractions 
containing the complex were pooled and concentrated using centrifugal filters. 
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4.2.3 Protein labeling for NMR spectroscopy 
Labeling of proteins with NMR-active nuclei was achieved by over-expression of the gene in 
M9 minimal medium. The growth medium was supplemented with 1 g/L 14NH4Cl as the sole nitrogen 
source and 2 g/L 2H12C-glucose, if the medium was based on 100 % D2O, or 4g/L 1H12C-glucose, if the 
deuteration level was less. Labeling of the Ala-β, Ile-δ1, Met-ε, Leu-δ1/δ2 and Val-γ1/γ2 methyl groups 
(ILVMA-labeling) within a U-[2H,12C]-background was achieved by supplementing the medium with  
α-ketobutyrate (3-2H2-4-13C; 60 mg/L), L-methionine (methyl-13CH3; 100 mg/L) and α-ketoisovalerate 
(3-2H-3-(methyl-13CH3)-4-13C; 100 mg/L) one hour prior to induction. L-alanine (2-2H-3-13C, 100 mg/L) 
was added 20 minutes prior to induction. For samples to be labeled in Val but not Leu methyl groups, 
100 mg/L unlabeled α-ketoisocaproate is added in combination with methyl-labeled α-ketoisovalerate. 
For labeling of Ala-β methyl groups without simultaneous labeling of valine and leucine, the medium 
is supplemented with perdeuterated α-ketoisovalerate instead of its methyl-labeled form (Figure 1.4). 
4.2.4 NMR spectroscopy 
All NMR samples were prepared in buffer C and contained 5 % D2O in the case of IM-, IA-, IV-, 
IMA- and IMV-labeled samples, or 100 % D2O for ILVMA-labeled samples. The latter were used to 
record 3D HMQC-NOESY-HMQC spectra with short and long mixing times (40-60 ms and 300 ms, 
respectively) for automated methyl group assignments using MAGIC240. NMR spectra were recorded 
at 298 K on a Bruker AVIII-800 spectrometer equipped with a cryogenic probe-head. NMR titration 
experiments were carried out with 40 μM IM-labeled Dhh1 RecA2 and a 4-fold excess of unlabeled 
Dhh1 RecA1. NMR spectra were processed using the NMRPipe/NMRDraw software suite267. Figures 
displaying NMR spectra were prepared using NMRview (onemoonscientific.com) or Sparky338. 
4.2.5 RNA in vitro transcription and purification 
In vitro transcription and purification of a 30mer RNA (Table 4.2) was carried out as described 
before252. A DNA primer served as the template and transcription was accomplished using in-house 
purified T7 RNA polymerase263. In brief, transcribed RNA was purified under denaturing conditions 
using anion exchange chromatography, followed by isopropanol precipitation and desalting. Solvent 
evaporation resulted in the pure dry RNA product, which was resuspended at a concentration required 
for phase separation experiments. The quality and integrity of the RNA was controlled using urea-
polyacrylamide gel electrophoresis in 1x TBE (89 mM Tris, pH 8.0, 89 mM boric acid, 2 mM EDTA). RNA 
bands were visualized by methylene blue staining.  
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Table 4.2: 30mer RNA used in this study 
RNA Properties Sequence Internal reference 
30U15mer GA-only, but single U at 
position 15 
GGAGGAGAGGAAGGUAAGGGAAGAAAGAAG #10 primer 
4.2.6 Liquid-liquid phase separation experiments 
For LLPS experiments, proteins were prepared as 3x concentrated stock solutions in buffer C 
that contains 125 mM NaCl. 3.3 μL of protein were diluted into prepared mixtures (6.6 μL) of 20 mM 
MES/HEPES and NaCl that resemble a grid of conditions with the following final parameters: pH 6.0, 
6.5, 7.0, 7.5 and 35 mM, 50 mM, 75 mM, 100 mM NaCl. For each condition, three technical replicates 
were prepared. Immediately after dilution, the absorption at 600 nm (OD600) as a quantitative estimate 
of phase separation was measured on a Nanodrop spectrophotometer. Mean values for each technical 
replicate are from three measurements. Phase separation experiments were carried out at 20 °C unless 
stated otherwise.  
To investigate the temperature-dependence of the Dhh1 LLPS process, three 50 μL samples at 
100 μM protein concentration were prepared from a 3-fold concentrated stock solution at a final pH 
of 6.65 and a final salt concentration of 75 mM. The samples were kept for 2 minutes at a defined 
temperature (4, 20 or 37 °C) before the OD600 was measured on a Nanodrop spectrophotometer. 
Afterwards, the samples were transferred to another temperature. The steps were as follows: room 
temperature, 4 °C, 20 °C, 4 °C, 20 °C, 37 °C, 20 °C, 4 °C, 37 °C, 4 °C, 20 °C.   
4.3 RESULTS 
4.3.1 Dhh1 undergoes phase separation in the absence of RNA 
In previous work, we established that a synergistic network of protein-protein and protein-
RNA interactions promotes the formation of in vitro processing bodies252. We found that weak but 
multivalent binding events between decapping factors form the basis of theoretically infinite 
interaction networks which manifest in a liquid-liquid phase separation process in vitro and eventually 
processing body formation in vivo103,252. Considering the finding that Edc3 can undergo LLPS 
independent of any other binding partner, we hypothesized that S. cerevisiae Dhh1 may also possess 
a potential intrinsic phase separation capability.  
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To test our hypothesis, we first focused on the helicase core of Dhh1, which consists of the two 
RecA-like domains RecA1 and RecA2 but lacks the unstructured N- and C-terminal extensions  
(Figure 4.3 A). We assessed LLPS of the Dhh1 helicase core at different conditions (pH 6.0-7.4 and  
35-100 mM NaCl) with turbidity measurements that accurately report on the degree of LLPS134,252. We 
found that the Dhh1 core phase separated preferably at high pH and low salt concentrations and that 
this LLPS behavior is most pronounced at high protein concentrations (Figure 4.3 B). The observed LLPS 
process is dependent on the intact helicase core as a mixture of the two separately purified RecA-like 
domains (100 μM each) is not able to undergo phase separation (Figure 4.3 C). 
  
Figure 4.3: Phase separation of the Dhh1 helicase core. (A) Schematic representation of S. cerevisiae proteins, RNA and 
interactions important for LLPS in vivo. The DEAD-box RNA helicase Dhh1 is tightly embedded in an interaction network 
formed by mRNA degradation factors and RNA. Different interaction modes (colored arrows) complement each other in the 
formation of in vitro liquid droplets and in vivo processing bodies. (B) Phase diagrams of the S. cerevisiae Dhh1 helicase core 
protein at different concentrations. The protein undergoes LLPS in a concentration-dependent manner at high pH and low 
salt concentrations. White color indicates no phase separation, while red indicates a high degree of LLPS as assessed by 
turbidity measurements at 600 nm. The color scheme is the same for all grids shown in this chapter. (C) LLPS of Dhh1 is 
dependent on the intact helicase core. A mixture of individually expressed and purified RecA1 and RecA2 domains does not 
phase separate. An interaction between the two domains in trans is not sufficient for LLPS. (D) Phase separation of Dhh1 is 
temperature-dependent. Low temperatures promote phase separation, while at elevated temperatures liquid droplets 
dissolve. (E) Dhh1 LLPS does not depend on the type of salt present in the buffer. Experiments were carried out with 75 µM 
protein at pH 6.5. 
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Depending on the amino acid composition, the type of interactions and thermodynamic 
processes that govern phase separation, proteins can undergo liquid-liquid phase separation at low or 
high temperatures142,339. We found that Dhh1 undergoes phase separation at low temperatures  
(Figure 4.3 D). Enhanced phase separation at low temperatures is associated with polar residues that 
govern the LLPS process142,339. Moreover, the temperature-dependent phase separation of Dhh1 is 
reversible (Figure 4.3 D): at high temperatures, preformed liquid droplets of Dhh1 rapidly dissolve, 
while a subsequent decrease in temperature results in droplet re-formation. The observed reversibility 
is a hallmark of LLPS processes103,120,137,142,154,273. 
To test the influence of different salts on LLPS of the Dhh1 core, we performed phase 
separation experiments in the presence of NaCl, KCl and NH4Cl (Figure 4.3 E). We did not observe any 
strong salt dependency and thus used NaCl in all further experiments. Independent of the salt type, 
phase separation of the Dhh1 core is enhanced at lower temperatures (Figure 4.3 E right panel). 
4.3.2 Residues at the C-terminus of the RecA2 domain are crucial for LLPS 
We next asked which parts of the Dhh1 
helicase core mediate phase separation. To our 
surprise, we found that the C. thermophilum and  
S. cerevisiae Dhh1 helicase core proteins (CtDhh1 
and ScDhh1, respectively) show different phase 
separation patterns (Figure 4.4 left), although they 
share over 75 % sequence identity (Figure 4.5 A). 
As for ScDhh1, CtDhh1 shows a high degree of 
phase separation at low salt concentrations. 
However, LLPS of CtDhh1 is strongest at low pH, 
while for ScDhh1 LLPS is strongest at high pH 
(Figure 4.4, compare top left and bottom left).  
We used the C. thermophilum homolog of 
the S. cerevisiae Dhh1 protein as a toolbox to 
determine crucial residues for phase separation of 
the S.c. Dhh1 helicase core.  
  
Figure 4.4: Dhh1 phase separation patterns are species-
dependent. Phase diagrams for Dhh1 helicase core proteins 
from S. cerevisiae (top left), C. thermophilum (bottom left) 
and chimeric constructs (right) at 100 μM. S.c. and C.t. Dhh1 
proteins exhibit different LLPS patterns. The S.c. RecA2 
appears to promote phase separation as its loss (from wild-
type ScDhh1 to chimeric ScA1-CtA2) results in reduced 
phase separation. Conversely, gain of the S.c. RecA2 domain 
(from CtDhh1 to chimeric CtA1-ScA2) enhances phase 
separation. 
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First, we designed two chimeric proteins with swapped domains. The first chimera consists of 
the RecA1 domain of S.c. Dhh1 fused to the RecA2 domain of C.t. Dhh1 (ScA1-CtA2) and the second 
chimera consists of the RecA1 domain of C.t. Dhh1 fused to the RecA2 domain of S.c. Dhh1  
(CtA1-ScA2). We then assessed the phase separation behavior of the two chimeric proteins to 
determine if they exhibit intermediate phase separation patterns or if the LLPS patterns are dominated 
by only one of the two RecA-like domains. 
The phase separation pattern of the ScA1-CtA2 chimera is reminiscent of the pattern observed 
for the S.c. Dhh1 helicase core (ScDhh1) although the overall degree of phase separation is reduced 
relative to the wild-type protein (Figure 4.4, compare top left and right). In contrast, for the CtA1-ScA2 
chimera we observe a LLPS pattern which resembles that of CtDhh1 but shows enhanced phase 
separation compared to the latter (Figure 4.4, compare bottom left and right). These results indicate 
that the S.c. RecA2 domain is a driving force of Dhh1 phase separation: gain of the S.c. RecA2 domain 
(from CtDhh1 to CtA1-ScA2; Figure 4.4 bottom) enhances LLPS, while its loss (from ScDhh1 to  
ScA1-CtA2; Figure 4.4 top) reduces phase separation. 
We hypothesized that stepwise mutations at positions in the RecA2 domain, which are 
different in S. cerevisiae and C. thermophilum, would result in a transition of the LLPS pattern from 
ScDhh1 towards ScA1-CtA2 (Figure 4.4 top left and right). To that end, we identified three sequence 
stretches in the RecA2 domain which are least conserved between S. cerevisiae and C. thermophilum 
(Figure 4.5 A). These stretches (1-3) are solvent-exposed and, for stretch 1 and 2, alter the electrostatic 
surface potential of Dhh1 (Figure 4.5 B, top and bottom left). Changes in the presence and distribution 
of surface-exposed charged residues might influence the LLPS behavior of the Dhh1 protein, as 
electrostatic interactions are one possibility of proteins to undergo intracellular phase transitions119. 
Consequently, we expressed and purified Dhh1 helicase core proteins which harbor mutations 
in the three stretches. In that process, the wild-type S. cerevisiae Dhh1 sequence was changed towards 
the C. thermophilum protein, and LLPS behavior was tested based on pH/salt-grids (Figure 4.6). 
Changing the sequence in stretch 1 has no effect on Dhh1 LLPS, as this mutant (Figure 4.6, top right) 
shows phase separation comparable to wild-type ScDhh1 (Figure 4.6, compare top left and right), 
likewise, changing both stretch 1 and 2 has no strong effect on the Dhh1 LLPS behavior (compare left 
top and bottom). Contrarily, in the stretch 1+3 and stretch 3 mutants phase separation is completely 
abolished (Figure 4.6, bottom middle and right). Hence, we conclude that residues in stretch3 are 
important for Dhh1 LLPS.   
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Figure 4.5: Dhh1 proteins from S. cerevisiae and C. thermophilum are highly similar. (A) Sequence alignment of the Dhh1 
helicase core regions of S. cerevisiae and C. thermophilum. Domain boundaries are indicated in gray. Three sequence stretches 
in the RecA2 domain (stretch 1-3, black) exhibit low conservation between the two yeast species. (B) Electrostatic surface 
potentials of S.c. Dhh1 (top) and C.t. Dhh1 (bottom). The three stretches are solvent-exposed, and their location is indicated. 
The sequence variations in these patches between S. cerevisiae and C. thermophilum results in an altered surface potential 
(compare especially patch 1 and 2 of S.c. and C.t. Dhh1). The orientation is the same for S.c. and C.t. Dhh1 and the location 
of the RecA2 domain is indicated. Surface potentials were calculated in pymol 2.3 (Schrödinger, LLC; https://pymol.org/2/) 
and color-coded from red (negatively charged) to blue (positively charged). The structure of C.t. Dhh1 is a homology model 
obtained with SWISS-MODEL (https://swissmodel.expasy.org/) and based on the crystal structure of S.c. Dhh1 (pdb: 1s2m).  
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Two sets of sequence variations in stretch 3 (residues 407-423) between S. cerevisiae and the 
C. thermophilum caught our attention. First, in the crystal structure of S.c. Dhh1 A407 and A408 form 
a small β-strand which augments the central β-sheet of the RecA2 domain318. In C. thermophilum, these 
two alanine residues are substituted by a His-Pro dipeptide (Figure 4.5 A). As proline is generally 
considered to break secondary structures340,341, the A408P substitution might thus prohibit β-sheet 
augmentation, which could be the reason for the different LLPS behavior of S. cerevisiae and  
C. thermophilum Dhh1. And second, the aspartate residues D414 and D423, which are in a loop in  
S.c. Dhh1, are substituted by proline residues in C.t. Dhh1 (Figure 4.5 A). Since LLPS can be mediated 
by charge-charge interactions119, net loss of two negative charges due to the double Asp-to-Pro 
substitution might result in reduced phase separation. 
Figure 4.6: Mutations in the C-terminus of the RecA2 domain abolish LLPS of Dhh1. (A) Phase diagrams of Dhh1 helicase 
core proteins at 25 µM. Mutations in two regions (stretch 1 and stretch 2; top right and bottom left, respectively), which 
exhibit sequence variations between S.c. and C.t. (see Figure 4.5), do not reduce phase separation compared to wild-type 
ScDhh1 (top left). Mutations in the very C-terminus of the RecA2 domain (stretch 3) from S.c. to C.t. sequence result in a 
complete loss of LLPS (bottom middle and right). The chimeric ScA1-CtA2 protein still exhibits a small degree of phase 
separation under these conditions (top middle). (B) Phase diagrams of mutant Dhh1 helicase core proteins at 100 µM. The 
phase diagram of wild-type Dhh1 is shown as a reference (left). Within stretch 3, double mutation of an Ala-Ala dipeptide, 
which is engaged in augmentation of a β-sheet in the RecA2 domain, has no influence on LLPS of ScDhh1 (middle). Stretch 3 
also contains two Asp residues, whose double mutation to Pro is sufficient to abolish phase separation completely (right). 
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To test which of these two features are important for the LLPS of Dhh1, we created the double 
mutants ScDhh1 A407H, A408P (“AAtoHP”) and ScDhh1 D414P, D423P (“DDtoPP”) and tested their 
phase separation capability (Figure 4.6 B). The AAtoHP double mutant (bottom left) shows phase 
separation to the same extent as the wild-type ScDhh1 protein (top left), indicating that the differences 
in the β-sheet architecture are not important for the enhancement of LLPS. On the other hand, the 
DDtoPP double mutant is sufficient to abolish phase separation (bottom middle). This indicates that 
charge-charge interactions involving in the RecA2 domain are responsible for the phase separation of 
Dhh1. Importantly, these results demonstrate that few (in this case two) amino acid substitutions can 
have a drastic impact on the phase separation behavior of a protein.  
4.3.3 The unstructured extensions enhance LLPS of the Dhh1 helicase core 
As we have previously established that the IDR in S. pombe Edc3 is important for phase 
separation of this protein, we now speculate that the disordered N- and C-terminal extensions  
(NTE and CTE, respectively) of S. cerevisiae Dhh1 might enhance phase separation of the helicase core. 
To test that, we prepared Dhh1 constructs that either include or lack the NTE, CTE or both extensions 
and evaluated their LLPS behavior (Figure 4.7 A). The Dhh1 helicase core (ΔNC) shows only limited LLPS 
at 25 μM protein concentration (bottom right). For a Dhh1 construct comprising the NTE and the 
helicase core but lacking the longer CTE (Dhh1 ΔC), phase separation is slightly enhanced relative to 
the Dhh1 core (Figure 4.7 A, compare bottom left and right). A stronger enhancement of LLPS relative 
to the Dhh1 core was observed for a construct comprising the helicase core and the CTE (Dhh1 ΔN; 
Figure 4.7 A, compare top and bottom right). The highest degree of phase separation was observed 
for full-length Dhh1 (Figure 4.7 A, top left), where both extensions are present. Our results indicate 
that both the N- and the C-terminal extensions provide additional interactions between the Dhh1 
proteins, which results in a shift of the phase separation boundary towards higher salt concentrations 
and lower pH. The contribution of the CTE to LLPS of full-length Dhh1 is higher than that of the  
N-terminal extension, probably due to the pronounced prion-like nature of the CTE. These data are 
consistent with previous studies that also showed in vitro phase separation for full-length Dhh1164.  
4.3.1 ATP and RNA strongly enhance LLPS of full-length Dhh1 
The DEAD-box helicase Dhh1 is able to interact with nucleotides, including ATP323. 
Interestingly, in the presence of a 100-fold excess of ATP, phase separation of the full length Dhh1 
protein is strongly enhanced (Figure 4.7 B, compare top left and right). It should be noted that in our 
assays the turbidity is measured immediately after induction of LLPS.  
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Given the low intrinsic ATPase activity of Dhh1 in the absence of RNA323, the observed increase 
of LLPS in the presence of ATP is likely not due to ATP hydrolysis or consequential effects such as ADP 
binding. 
RNA is a key factor for the formation of cytoplasmic granules, such as processing bodies, and 
as such RNA has been shown to enhance in vitro LLPS150,151,252,342. In previous reports, poly(U) RNA has 
been shown to enhance the LLPS tendency of Dhh1152,164. Poly(U) RNA is a mixture of RNAs with 
undefined lengths up to a few thousand nucleotides. This inhomogeneity poses a difficulty when 
investigating the contributions from different interactions on the phase separation process of Dhh1. 
Therefore, we here make use of a well-defined in vitro transcribed RNA: an unstructured 30mer with 
a sequence composed of adenosine and guanosine nucleotides and a single uridine at position 15 
(30mer GA-RNA, see Table 4.2). Based on crystal structures of other DEAD-box RNA helicases in 
complex with RNA319–322,343–346, Dhh1 likely binds 6-10 nucleotides in a cleft that is formed in the closed 
conformation of the helicase core. The length of the RNA we used here was chosen such that at least 
two Dhh1 molecules can bind simultaneously to one RNA molecule, and thereby bridging of two Dhh1 
proteins via one RNA molecules is possible.  
In our LLPS assays, we added a two-fold molar excess of the 30mer GA-RNA to full-length Dhh1. 
Unexpectedly, we observed an “inversion” of the phase separation pattern relative to the full-length 
Dhh1 protein (Figure 4.7 B, compare left top and bottom).  
Figure 4.7: LLPS of the Dhh1 core is enhanced by the unstructured tails, ATP and RNA. (A) Phase separation diagrams for 
full-length (FL) Dhh1 as well as truncation constructs lacking either the N- (ΔN) or the C-terminus (ΔC) or both (ΔNC) at 25 μM 
protein concentration. The disordered tails enhance phase separation of the Dhh1 helicase core (ΔNC) indicated by the shift 
of the phase separation boundary towards lower pH and higher salt concentrations. (B) Phase diagram of 25 μM FL Dhh1 (top 
left) and in presence of a 100-fold excess of ATP (top right), a 2-fold excess of 30mer RNA (bottom left) or both ATP and RNA 
(bottom right). ATP enhances phase separation of Dhh1, while presence of RNA inverts the phase separation pattern.  
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For full-length Dhh1, we observe LLPS at high pH and low salt concentrations. In the presence 
of RNA, we observe strong phase separation at lower pH (6.5) and high salt concentrations, where the 
full-length protein displays no phase separation. The addition of ATP to the Dhh1:RNA complex lowers 
the LLPS boundary, without further changing the salt and pH preferences (Figure 4.7 B, compare 
bottom left and right). These results indicate that the Dhh1 protein exploits different phase separation 
mechanisms in the absence and presence of RNA.  
4.3.2 Binding of Edc3 or Pat1 disrupts phase separation of the Dhh1 core 
Dhh1 is tightly embedded in the mRNA degradation network (Figure 4.3 A) and we aimed to 
assess the effect of decapping factors on Dhh1 phase separation. Here, we focused on the Dhh1 
helicase core as the known interaction partners Pat1 and Edc3 bind in a mutually exclusive manner to 
the Dhh1 RecA2 domain105. The two conserved Dhh1-interaction motifs FG/WQ and FDF reside in the 
disordered Pat1 N-terminus and in the IDR of Edc3 (Figure 4.3 A). The Edc3 IDR additionally harbors a 
Dhh1-interacting FNK motif, which is not present in Pat1.   
To test the effect of Pat1 and Edc3 on Dhh1 LLPS, we reconstituted complexes of the Dhh1 
helicase core with peptides of either Edc3 (residues 86-125; Edc3_idr) or Pat1 (residues 5-79; Pat_N) 
(Figure 4.8). Remarkably, the presence of Pat1 or Edc3 almost completely abolishes the phase 
separation propensity of Dhh1 (Figure 4.9 A, compare middle and right panels with left panel). 
Interestingly, in the presence of Pat1, a strong phase separation at low pH and low salt is 
reproducibly observed. It remains unclear if this is due to an altered phase separation behavior of the 
Dhh1:Pat_N complex or if Pat_N dissociates from the complex with Dhh1 under the aforementioned 
conditions and starts to undergo homotypic phase separation. 
In summary, we have shown that the Dhh1 helicase core is able to undergo LLPS. We have 
identified two aspartate residues on the RecA2 domain that are important for LLPS. The phase 
separation behavior of Dhh1 is enhanced by the N- and C-terminal extensions, as well as by ATP and 
RNA. The interaction of Pat1 and Edc3 on the other hand diminish in vitro LLPS of Dhh1 in the absence 
of ATP and RNA. Structurally, the mechanism of this behavior is not clear, as Pat1 and Edc3 bind in a 
region that is remote from the important aspartate residues.  
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Figure 4.9: Binding of Pat1 and Edc3 peptides affects LLPS of the Dhh1 helicase core. (A) Phase diagrams of the Dhh1 helicase 
core (left), the Dhh1:Pat_N (middle) and the Dhh1:Edc3_idr (right) complex at 100 μM. Binding of Pat_N changes the phase 
separation pattern of the Dhh1 helicase core protein towards low pH and low salt, while binding of the Edc3 peptide almost 
completely abolishes phase separation. (B) LLPS experiments for the Dhh1:Edc3_idr complex at 4 °C reveal that there is 
residual phase separation at high pH and low salt. This indicates that binding of the Edc3_idr peptide significantly reduces 
phase separation but does not change the LLPS pattern observed for free Dhh1 protein.  
 
 
Figure 4.8: The Dhh1 helicase core forms stable complexes with Pat1 and Edc3 peptides. (A, B) Analytical gel filtration 
chromatograms of Edc3_idr (green), Pat_N (blue), Dhh1 helicase core (red) and complexes thereof, Dhh1:Edc3_idr (brown) 
and Dhh1:Pat_N (violet). Peak fractions of the complexes (VE of 11.6 and 10.8 mL for Dhh1:Edc3_idr and Dhh1:Pat_N, 
respectively) were concentrated and subjected again to analytical gel filtration (orange and magenta chromatograms). The 
Dhh1:Edc3_idr and Dhh1:Pat_N complexes are stable as the re-run complexes do not show significant amounts of the free 
peptides, which were used in excess for complex reconstitution. Black arrows indicate the shift in elution volume from free 
Dhh1 to Dhh1:Edc3_idr or Dhh1:Pat_N, respectively, indicative for the formation of stable complexes. (C) SDS-PAGE analysis 
of peak fractions from analytical gel filtration. The reconstituted complexes contain the Dhh1 helicase core protein and the 
Pat_N or Edc3_idr peptides. Note that the peptides do not run true-to-size and stain poorly.  
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4.3.3 In solution, the two RecA domains of Dhh1 tumble independently 
To gain structural insights into the molecular interactions within the phase-separated Dhh1 
protein, we turned to NMR. Recently, we demonstrated that solid-state NMR is suitable to study a 
matured, gel-like phase of the Edc3 protein from S. pombe (Damman R, Schütz S, et al., under revision; 
see CHAPTER 3). Here, we aim at applying solution-state NMR to study liquid droplets of the folded 
Dhh1 helicase core. Solution NMR studies on phase-separated proteins are still rare and mostly involve 
intrinsically disordered proteins only283,347,348. We applied methyl TROSY techniques, as these are well 
suited to study high-molecular weight assemblies in solution184. 
1H,13C-HMQC spectra of the ILVMA-labeled 45 kDa Dhh1 helicase core protein under non-
phase separating conditions (Figure 4.10) are of very high quality. This spectrum (black) overlays very 
well with the spectra of the isolated RecA1 and RecA2 domains (red and green, respectively). This 
indicates that both RecA domains tumble independently in the full-length protein. The previous finding 
that both domains do not interact in the absence of RNA and ATP is confirmed by the lack of chemical 
shift perturbations when the NMR-inactive RecA1 domain is added to the NMR-active RecA2 domain 
(Figure 4.11). Remarkably, in the crystal structure of apo Dhh1 extensive interdomain contacts were 
associated with a compact open conformation. Our results indicate that these contacts are released 
or absent in solution. 
Figure 4.10: The two RecA-like 
domains of Dhh1 tumble indepen-
dently in solution. Methyl TROSY 
spectra of ILVMA-labeled Dhh1 
(black), Dhh1 RecA1 (red) and Dhh1 
RecA2 (green). The black spectrum is, 
in good approximation, the sum of 
the red and the green spectrum, 
indicating that both RecA-like 
domains in the Dhh1 protein have 
limited contacts in solution. 
Resonance assignments by residue 
type can be approximated from the 
peak positions in the spectrum187 as 
indicated by the dashed rectangles. 
These boundaries are not exclusive, 
overlap of the respective regions and 
outliers can occur. However, absolute 
residue-type specific assignments are 
required to facilitate automated 
assignment procedures240.  
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4.3.4 Assignment of the Dhh1 methyl groups 
To assign the methyl resonances in the Dhh1 protein we took advantage of the divide-and-
conquer approach (see 1.4.4). Traditional assignment strategies based on backbone experiments 
turned out to be insensitive and the individual domains were thus assigned based on the MAGIC 
approach240. In this approach, methyl resonances are assigned based on an existing structural model 
and experimental NOEs240. To facilitate the assignment, we assigned the residue type of each methyl 
resonance in the Dhh1 RecA domains by preparing a set of protein samples that are methyl-labeled 
only in IMA or IMV residues (for RecA1) and IA or IV (for RecA2) (Figure 4.12). From these spectra, we 
conclude that all the expected Ile (16), Met (8) and Ala (14) as well as 26 of 28 Val resonances and most 
of the Leu methyl groups (47 of 54) can be detected in the RecA1 domain (Figure 4.12 A). For the RecA2 
domain, the expected 15 Ile, 2 Met, 12 Ala and 18 Val methyl groups as well as at least 35 out of 38 
expected Leu resonances are visible (Figure 4.12 B). 
  
Figure 4.11: The RecA-like domains of 
Dhh1 do not interact in solution. 
Methyl TROSY spectra of the IM-
labeled Dhh1 RecA2 domain in the 
absence (green) and presence 
(magenta) of a four-fold excess of 
unlabeled RecA1. The absence of clear 
CSPs indicates that both domains do 
not interact in trans under these 
conditions.  
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 The MAGIC-based methyl group assignment of the RecA1 domain was based on the crystal 
structure of the Dhh1 helicase core (pdb: 1s2m) and on HMQC-NOESY-HMQC data that was recorded 
with NOE mixing times of 40 and 300 ms. The two strongest methionine resonances in the RecA1 
methyl TROSY spectrum (Figure 4.13 A, dashed arrows) correspond to highly flexible residues. We thus 
assigned these to the N-terminal methionine M29, which originates from the cloning site, and to the 
C-terminal methionine M250, which is part of the short linker region between the two RecA-like 
domains. Accordingly, the strongest alanine resonance was assigned to the N-terminal alanine residue 
A28 (Figure 4.13 A, open arrow), which originates from the cloning site as well. During the automated 
assignment process these assignments were fixed. The MAGIC algorithm subsequently assigned all 
isoleucine (16), methionine (8) and alanine (14) resonances. For three out of the 26 visible valine 
resonances and eight out of the 47 visible leucine methyl groups an assignment was not possible.  
For the methyl resonance assignment of the Dhh1 RecA2 domain, HMQC-NOESY-HMQC 
experiments with NOE mixing times of 60 and 300 ms were recorded. This NMR data together with a 
crystal structure of the Dhh1 helicase core (pdb: 1s2m) provided the basis for the assignment process 
which was also based on the MAGIC algorithm.  
  
Figure 4.12: Residue type-specific assignment of the Dhh1 RecA-like domains. (A) Three methyl-labeled samples were 
prepared for the residue type-specific resonance assignment of the Dhh1 RecA1 domain: ILVMA (black), IMA (cyan) and IMV 
(magenta). Peaks colored in black only correspond to Leu methyl groups. Resonances in cyan and black correspond to Ala 
methyl groups, while overlays of magenta and black peaks correspond to Val methyl groups. Peaks appearing in black, cyan 
and magenta correspond to Ile and Met. Resonances of both residue types are distinguished by their location in the spectrum. 
Occurrence of Ile resonances in the typical Met region and vice versa is scarce. (B) Analogously to the RecA1 domain, ILVMA- 
(black), IA- (cyan) and IV-labeled samples (magenta) were prepared to assign methyl groups of the RecA2 domain in a residue 
type-specific manner. Resonances in cyan and black correspond to Ala residues and resonances in black and magenta 
resemble Val methyl groups. Overlays of cyan, magenta and black peaks correspond to Ile residues. Peaks appearing only in 
black correspond to either Met or Leu. Resonances of both residue types are easily distinguished by their location in the 
spectrum. Overlap of regions where Met and Leu resonances appear is not observed. 
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Figure 4.13: Methyl group assignment of the Dhh1 RecA1 domain obtained by the MAGIC algorithm. HMQC spectra of an 
(A) IMA-labeled sample and (B) a superposition of spectra obtained on IMV- (magenta) and ILVMA- (blue; for clarity, Ala 
resonances are in cyan) labeled samples. Assignments as obtained from MAGIC are indicated. The assignment was based on 
two HMQC-NOESY-HMQC experiments measured on an ILVMA-labeled sample with long and short NOE mixing times of  
300 and 40 ms, respectively, and a 2.1 Å crystal structure of the Dhh1 helicase core (pdb: 1s2m). Methyl groups of Ala, Ile 
and Met residues are assigned to 100%. The assignment of the two most intense methionine resonances (dashed arrows) 
and the most intense alanine resonance (open arrow) was fixed to the terminal residues A28, M29, M250. Resonances that 
were not assigned (NA) by MAGIC are indicated with gray labels and arrows. 
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The strongest alanine resonances in the RecA2 methyl TROSY spectrum (Figure 4.14 A, open 
arrow) corresponds to a highly flexible residue. We thus assigned it to the N-terminal alanine A249, 
which originates from the cloning site. Note that the cloning site-derived residues A28 and A249 in the 
RecA1 and RecA2 domain, respectively, resonate at the same frequency (1H: 1.33 ppm; 13C: 16.4 ppm; 
compare Figure 4.13 and Figure 4.14) as they are both part of the unstructured N-terminal  
GAM-tripeptide and thus have a very similar chemical environment. For a single Ala resonance, no NOE 
could be detected. We thus assigned it to the isolated A411 (Figure 4.14, dashed arrow), whose methyl 
group is separated by 8.6 Å from the closest methyl bearing amino acid. During the automated 
assignment process the assignments of A249 and A411 were fixed.  
  
Figure 4.14: Methyl resonance assignment of the Dhh1 RecA1 domain. Superposition of spectra obtained on IV- (magenta) 
and ILVMA- (blue) labeled samples. Assignments as obtained from MAGIC are indicated. The assignment was based on two 
HMQC-NOESY-HMQC experiments measured on an ILVMA-labeled sample with long and short NOE mixing times of  
300 and 60 ms, respectively, and a 2.1 Å crystal structure of the Dhh1 helicase core (pdb: 1s2m). Methyl groups of Ile, Met 
and Val residues are assigned to 100%. The assignment of the most intense alanine resonance (open arrow) and only alanine 
resonance for which no NOE could be detected (open arrow) was fixed to A249 and A411, respectively. Resonances that were 
not assigned (NA) or for which no unambiguous assignment could be obtained by MAGIC are indicated in gray.  
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All isoleucine (15), methionine (2) and valine (18) methyl groups have been assigned by MAGIC 
(Figure 4.14). For two out of the twelve alanine resonances an unambiguous assignment was not 
possible. These two resonances correspond to the A407 and A408 methyl groups, which are separated 
by 5.3 Å (Figure 4.15). Between these two methyl groups we could detect an NOE. However, the next 
closest methyl group (A263) is over 8 Å apart such that no NOE could be detected. Hence, the isolation 
of the two Ala methyl groups prevented the unambiguous assignment of the two corresponding 
resonances. Furthermore, 34 out of 35 visible leucine resonances (corresponding to 17 out of 19 
leucine residues) have been assigned (Figure 4.14).  
In Figure 4.15, the confidence of the computationally obtained assignments for the RecA1 
and RecA2 domains is indicated. Individual methyl groups are depicted as spheres and colored from 
red to blue according to the completeness (low to high) of the NOE assignment for the respective 
NOESY strip. Additionally, the methyl-methyl connections, depicted as dashed lines, as constructed by 
MAGIC are color-coded according to their confidence score from red (low) to blue (high). It is important 
to note that most resonances that were assigned by MAGIC are of the high confidence class. Not 
unexpectedly, isolated methyl groups were either not assigned (gray) or the confidence level was very 
low (red). 
Figure 4.15: Confidence of MAGIC assignments for the Dhh1 methyl groups. The Dhh1 helicase core is displayed in a cartoon 
representation with the RecA1 in dark gray and the RecA2 in light gray (pdb: 1s2m). The orientation is as in Figure 4.1 A. Each 
methyl group is displayed as a sphere with a color code ranging from red to blue representing the completeness (0 – 100 %) 
of the NOE assignment for the related NOESY strip. Methyl-methyl connections are depicted as dashed lines and are colored 
according to the confidence score of the peak-peak connection constructed by MAGIC. The color gradient ranges from red 
(confidence score of 0) to blue (confidence score ≥ 2). Unassigned methyl groups are depicted as grey spheres. No electron 
density is observed for residues preceding N46 and succeeding; this includes A28 and M29 as well as V40 and L41.  
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4.3.5 Residues in the RecA-like domains sense the phase-separated state 
To independently assess which residues are affected by the liquid-liquid phase separation 
process of the Dhh1 helicase core, we prepared NMR samples under non-phase separation and under 
phase separation conditions. In brief, we mixed ILVMA-labeled and unlabeled Dhh1 in a 1:3 molar ratio 
and concentrated the protein solution to 300 µM and induced phase separation by lowering the salt 
concentration. Methyl TROSY spectra of these samples were recorded immediately and compared with 
spectra obtained for ILVMA-labeled Dhh1 under non-phase separating conditions.  
An overlay of spectra obtained under non-phase separation and under phase separation 
conditions revealed small but significant CSPs for a subset of resonances (Figure 4.16). The 
corresponding residues are located both in the RecA1 and RecA2 domain. Assignments obtained with 
the MAGIC approach (see above) identified them as M59, M194 and A197 in the RecA1 domain. While 
M59 is solvent-exposed, M194 and A197 are located in the DEAD-motif that is involved in ATP-binding 
and hydrolysis (Figure 4.15, see also Figure 4.1). Additionally, I347 and L337 in the RecA2 domain are 
affected by LLPS of the Dhh1 helicase core protein. Future research will explore how these two buried 
residues (Figure 4.15) sense the protein-protein contacts that take place at the LLPS boundary.  
4.4 DISCUSSION 
We recently showed that a synergistic network of protein-protein and protein-RNA 
interactions in the mRNA degradation machinery results in the formation of in vitro processing bodies 
(P-bodies)252. This network effects the mRNA decapping activity of the Dcp1:Dcp2 complex as long 
mRNAs are protected against decapping under phase separation conditions. These findings supported 
the hypothesis that P-bodies function as mRNA storage compartments307,325,349,350. Dhh1 is a conserved 
DEAD-box helicase with high cellular abundance that is involved in mRNA decay and P-body formation. 
In vivo P-body formation can be reproduced in vitro in a liquid-liquid phase separation process103,252.  
In a previous study, Dhh1 was reported to undergo in vitro phase separation in a strictly ATP- 
and RNA-dependent manner164. Here, we establish that the isolated helicase core of Dhh1 undergoes 
LLPS at concentrations as low as 25 µM and in the absence of ATP and RNA. As many other systems, 
apo Dhh1 phase separates at low salt concentrations, indicative for a phase separation process that is 
dominated by charge-charge and cation-π interactions119. We also find that Dhh1 phase separation is 
promoted by high pH (in the range of 7.4 as compared to 6.0). Notably, the concentrations we used 
are higher by a factor of 10-30 compared with LLPS experiments that used full-length, mCherry-tagged 
Dhh1 in the presence of ATP and poly(U) RNA164.  
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Figure 4.16:  Residues in the RecA-like domains of Dhh1 sense the phase separated state. (A) Superposition of methyl TROSY 
spectra of Dhh1 under non-phase separation conditions (black) and after phase separation (red). A few resonances 
experience CSPs in the phase-separated state relative to the non-phase separated state. Regions containing such resonances 
are highlighted by boxes and are enlarged in the panels (B)-(E). Assignments of perturbed resonances are indicated. 
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These observations indicate that Dhh1 phase separation receives contributions from (1) the 
helicase core, (2) the N- and C-terminal extensions and (3) RNA and ATP. Additionally, the mCherry-tag 
used in the previous report164 might confer solubility and thereby increase the protein concentrations 
that are required to cross the phase boundary. 
Using the homologous C. thermophilum Dhh1 protein with different phase separation behavior 
as a toolbox, we identified the RecA2 domain to be the driving force for phase separation of  
S. cerevisiae Dhh1. Thereby, two aspartate residues in the C-terminus of the S. cerevisiae RecA2 
domain appeared to be essential for the phase separation process, as their mutation to prolines as in 
the C. thermophilum homolog abolished phase separation completely. These results demonstrate that 
even small changes in the amino acid sequence can have a drastic impact on the liquid-liquid phase 
separation behavior of a protein. Liquid droplets are highly dynamic entities, where subtle 
environmental changes or interference with the interaction network can rapidly influence the degree 
of LLPS.  
We extended our LLPS studies from the Dhh1 helicase core to constructs that include its 
terminal extensions. Phase separation is increased relative to the helicase core for Dhh1 constructs 
that harbor either one or both disordered terminal extensions, whereof full-length Dhh1 shows the 
highest degree of LLPS. The importance of the prion-like N- and C-terminal extensions for efficient in 
vitro LLPS of full-length Dhh1 agrees with in vivo studies, where the deletion of the C-terminal 
extension resulted in a three-fold reduction of P-body assembly relative to the wild-type protein146. 
Moreover, phase separation of full-length Dhh1 is enhanced in the presence of 2.5 mM ATP 
relative to the apo protein. Remarkably, ATP has been suggested as a general hydrotrope at 
physiological concentrations between 5 and 10 mM160. As such, ATP is thought to prevent the 
formation of liquid droplets, to promote their disassembly and to confer solubility for a high fraction 
of the human proteome160,162. Our results indicate that this property of ATP might not apply to all 
protein aggregates or phase separated assemblies. Future experiments will address the question if ATP 
also acts on Dhh1 LLPS as a general hydrotrope at concentrations between 5-10 mM. It has been 
suggested that ATP-binding and ATP-dependent RNA-binding to Dhh1 result in a conformational 
rearrangement of the two RecA-like domains318. The increase in Dhh1 phase separation that we 
observe in the presence of ATP might thus be due to a different orientation of both RecA-like domain, 
which facilitates intermolecular contacts.  
Dhh1 in isolation and Dhh1 in the presence of RNA undergo maximum phase separation under 
significantly different conditions. In the presence of RNA, we observe Dhh1 phase separation at high 
salt (75-100 mM) and low pH (6.0-6.5), while apo Dhh1 phase separates at low salt and high pH.  
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This argues for different molecular mechanisms that are responsible for Dhh1 phase 
separation in the free and in the RNA-bound form. Additionally, Dhh1 phase separation in the presence 
of RNA is higher relative to the apo form, indicative for an increase in intermolecular interactions in 
RNA-bound Dhh1. These results also clearly indicate the importance of performing phase separation 
assays in a two-dimensional grid of conditions, as drastic changes in the phase separation pattern 
cannot be detected if LLPS is monitored at a single condition. Conclusions that are drawn based on 
observations made for a single condition might thus be misleading. 
The molecular basis by with RNA enhances Dhh1 phase separation is not clear so far. RNA 
might use three potential binding sites on Dhh1 to enhance phase separation: First, the canonical RNA 
interaction surface that is found in many DEAD-box helicases, where single-stranded RNA induces a 
closure of the two RecA-like domains in an ATP-dependent manner319–322. The closed state is supported 
by the RNA binding site that runs across both domains on the surface of the helicase core. It is thus 
tempting to speculate that in our phase separation experiments the single-stranded 30mer RNA also 
binds to the canonical RNA binding surface and potentially closes both domains. This domain 
reorientation can result in enhanced intermolecular contacts which further enhance LLPS. Second, 
surface patches on the RecA2 domain that bind RNA have been identified105. Interestingly, these 
patched are also responsible for the interaction with Pat1 and Edc3 FG and FDF motifs. This suggests 
a mutually exclusive interaction of Dhh1 with RNA, Pat1 and Edc3105. We find that Pat1 or Edc3 reduced 
Dhh1 phase separation. The molecular mechanism by which this takes place is likely through inter-
ference with intermolecular contacts that are important for LLPS. Third, the disordered C-terminal 
extension of Dhh1 contains 13 aromatic residues (His, Phe and Tyr) which could potentially engage in 
π-π-interactions with the RNA bases. Further NMR-driven studies will explore which of the three 
putative RNA binding sites is able to bind RNA and which interactions contribute to LLPS of the 
Dhh1:RNA complex.  
To obtain residue specific information on the LLPS process of Dhh1 we here use methyl TROSY 
NMR techniques and show that a small number of methyl groups is involved in the initial process of 
LLPS. Based on initial assignments, these residues can be localized to both RecA domains, in agreement 
with the importance of both domains for LLPS. Future studies will reveal how these sites sense the 
phase-separated state and how they interact in detail to mediate LLPS.  
In summary, we here show that the Dhh1 protein exploits a large number of intermolecular 
interactions to induce LLPS. These interactions include the folded RecA domains, the disordered N- 
and C-terminal tails as well as contacts with RNA and ATP. Interestingly, the LLPS behavior of Dhh1 can 
be modulated by Edc3 and Pat1, showing that the formation of cellular mRNP foci is a result of multiple 
constructive and destructive interactions.   
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CHAPTER 5 Conclusion 
This thesis provides a rationale how several distinct inter- and intramolecular interactions, 
which on their own contribute only weakly to overall LLPS and do so only under non-physiological 
conditions, act together in an additive manner to mediate the formation of membrane-less organelles 
in a cellular setting. The presented results explicitly do not rule out the possibility that these 
interactions show cooperativity in vivo. 
Importantly, a high-throughput assay has been developed in this thesis that allows for the 
rapid, reliable and resource-efficient screening of hundreds of conditions for LLPS making use of 
robotic small-volume pipetting and turbidity measurements. 
Further, it has been demonstrated in this work that the same interactions that result in LLPS 
are preserved in and contribute to a second phase transition towards a more gel-like state. For the 
Edc3 protein, which is composed of disordered regions and well-folded domains, this maturation 
process is not associated with the formation of disease-related amyloid-like fibers that are frequently 
observed for phase-separating IDPs containing low-complexity regions or prion-like domains. These 
results indicate that interactions other than fibrillization can also contribute to the maturation of 
phase-separated liquid droplets. 
Additionally, it was shown here that the enzymatic activity for the Dcp2 decapping enzyme is 
reduced when the protein and the capped RNA are localized to liquid droplets compared to when they 
are free in solution. An important aspect for future research will be to determine how the ATPase 
activity of Dhh1 is modulated under phase separation conditions and if Dhh1 possesses helicase 
activity in liquid droplets. Based on these results it will be possible in the future to propose models 
how cellular phase separation effects the function and activity of enzymes within membrane-less 
organelles.  
In summary, this thesis contributes to the deeper understanding of the biological function of 
processing bodies and other cellular foci that form via liquid-liquid phase separation processes.    
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